candesartan has been researched along with angiotensin ii in 416 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 95 (22.84) | 18.2507 |
2000's | 233 (56.01) | 29.6817 |
2010's | 80 (19.23) | 24.3611 |
2020's | 8 (1.92) | 2.80 |
Authors | Studies |
---|---|
De Backer, JP; Fierens, FL; Fraeyman, N; Vanderheyden, PM; Vauquelin, G | 1 |
Åqvist, J; Gutiérrez-de-Terán, H; Hallberg, A; Sallander, J; Wallinder, C | 1 |
Bernhardt, G; Biselli, S; Buschauer, A; Cabrele, C; Einsiedel, J; Gmeiner, P; Hübner, H; Keller, M; Kuhn, KK; Mollereau, C; Svobodová, J; Vanderheyden, PM; Wifling, D | 1 |
Li, XC; Widdop, RE | 2 |
Fukuo, K; Inoue, T; Jiang, B; Koh, E; Morimoto, S; Nabata, T; Ogihara, T; Rakugi, H; Tomita, J | 1 |
Kawahara, Y; Nakayama, I; Okuda, M; Tsuda, T; Yokoyama, M | 1 |
Kadowaki, T; Katoh, Y; Komuro, I; Nagai, R; Tobe, K; Yamazaki, T; Yazaki, Y | 1 |
Ando, A; Fujibayashi, M; Fujiwara, Y; Imai, E; Kamada, T; Kaneko, T; Moriyama, T; Ueda, N; Xia, C | 1 |
Paulson, OB; Strandgaard, S; Vraamark, T; Waldemar, G | 1 |
Hiroi, Y; Komuro, I; Kudoh, S; Mizuno, T; Shiojima, I; Takano, H; Tobe, K; Ueki, K; Yamazaki, T; Zou, Y | 1 |
Düsing, R; Feltkamp, H; Flesch, M; Ko, Y; Sachinidis, A; Seul, C; Vetter, H | 1 |
Hoshijima, M; Kawahara, Y; Nakayama, I; Okuda, M; Yokoyama, M | 1 |
Gross, V; Lippoldt, A; Luft, FC; Schneider, W | 1 |
Baba, A; Hano, T; Mizukoshi, M; Nakamura, N; Nishio, I | 1 |
Higaki, J; Higashimori, K; Mikami, H; Ogihara, T; Rakugi, H; Shi, SJ | 1 |
Abe, Y; Aki, Y; He, H; Kimura, S; Kita, T; Tamaki, T; Tomohiro, A | 1 |
Eguchi, S; Hirata, Y; Kanno, K; Kano, H | 1 |
Habuchi, Y; Lu, LL; Morikawa, J; Yoshimura, M | 1 |
Inada, Y; Nishikawa, K; Noda, M; Ojima, M; Sanada, T; Shibouta, Y; Wada, T | 1 |
Inada, Y; Kohara, Y; Kubo, K; Naka, T; Nishikawa, K; Noda, M; Ojima, M; Sanada, T; Shibouta, Y; Wada, T | 2 |
Fukiyama, K; Matayoshi, R; Muratani, H; Sesoko, S; Takishita, S; Teruya, H | 1 |
Akimoto, Y; Aoki, H; Hirano, H; Karube, M; Koyama, N; Nagai, A; Nakamura, Y; Oda, T; Yoshimura, Y | 1 |
Hashimoto, S; Kawata, T; Koike, T | 1 |
Fukuda, N; Izumi, Y; Kanmatsuse, K; Kubo, A; Soma, M | 1 |
Düsing, R; el-Haschimi, K; Ko, Y; Sachinidis, A; Seul, C; Vetter, H | 1 |
Fujimoto, M; Hara, M; Itazaki, K; Itoh, N | 1 |
el-Haschimi, K; Epping, P; Ko, Y; Sachinidis, A; Seul, C; Vetter, H | 1 |
Hazon, N; Takei, Y; Tierney, M | 1 |
Inada, Y; Kubo, K; Nishikawa, K; Ojima, M; Sanada, T; Shibouta, Y; Wada, T | 1 |
Ito, M; Iwao, T; Nakagawa, M; Saikawa, T; Sakata, T; Takakura, T; Yasunaga, S; Yonemochi, H | 1 |
Inada, Y; Kanehara, H; Kurobe, Y; Miyazaki, M; Nishikawa, K; Song, K; Wada, T | 1 |
Aikawa, J; Fukazawa, M; Ishikawa, M; Moroi, M; Namiki, A; Yamaguchi, T | 1 |
Fukamizu, A; Hibi, K; Ishigami, T; Ishii, M; Kihara, M; Mizuno, K; Murakami, K; Nyui, N; Ochiai, H; Ohno, S; Tamura, K; Umemura, S; Yabana, M | 1 |
Miura, T; Nakano, A; Shimamoto, K; Suzuki, K; Ura, N | 1 |
Champion, HC; Kadowitz, PJ | 1 |
Abe, I; Fujii, K; Fujishima, M; Onaka, U | 1 |
Abe, K; Abe, M; Arima, S; Endo, Y; Ito, S; Ogawa, S; Omata, K; Takeuchi, K; Tsunoda, K; Yaoita, H | 1 |
Abe, K; Arima, S; Endo, Y; Ito, S; Omata, K; Takeuchi, K; Tsunoda, K; Yaoita, H | 1 |
Jin, D; Miyazaki, M; Oka, Y; Shiota, N; Song, K; Takai, S | 1 |
Higaki, J; Mikami, H; Moriguchi, A; Ogihara, T; Zhu, DN | 1 |
Champion, HC; Czapla, MA; Kadowitz, PJ | 1 |
Chen, X; Fogo, A; Ichikawa, I; Inagami, T; Matsusaka, T; Niimura, F; Nishimura, H; Okubo, S; Tsuchida, S; Utsunomiya, H | 1 |
Fukuda, K; Hori, S; Kodama, H; Makino, S; Ogawa, S; Pan, J; Sano, M; Takahashi, T | 1 |
Aikawa, R; Komuro, I; Kudoh, S; Nagai, R; Uozumi, H; Yamazaki, T; Yazaki, Y; Zou, Y | 1 |
Hamanaka, I; Harada, M; Ishikawa, M; Itoh, H; Kajiyama, N; Kamitani, S; Kuwahara, K; Masuda, I; Miyamoto, Y; Nakagawa, O; Nakao, K; Ogawa, E; Saito, Y; Takahashi, N | 1 |
Belz, GG; Breithaupt-Grögler, K; Butzer, R; Fuchs, B; Herrmann, V; Högemann, A; Magin, SG; Malerczyk, C; Mutschler, E; Roll, S; Voith, B | 1 |
Hibi, K; Ishigami, T; Ishii, M; Kihara, M; Nyui, N; Tamura, K; Toya, Y; Umemura, S | 1 |
Brilla, CG; Rupp, H; Scheer, C | 1 |
Baltatu, O; Buikema, H; Ganten, D; Nishimura, H; Urata, H | 1 |
Fujimura, A; Gotoh, E; Ishii, M; Iwamoto, T; Shionoiri, H; Sugimoto, K; Takasaki, I; Takizawa, T; Tokita, Y | 1 |
Abe, I; Fujishima, M; Kagiyama, S; Liu, Y; Matsumura, K; Tsuchihashi, T | 1 |
Nanbu, A; Nishimura, M; Ohtsuka, K; Sakamoto, M; Takahashi, H; Yoshimura, M | 1 |
Dendorfer, A; Dominiak, P; Raasch, W; Tempel, K | 2 |
Arai, K; Demura, H; Imaki, T; Kobayashi, M; Miyazaki, H; Naruse, K; Naruse, M; Seki, T; Tanabe, A; Yoshimoto, T | 1 |
Fujio, Y; Kishimoto, T; Kunisada, K; Matsui, H; Negoro, S; Oh, H; Tone, E; Yamauchi-Takihara, K | 1 |
De Backer, JP; Fierens, FL; Vanderheyden, PM; Vauquelin, G | 2 |
Ardaillou, R | 1 |
Ardaillou, R; Chansel, D; Chatziantoniou, C; Dussaule, JC | 1 |
Arendshorst, WJ; Iversen, BM | 1 |
Bivalacqua, TJ; Champion, HC; Kadowitz, PJ; Lambert, DG; McNamara, DB | 2 |
Bivalacqua, TJ; Champion, HC; Dalal, A; Kadowitz, PJ; Lambert, DG | 1 |
Cervenka, L; Navar, LG | 1 |
Arendshorst, WJ; Coffman, TM; Oliverio, MI; Purdy, KE; Ruan, X | 1 |
Demeilliers, B; Jover, B; Mimran, A | 1 |
Goligorsky, MS; Kornfeld, M; Moore, LC; Thorup, C | 1 |
Bell, PD; Peti-Peterdi, J | 1 |
Cervenka, L; Mitchell, KD; Navar, LG; Wang, CT | 1 |
Higaki, J; Moriguchi, K; Ogihara, T; Ohishi, M; Okamura, A; Rakugi, H; Suzuki, K; Takiuchi, S; Yanagitani, Y | 1 |
Akashi, K; Asayama, J; Kawahara, A; Keira, N; Kobara, M; Matoba, S; Nakagawa, M; Tatsumi, T | 1 |
Kawachi, H; Kimura, H; Nakamura, T; Obata, J; Ohno, S; Shimizu, F; Yoshida, Y | 1 |
Inada, M; Iwasaka, T; Maruyama, K; Masaki, H; Matsubara, H; Mori, Y; Moriguchi, Y; Murasawa, S; Sakamoto, K; Shibasaki, Y; Tanaka, Y; Tsutumi, Y | 1 |
Arendshorst, WJ; Brännström, K | 1 |
Yamazaki, T; Yazaki, Y | 1 |
De Backer, JP; Fierens, F; Vanderheyden, PM; Vauquelin, G | 1 |
Buter, H; de Jong, PE; de Zeeuw, D; Navis, GY; Woittiez, AJ | 1 |
Fujita, T; Ishigami, T; Iwamoto, T; Kihara, M; Kobayashi, S; Toya, Y; Umemura, S; Yabana, M | 1 |
Cervenka, L; Harrison-Bernard, LM; Imig, JD; Mitchell, KD; Navar, LG; Wang, CT | 1 |
Sharma, A; Singh, M | 1 |
Fukuda, N; Hu, WY; Izumi, Y; Kanmatsuse, K; Kishioka, H; Kubo, A; Satoh, C; Soma, M; Watanabe, Y | 1 |
Abrahamsson, T; Adler, G; Brandt-Eliasson, U; Karp, L; Morsing, P; Ohlson, K; Renberg, L; Sjöquist, PO | 1 |
Nishimura, Y; Saavedra, JM | 1 |
Kirk, JK | 1 |
Rydén, L; Shimizu, M; Sjöquist, PO; Wang, QD | 1 |
Garcha, RS; Hughes, AD; Sever, PS | 2 |
Inoue, K; Kawamura, K; Kubota, J; Nishimura, H | 1 |
Grohé, C; Löbbert, K; Stimpel, M; van Eickels, M; Vetter, H | 1 |
Kaplan, NM | 1 |
Sjöquist, PO; Wang, QD | 1 |
Imaizumi, A; Johns, EJ; Kohsaka, T; Nakamura, A; Yanagawa, Y | 1 |
Bivalacqua, TJ; Champion, HC; Dalal, A; Kadowitz, PJ | 1 |
van Veldhuisen, DJ; Voors, AA | 1 |
Ardaillou, R; Chansel, D; Llorens-Cortes, C; Vandermeersch, S | 1 |
Ichimori, Y; Noda, M; Tani, A | 1 |
Benedict, C; Bunt, AM; Conlin, PR; Ribeiro, AB; Saito, I; Spence, JD; Williams, B | 1 |
Ishii, K; Isobe, K; Kawakami, Y; Nakai, T; Nanmoku, T; Takekoshi, K | 1 |
Casado, S; Farré, J; Gómez, J; Jiménez, A; López-Blaya, A; López-Farré, A; Montón, M; Núñez, A; Sánchez de Miguel, L; Zalba, LR | 1 |
Arakawa, K; Gondo, N; Ideishi, M; Kumagai, K; Nakashima, H; Urata, H | 1 |
Howes, L; Wong, W | 1 |
El Dahr, SS; Majid, DS; Navar, LG; Omoro, SA | 1 |
Meredith, PA | 1 |
Inada, Y; Nishikawa, K; Ojima, M; Sanada, T; Shibouta, Y; Wada, T | 1 |
Chatziantoniou, C; Dussaule, JC; Fakhouri, F; Tharaux, PL | 1 |
Guo, DF; Inagami, T; Kimura, H; Naito, A; Nakamura, T; Obata, J; Shimizu, F; Takano, H; Yoshida, Y | 1 |
Bader, M; Baltatu, O; Caligiorne, SM; Campagnole-Santos, MJ; Fontes, MA; Ganten, D; Santos, RA | 1 |
Ito, T; Nishimura, Y; Saavedra, JM | 1 |
Bouchie, JL; Chen, HC; Clermont, AC; Feener, EP; Hampe, J; Izumo, S; Perez, AS | 1 |
Fukuda, N; Kanmatsuse, K; Kishioka, H; Kubo, A; Nakayama, M; Satoh, C; Teng, J | 1 |
Aneman, A; Ewert, S; Fändriks, L; Laesser, M; Pettersson, A | 1 |
Fierens, FL; Vanderheyden, PM; Vauquelin, G | 1 |
Badguet, JP; Mallion, JM | 1 |
Eto, T; Imamura, T; Kato, J; Kitamura, K; Koiwaya, Y; Matsuo, T; Onitsuka, H; Tsumori, Y; Yamakawa, H | 1 |
Bader, M; Böhm, M; Bricca, G; Ganten, D; Monti, J; Schinke, M | 1 |
Beppu, S; Ishikura, F; Kobayashi, H; Omura, T; Takeuchi, K; Yoshikawa, J; Yoshiyama, M | 1 |
De Backer, JP; Fierens, FL; Morsing, P; Vanderheyden, PM; Vauquelin, G | 1 |
Cerra, MC; Hazon, N; Takei, Y; Tierney, ML; Tota, B | 1 |
Baican, M; Coltau, M; Domuta, G; Gilau, L; Hecht, A; Pasca, R; Puscas, I | 1 |
Bader, M; Baltatu, O; Caligiorni, S; Campagnole-Santos, MJ; Fontes, MA; Ganten, D; Santos, RA | 1 |
Ardaillou, R; Chansel, D; Curat, C; Oko, A; Vandermeersch, S | 1 |
Vidt, DG | 1 |
Ramahi, TM | 1 |
De Backer, J; Fierensa, FL; Roggeman, C; Thekkumkara, TJ; Vanderheyden, PM; Vauquelin, G | 1 |
Ishibashi, T; Maruyama, Y; Nagata, K; Nakazato, K; Ohkawara, H; Sakamoto, T; Seino, Y; Teramoto, T; Yokoyama, K | 1 |
Eshima, K; Hirooka, Y; Shigematsu, H; Shihara, M; Tagawa, T; Takeshita, A | 1 |
Hauner, H; Lee, YM; Skurk, T | 1 |
Derebail, VK; Pollock, DM; Pollock, JS; Yamamoto, T | 1 |
Fujita, M; Fukai, M; Furukawa, H; Horiuchi, H; Ishikawa, H; Jin, MB; Magata, S; Masuko, H; Nagashima, K; Ogata, K; Shimamura, T; Suzuki, T; Taniguchi, M; Todo, S | 1 |
Berlowitz, MS; Colombo, PC; Ennezat, PV; Hankins, SR; Latif, F; Le Jemtel, TH; Moskowitz, R; Tandon, S | 1 |
Benedict, CR; Katagiri, T; Pakala, R; Watanabe, T | 1 |
McMurray, JJ | 1 |
Ishii, K; Isobe, K; Kawakami, Y; Nakai, T; Takekoshi, K | 1 |
Cervenka, L; Heller, J; Kramer, HJ; Malý, J | 1 |
Fukui, H; Ikenaka, Y; Kuriyama, S; Nakatani, T; Noguchi, R; Tsujinoue, H; Yoshii, J; Yoshiji, H | 1 |
Emoto, N; Fukuya, H; Ikeda, K; Nonaka, H; Okamura, H; Raharjo, SB; Rohman, MS; Yagita, K; Yokoyama, M | 1 |
Dechow, C; Haxsen, V; Lehrke, I; Morath, C; Peters, J; Ritz, E; Wagner, J; Waldherr, R | 1 |
Ishii, K; Isobe, K; Kawakami, Y; Nakai, T; Shibuya, S; Takekoshi, K | 2 |
Balt, JC; Mathy, MJ; Pfaffendorf, M; van Zwieten, PA | 1 |
Bell, PD; Kovács, G; Peti-Peterdi, J; Rosivall, L | 1 |
Fukuuchi, Y; Inoue, K; Kobari, M; Otomo, M; Takao, M; Tanahashi, N; Tomita, M; Tomita, Y; Yokoyama, M | 1 |
Benes, E; Hammond, TG; Imig, JD; Navar, LG; Orengo, S; Zhuo, JL | 1 |
Bartels, T; Dendorfer, A; Dominiak, P; Gieselberg, A; Raasch, W | 1 |
Hautala, N; Ruskoaho, H; Szokodi, I; Tenhunen, O | 1 |
Brunner, HR; Burnier, M; Centeno, C; Maillard, MP; Nussberger, J; Würzner, G | 1 |
Fisher, ND; Hollenberg, NK; Lansang, MC; Osei, SY; Price, DA | 1 |
Lippert, C; Mueck, AO; Seeger, H; Wallwiener, D | 1 |
Howes, L; Phoon, S; Tran, D | 1 |
Andersen, JL; Bie, P; Sandgaard, NC | 1 |
Belz, GG; Butzer, R; Kober, S; Mutschler, E | 1 |
Thurston, H | 1 |
Andersen, JL; Bie, P; Holstein-Rathlou, NH; Sandgaard, NC | 1 |
Bell, PD; Peti-Peterdi, J; Warnock, DG | 1 |
Honda, T; Kobayashi, N; Kobayashi, T; Matsuoka, H; Mita, S; Nakano, S; Tsubokou, Y | 1 |
Endoh, M; Ichiyanagi, O; Ishii, K | 1 |
Howes, LG; Phoon, S | 1 |
Fujii, S; Kato, S; Kubota, I; Miyamoto, T; Miyashita, T; Takahashi, H; Takeishi, Y; Tomoike, H; Yoshimura, T | 1 |
Durie, M; Levy, BI; Silvestre, JS; Tamarat, R | 1 |
Culman, J; Gohlke, P; Jürgensen, T; Kox, T; Rascher, W; Unger, T; von Kügelgen, S | 1 |
Balt, JC; Mathy, MJ; Nap, A; Pfaffendorf, M; van Zwieten, PA | 1 |
Bergström, G; Jia, J; Johansson, M; Lambert, G; Nyström, HC | 1 |
Böhm, M; Hilgers, S; Laufs, U; Nickenig, G; Wassmann, S | 1 |
Imuro, Y; Iwasaka, T; Izuoka, T; Kitashiro, S; Mimura, J; Miyoshi, H; Saito, D; Takayama, Y; Tokioka, M; Yamamoto, S | 1 |
He, G; Jing, T; Liu, J; Wang, G; Wang, H; Wu, H | 1 |
Ichihara, S; Iwase, M; Izawa, H; Nagasaka, T; Nagata, K; Nakashima, N; Obata, K; Odashima, M; Somura, F; Yamada, Y; Yokota, M | 1 |
Brunner, HR; Burnier, M; Centeno, C; Maillard, MP; Perregaux, C; Stangier, J; Wienen, W | 1 |
Bottari, S; De Backer, JP; Vanderheyden, PM; Vauquelin, G; Verheijen, I | 1 |
Hattori, Y; Jesmin, S; Kitabatake, A; Mowa, CN; Sakuma, I | 1 |
Andersson, OK; Elmfeldt, D; Friberg, PR; Fridman, KU; Wysocki, M | 1 |
Imai, M; Kawai, A; Kumagai, H; Matsuura, T; Onimaru, H; Oshima, N; Sakata, K; Saruta, T | 1 |
Holtz, J; Morawietz, H; Quinn, MT; Rueckschloss, U | 1 |
Coffman, TM; Cook, AK; Harrison-Bernard, LM; Oliverio, MI | 1 |
Edvinsson, L; Malmsjö, M; Pantev, E; Stenman, E; Wackenfors, A | 1 |
Fujimura, M; Hashimoto, T; Ishiura, Y; Kamio, Y; Kita, T; Myou, S; Nakao, S; Watanabe, K | 1 |
Bovim, G; Helde, G; Sand, T; Stovner, LJ; Tronvik, E | 1 |
deChâtel, R; Ilves, M; Kinnunen, P; Piuhola, J; Ruskoaho, H; Szokodi, I; Vuolteenaho, O | 1 |
Alvarez, A; Fernández-Calotti, P; Gamberale, R; Geffner, JR; Giordano, M; Nahmod, KA; Nahmod, V; Raiden, S; Salamone, G; Vermeulen, ME | 1 |
Chiba, S; Inada, Y; Nakane, T | 1 |
DiBona, GF | 1 |
Aslam, S; Blau, J; Chabrashvili, T; Karber, A; Kitiyakara, C; Welch, WJ; Wilcox, CS | 1 |
Matsuoka, S; Nagaoka, M; Okamoto, H; Shimazu, E; Takano, M; Yayama, K | 1 |
Itoh, T; Kajikuri, J; Mabuchi, Y; Suzuki, Y; Tada, T | 1 |
Boonstra, PW; Buikema, H; Lübeck, RH; van Buiten, A; van Gilst, WH; van Veldhuisen, DJ; Voors, AA; Wagenaar, LJ | 1 |
Head, GA; Mayorov, DN | 1 |
Ageloff, S; Beutler, KT; Brooks, HL; Fenton, RA; Knepper, MA; Masilamani, S; Nielsen, J; Packer, RK; Turban, S | 1 |
Ando, H; Armando, I; Baiardi, G; Bregonzio, C; Jezova, M; Saavedra, JM | 1 |
Nielsen, LR | 1 |
Boulanger, CM; Ebrahimian, T; Mathieu, E; Silvestre, JS | 1 |
Kinugawa, K; Nagai, R; Takahashi, T | 1 |
Alesse, E; Bravi, MC; Croce, G; Desideri, G; Ferri, C; Marinucci, MC; Santucci, A; Tucci, M | 1 |
Schieffer, B; Schmidt, B | 1 |
Cachofeiro, V; Cediel, E; de las Heras, N; González Pacheco, FR; Jiménez, J; Lahera, V; Oubina, MP; Sanz-Rosa, D; Vegazo, O | 1 |
Jandhyala, BS; Tallam, LS | 1 |
Fine, LG; Norman, JT; Singer, M; Stidwill, R | 1 |
DiBona, GF; Jones, SY | 1 |
Buikema, H; de Zeeuw, D; Gschwend, S; Henning, RH; Pinto, YM; van Gilst, WH | 1 |
Schiffrin, EL; Touyz, RM | 1 |
Adam, AG; Jaimes, EA; Raij, L; Zhou, MS | 1 |
Endoh, S; Hayashi, T; Kitaura, Y; Mori, T; Okabe, M; Shimomura, H; Sohmiya, K; Terasaki, F; Ukimura, A | 1 |
Navar, LG; Nishiyama, A; Seth, DM | 1 |
Dominiak, P; Häuser, W | 1 |
Abe, Y; Kimura, S; Nishiyama, A; Rahman, M; Shokoji, T; Zhang, GX | 1 |
Brunner, HR; Burnier, M; Chiclero, A; Chioléro, A; Maillard, M; Nussberger, J; Wuerzner, G | 1 |
Amiri, F; Banes, AK; Jenkins, J; Marrero, MB; Pollock, DM; Redd, H; Shaw, S | 1 |
Imaizumi, T; Kai, H; Koga, M; Kudo, H; Kuwahara, F; Tahara, N; Takemiya, K; Tokuda, K; Yamamoto, T; Yasukawa, H | 1 |
Cuspidi, C; Leonetti, G; Zanchetti, A | 1 |
Imaizumi, T; Kai, H; Kuwahara, F; Tokuda, K | 1 |
Edvinsson, L; Stenman, E | 1 |
Backer, JP; Tourlousse, D; Vanderheyden, PM; Vauquelin, G; Verheijen, I | 1 |
Anzai, T; Hashimoto, K; Himeno, H; Imai, K; Kawana, M; Kitakaze, M; Koretsune, Y; Maruyama, S; Masaoka, Y; Matsubara, H; Matsuoka, T; Miyao, Y; Miyatake, K; Miyauchi, T; Nakamura, Y; Nomura, F; Okamoto, H; Ozono, K; Sekiya, M; Shinohara, H; Shintani, U; Shiraki, T; Takaoka, H; Tsutamoto, T; Yasumura, Y; Yokoya, K; Yokoyama, H | 1 |
Critchley, J; Critchley, L; Ding, B; Fok, B; James, A; Thomas, GN; Tomlinson, B; Wang, D | 1 |
Agarwal, A; Fisher, ND; Hollenberg, NK; Laffel, LM; Lansang, MC; Price, DA; Stevanovic, R; Williams, GH | 1 |
Hara, Y; Imaki, T; Naruse, M; Nishikawa, T; Sato, A; Takano, K; Tanabe, A; Tsuchiya, K | 1 |
Lochard, N; Reudelhuber, TL; Silversides, DW; Thibault, G; Touyz, RM | 1 |
Bäcker, A; Bader, M; Cervenka, L; Ganten, D; Husková, Z; Kopkan, L; Kramer, HJ; Vanourková, Z | 1 |
Hauner, H; Skurk, T; van Harmelen, V | 1 |
Akazawa, H; Fujita, T; Fukamizu, A; Iiri, T; Iwanaga, K; Kihara, M; Komuro, I; Kudoh, S; Makita, N; Minamino, T; Nagai, T; Qin, Y; Sano, M; Takano, H; Tamura, K; Toko, H; Umemura, S; Zhu, W; Zou, Y | 1 |
Ahn, JY; Ahn, TH; Chung, WJ; Han, SH; Jin, DK; Kang, WC; Kim, HS; Koh, KK; Park, GS; Shin, EK | 1 |
Iigaya, K; Kumagai, H; Onami, T; Saruta, T; Takimoto, C | 1 |
Hayashi, K; Iwamoto, K; Kizawa, Y; Koike, K; Kusama, T; Murakami, H; Ohsawa, M; Ohuchi, N; Sano, M; Taniguchi, Y | 1 |
Ando, H; Jezova, M; Saavedra, JM; Zhou, J | 1 |
Harada, S; Kido, H; Morimoto, S; Nakagawa, M; Oguni, A; Sasaki, S; Takeda, K | 1 |
Harris, PJ; Hiranyachattada, S | 1 |
Ebinger, G; Fournié-Zaluski, MC; Michotte, Y; Sarre, S; Stragier, B; Vanderheyden, P; Vauquelin, G | 1 |
Bergmann, P; Biarent, D; Hubloue, I; Kerbaul, F; Leeman, M; Milani, GM; Naeije, R; Rondelet, B; Staroukine, M | 1 |
Boomsma, F; de Boer, RA; Flesch, M; Pinto, YM; Pokharel, S; Suurmeijer, AJ; van Gilst, WH; van Kampen, DA; van Veldhuisen, DJ | 1 |
Armando, I; Baiardi, G; Bregonzio, C; Saavedra, JM; Seltzer, A | 1 |
Chen, K; Joseph, J; Joseph, L; Li, D; Mehta, JL | 1 |
Biswas, P; Centracchio, J; Dworkin, LD; Gong, R; Roy, A; Tolbert, E; Yango, A | 1 |
Hakam, AC; Hussain, T | 1 |
Delles, C; Fleischmann, EH; John, S; Schmidt, BM; Schmieder, RE; Schneider, MP | 1 |
Ando, T; Itoh, M; Joh, T; Kuno, A; Masuda, K; Nakamura, S; Nomura, T; Ogawa, K; Ohara, H; Okamoto, T; Shirai, T; Tang, M; Yamada, T | 1 |
Bivol, LM; Iversen, BM; Vågnes, OB | 1 |
Ino, K; Kajiyama, H; Kikkawa, F; Mizutani, S; Nagasaka, T; Shibata, K; Suganuma, T | 1 |
Ioroi, T; Iwao, H; Izumi, Y; Izumiya, Y; Kim-Mitsuyama, S; Tanaka, T; Wanibuchi, H; Yamamoto, E; Zhan, Y | 1 |
Nagane, Y; Obara, D; Terayama, Y; Utsugisawa, K; Utsugisawa, T | 1 |
De Backer, JP; Hunyady, L; Le, MT; Vanderheyden, PM; Vauquelin, G | 1 |
Becker, BN; Chiriva-Internati, M; Djamali, A; Hullett, DA; Jacobson, LM; Muehrer, RJ; Sprague, J; Thekkumkara, TJ; Weidanz, JA; Wittman, V | 1 |
Battegay, E; Zeller, A | 1 |
Eppel, GA; Evans, RG; Rajapakse, NW; Sampson, AK | 1 |
Awayda, MS; Fuller, AJ; Gonzalez-Villalobos, R; Hauschild, BC; Imig, JD; Inscho, EW; Navar, LG | 1 |
Blum, WF; Hauner, H; Skurk, T; van Harmelen, V | 1 |
Iigaya, K; Kawai, A; Kumagai, H; Matsuura, T; Onami, T; Onimaru, H; Oshima, N; Sakata, K; Saruta, T; Sugaya, T | 1 |
Ohashi, H; Takagi, H | 1 |
Cervenka, L; Husková, Z; Kopkan, L; Kramer, HJ; Skaroupková, P; Thurmová, M; Vanourková, Z | 1 |
Mitchell, KD; Mullins, JJ | 1 |
Ebinger, G; Hristova, I; Michotte, Y; Sarre, S; Stragier, B | 1 |
De Matteo, R; Head, GA; Mayorov, DN | 1 |
Harris, PJ; Hiranyachattada, S; Saetew, S | 1 |
Ichikawa, S; Kurabayashi, M; Miya, Y; Sakamaki, T; Sumino, H | 1 |
Armando, I; Bregonzio, C; Juorio, A; Macova, M; Pavel, J; Saavedra, JM; Sanchez-Lemus, E | 1 |
Bargetto, J; Galaz, A; Jalil, JE; Lavandero, S; Ocaranza, MP; Pérez, A | 1 |
Gao, J; Gessner, R; Köttgen, E; Niessen, H; Ohlemeyer, C; Roos, D; Wu, S | 1 |
De Cavanagh, EM; Ferder, L; Fraga, CG; Inserra, F; Piotrkowski, B; Stella, I; Toblli, JE | 1 |
Akutsu, H; Iwa, Y; Kizawa, H; Kondoh, R; Nagane, Y; Terayama, Y; Tohgi, H; Utsugisawa, K | 1 |
Ahn, YB; Cha, BY; Hong, OK; Jeong, IK; Kim, JW; Kim, MJ; Ko, SH; Son, HY; Song, KH; Yoon, KH | 1 |
Edvinsson, L; Malmsjö, M; Nilsson, E; Vikman, P; Wackenfors, A | 1 |
Dendorfer, A; Dodt, C; Dominiak, P; Jöhren, O; Pahlke, F; Raasch, W; Voges, I; Wittmershaus, C | 1 |
Cazaubon, S; Couraud, PO; Deshayes, F; Nahmias, C | 1 |
Delgiacco, E; Dou, J; Ge, L; Imboden, H; Macova, M; Nishioku, T; Pavel, J; Saavedra, JM; Yu, ZX; Zhou, J | 1 |
Jin, D; Katayama, H; Kishi, K; Miyazaki, M; Muramatsu, M; Takai, S; Tamai, H | 1 |
Frische, S; Frøkiaer, J; Jensen, AM; Knepper, MA; Li, C; Nielsen, S; Nørregaard, R; Praetorius, HA | 1 |
Clinckers, R; De Bundel, D; Ebinger, G; Meurs, A; Michotte, Y; Sarre, S; Smolders, I; Stragier, B | 1 |
Beutler, KT; Fenton, RA; Knepper, MA; Masilamani, S; Morris, RG; Packer, RK; Turban, S | 1 |
Fukushima Kusano, K; Hisamatsu, K; Ishihara, K; Kajiya, M; Miura, A; Miura, D; Miura, R; Morita, H; Nagase, S; Nakamura, K; Ohe, T | 1 |
Hirase, T; Inoue, T; Node, K; Wang, D | 1 |
Arenas, IA; Armstrong, SJ; Davidge, ST; Xu, Y | 1 |
Date, T; Kawai, M; Mochizuki, S; Seki, S; Shimizu, M; Taniguchi, I; Taniguchi, M; Yoshida, S | 1 |
Bautista, R; Franco, M; Herrera-Acosta, J; Johnson, RJ; Martínez, F; Montoya, A; Nepomuceno, T; Rodríguez-Iturbe, B; Santamaría, J; Tapia, E | 1 |
Ito, S; Sugawara, A | 1 |
Bie, P; Gammelgaard, I; Wamberg, S | 1 |
Piuhola, J; Ruskoaho, H; Szokodi, I | 1 |
Cai, H; Oak, JH | 1 |
Heidland, A; Kanase, N; Lakner, U; Rutkowski, P; Schmid, U; Schupp, N; Stopper, H | 1 |
Casselbrant, A; Edebo, A; Fändriks, L; Helander, HF; Lönroth, H; Lundell, L; Vieth, M; Wennerblom, J | 1 |
Fukui, D; Imaizumi, T; Kai, H; Kudo, H; Kuwahara, F; Mori, T; Sugi, Y; Tahara, N; Takayama, N; Takemiya, K; Tokuda, K; Yasukawa, H | 1 |
Cao, TB; Li, ZB; Liu, DY; Ma, LQ; Wang, LJ; Zhang, LL; Zhang, YP; Zhu, ZM | 1 |
Dworkin, LD; Gong, R; Rifai, A; Tolbert, EM; Yu, C | 1 |
Amara, AB; Jackson, MJ; McArdle, F; Rustom, R; Shalamanova, L | 1 |
Eskild-Jensen, A; Frøkiaer, J; Nyengaard, JR; Olesen, P; Paulsen, LF; Pedersen, L; Wogensen, L | 1 |
Baker, KM; Bhat, VB; Kumar, R; Le, B; Singh, VP | 1 |
Benicky, J; Saavedra, JM | 1 |
Re, R | 1 |
Banes-Berceli, AK; Ketsawatsomkron, P; Marrero, MB; Ogbi, S; Patel, B; Pollock, DM | 1 |
Hunyady, L; Karip, E; Süpeki, K; Szidonya, L; Turu, G | 1 |
Murakami, M; Nakagiri, A; Sunamoto, M | 1 |
Akazawa, H; Komuro, I; Qin, Y; Yasuda, N; Zou, Y | 1 |
Buikema, H; Morshuis, WJ; Nickenig, G; Plokker, HW; van de Wal, RM; van der Harst, P; van Gilst, WH; van Veldhuisen, DJ; Voors, AA; Wagenaar, LJ; Wassmann, S | 1 |
Jaimes, EA; Pearse, DD; Puzis, L; Raij, L; Zhou, MS | 1 |
Carey, RM; Fournie-Zaluski, MC; Howell, NL; Kemp, BA; Padia, SH; Roques, BP | 1 |
Connors, SG; Mendonca, M; Palm, F; Welch, WJ; Wilcox, CS | 1 |
Baker, KM; Kumar, R; Singh, VP | 1 |
Ecelbarger, CM; Hu, X; Madala Halagappa, VK; Riazi, S; Tiwari, S | 1 |
Iorgulescu, JB; Jaimes, EA; Nigro, J; Pearse, DD; Puzis, L; Tian, RX | 1 |
Arnold, AC; Diz, DI; Ferrario, CM; Ganten, D; Sakima, A | 1 |
Fraser, HM; Hack, G; Herr, D; Konrad, R; Kreienberg, R; Rodewald, M; Wulff, C | 2 |
Jugdutt, BI; Konig, A; Liu, P; Moe, G | 1 |
Dohi, K; Ito, M; Kato, S; Nobori, T; Onishi, K; Takamura, T; Wada, H; Yamada, N; Yamanaka, T | 1 |
Hirafuji, M; Iizuka, K; Kawaguchi, H; Machida, T | 1 |
Hattori, A; Ishii, M; Ishiura, S; Kobayashi, H; Mizutani, S; Murohara, T; Numaguchi, Y; Tsujimoto, M; Wright, JW | 1 |
Baker, KM; Khode, R; Kumar, R; Le, B; Singh, VP | 1 |
Fukumoto, M; Ikeda, T; Ishizaki, E; Jin, D; Miyazaki, M; Oku, H; Sakaguchi, M; Sakonjo, H; Sugiyama, T; Takai, S | 1 |
Banday, AA; Lokhandwala, MF | 1 |
Bae, EH; Fenton, RA; Frøkiaer, J; Jensen, AM; Kim, SW; Nielsen, S; Nørregaard, R | 1 |
Hongo, S; Kanome, T; Miyazaki, A; Nishio, K; Takahashi, K; Watanabe, T | 1 |
Higashikuni, Y; Hirata, Y; Koibuchi, N; Kugiyama, K; Nagai, R; Nakamura, K; Nishimatsu, H; Sata, M | 1 |
Benicky, J; Murakami, Y; Pavel, J; Saavedra, JM; Sanchez-Lemus, E | 1 |
Bursell, SE; Chilcote, TJ; Clermont, AC; Feener, EP; Phipps, JA; Sinha, S | 1 |
Raij, L; Schulman, IH; Zhou, MS | 1 |
Ding, G; Jia, R; Lv, J; Yang, D; Zhu, J | 1 |
Afzal, R; Floras, J; McKelvie, RS; Rouleau, JL; White, M; Yusuf, S | 1 |
Horie, M; Matsuura, H; Omatsu-Kanbe, M; Toyoda, F; Zankov, DP | 1 |
Nyengaard, JR; Razga, Z | 1 |
Fujimura, T; Fujita, H; Fushida, S; Harada, S; Hirakawa, K; Kayahara, M; Kinami, S; Kinoshita, J; Ninomiya, I; Ohta, T; Yagi, Y; Yashiro, M | 1 |
Fujikake, T; Fujioka, K; Hanamoto, T; Ikeda, T; Ishizuka, T; Kajita, K; Mori, I; Morita, H; Nagano, I; Okada, H; Takahashi, Y; Uno, Y; Zhiliang, W | 1 |
He, G; He, Y; Jing, T; Liu, J; Miao, L; Srivenugopal, KS; Wang, H | 1 |
Homma, I; Iigaya, K; Kobayashi, Y; Minoura, Y; Onimaru, H | 1 |
Hayashi, T; Inoue, N; Jin, D; Katayama, H; Kitaura, Y; Miyazaki, M; Muramatsu, M; Takai, S; Tamai, H | 1 |
Higuchi, T; Horikoshi, H; Hosono, Y; Matsumoto, M; Nakanishi, T; Nakayama, M; Ohsuzu, F; Okada, M; Suzuki, K; Takada, K | 1 |
Anegawa, T; Hirooka, Y; Ikeda, A; Imaizumi, T; Kai, H; Kajimoto, H; Kato, S; Koga, M; Kudo, H; Mifune, H; Mori, T; Takayama, N; Yasuoka, S | 1 |
Frøkiaer, J; Jonassen, T; Kim, SW; Knepper, MA; Kwon, TH; Lütken, SC; Marples, D; Nielsen, S | 1 |
Casselbrant, A; Edebo, A; Fändriks, L; Hallersund, P; Helander, HF; Jönson, C; Spak, E | 1 |
Akie, Y; Aritomi, S; Nakamura, Y; Nakayama, A; Satoh, Y; Sugiyama, A; Takahara, A; Wagatsuma, H | 1 |
Albiston, AL; Chai, SY; Dupont, AG; Gembardt, F; Smolders, I; Vanderheyden, P; Walther, T; Yang, R | 1 |
Fujii, M; Horie, M; Kawahara, C; Nishiyama, K; Tsutamoto, T; Yamaji, M; Yamamoto, T | 1 |
Hitomi, H; Hosomi, N; Kobori, H; Kohno, M; Masugata, H; Murao, K; Nakano, D; Nishiyama, A; Pelisch, N; Ueno, M | 1 |
Baron-Menguy, C; Cousin, M; Custaud, MA; Dumont, O; Guihot, AL; Henrion, D; Loufrani, L; Subra, JF; Toutain, B; Vessières, E | 2 |
Gemici, B; Izgüt-Uysal, VN; Ongüt, G; Tan, R | 1 |
Arun, SN; Bollag, WB; George, MV; Olala, L; Parker, PM; Shapiro, BA | 1 |
Masuyama, T; Matsumoto, M; Naito, Y; Ohyanagi, M; Okuda, S; Sakoda, T; Tsujino, T | 1 |
Coffman, TM; Facemire, C; Jensen, BL; Kjaersgaard, G; Madsen, K; Marcussen, N; Pedersen, M | 1 |
Bi, J; Chappell, MC; Contag, SA; Rose, JC | 1 |
Ichihara, A; Itoh, H; Kinouchi, K; Kurauchi-Mito, A; Murohashi-Bokuda, K; Narita, T; Nishiyama, A; Sakoda, M; Saleem, MA; Suzuki, F | 1 |
Kumagai, K | 1 |
Gao, YJ; Lee, RM; Lu, C; Su, LY | 1 |
Azegami, T; Hayashi, K; Ishiguro, K; Itoh, H; Sakamaki, Y; Sasamura, H | 1 |
Briggs, JP; Chen, L; Chen, M; Eisner, C; Gomez, RA; Huang, Y; Kim, SM; Li, L; Mizel, D; Oppermann, M; Schnermann, J; Sequeira Lopez, ML; Weinstein, LS | 1 |
Apablaza, F; Chiong, M; Godoy, I; Gonzalez, L; Hernandez, C; Jalil, JE; Lavandero, S; Lopez, R; Moya, J; Novoa, U; Ocaranza, MP; Pinto, M; Varas, M; Verdejo, H | 1 |
Arsenault, J; Cabana, J; Escher, E; Guillemette, G; Lanthier, L; Lavigne, P; Leduc, R; Lehoux, J | 1 |
Abidin, N; Choudhury, R; Garratt, CJ; Hall, MC; Kirubakaran, S; Peters, NS | 1 |
Guerra, MJ; Labandeira-Garcia, JL; Lanciego, JL; Rodriguez-Perez, AI; Valenzuela, R; Villar-Cheda, B | 1 |
Fujii, Y; Iino, Y; Isayama, H; Kamimura, H; Kihara, K | 1 |
Navar, LG; Seth, DM; Shao, W | 1 |
Agrawal, AN; Axtell, R; Ding, Z; Ho, PP; Lanz, TV; Luo, J; Platten, M; Srinagesh, H; Steinman, L; Wyss-Coray, T; Zhang, H | 1 |
Aslam, S; Griendling, K; Luo, Z; Teerlink, T; Welch, WJ; Wilcox, CS | 1 |
Kobori, H; Milani, CJ; Mitchell, KD; Mullins, JJ | 1 |
Danser, AH; van den Heuvel, M; van Esch, JH | 1 |
Ecelbarger, CM; Jose, PA; Li, F; Wang, X | 1 |
Guerra, MJ; Labandeira-Garcia, JL; Rodriguez-Perez, AI; Valenzuela, R; Villar-Cheda, B | 1 |
Chrousos, GP; Katsilambros, N; Kouskouni, E; Margeli, A; Mastorakos, G; Papassotiriou, I; Pavlatou, MG; Tentolouris, N | 1 |
Derosa, G; Fogari, R; Lazzari, P; Mugellini, A; Salvadeo, SA; Santoro, T; Zoppi, A | 1 |
Fu, H; Hitomi, H; Hosomi, N; Liu, G; Masugata, H; Matsumoto, M; Murao, K; Nishiyama, A; Pelisch, N; Ueno, M | 1 |
Mitsuyama, S | 1 |
Bahner, U; Grupp, C; Heidland, A; Klassen, A; Rutkowski, P; Schupp, N; Sebeková, K; Stopper, H | 1 |
Allen, AM; Bassi, JK; Delbridge, LM; O'Callaghan, EL; Porrello, ER; Thomas, WG | 1 |
Derosa, G; Fogari, R; Lazzari, P; Maffioli, P; Mugellini, A; Zoppi, A | 1 |
Karnik, SS; Kiya, Y; Matsuo, Y; Miura, S; Saku, K | 1 |
Gonzalez, AA; Kobori, H; Liu, L; McCormack, M; Navar, LG; Prieto, MC; Seth, DM | 1 |
Hata, M; Sezai, A; Shiono, M; Soma, M; Unosawa, S; Wakui, S; Yoshitake, I | 1 |
Banday, AA; Javkhedkar, AA; Lokhandwala, MF | 1 |
Agazatian, D; Bailey, JL; Coffman, TM; Farley, DB; Hong, S; Inagami, T; Kim, YH; Le, T; Matthews, SW; Pech, V; Verlander, JW; Wall, SM; Weiner, ID; Whitehill, FM | 1 |
Fu, H; Hosomi, N; Itano, T; Kohno, M; Liu, G; Masugata, H; Matsumoto, M; Miki, T; Nakano, D; Nishiyama, A; Pelisch, N; Sueda, Y; Ueno, M | 1 |
Fukui, A; Hara, M; Murozono, Y; Nagano-Torigoe, Y; Nakagawa, M; Ooie, T; Saikawa, T; Shinohara, T; Takahashi, N; Taniguchi, Y; Teshima, Y; Thuc, LC; Wakisaka, O; Yoshimatsu, H; Yufu, K | 1 |
Baumann, M; Heemann, U; Hermans, JJ; Lutz, J; Rusai, K; Schmaderer, C | 1 |
Iwao, H; Izumi, Y; Kita, H; Osada-Oka, M; Sato, T; Yagi, S | 1 |
El-Dahr, SS; Khalili, A; Preston, G; Song, R; Yosypiv, IV | 1 |
Denton, KM; Eppel, GA; Evans, RG; Head, GA | 1 |
Gabor, A; Leenen, FH | 2 |
Goshima, H; Ishizuka, T; Ozawa, A; Watanabe, Y | 1 |
Kittikulsuth, W; Pollock, DM; Pollock, JS | 1 |
Bell, JF; Carey, RM; Howell, NL; Kemp, BA; Navar, LG; Padia, SH; Rottkamp, DM; Shao, W | 1 |
Axelsson, J; Oberg, CM; Rippe, A; Rippe, B | 1 |
Li, YF; Yin, G; Zhang, CL; Zhang, H; Zhu, WY | 1 |
Baile, G; Gambini, J; Gíménez, I; Llinas, MT; Reverte, V; Salazar, FJ; Tapia, A | 1 |
Goel, R; Hanif, K; Najmi, AK; Nath, C; Pachauri, SD; Rajasekar, N; Tota, S | 1 |
Bivona, BJ; de Garavilla, L; Ford, SM; Harrison-Bernard, LM; Kobori, H; Park, S; Xu, S | 1 |
Albino-Teixeira, A; Fasching, A; Morato, M; Palm, F; Patinha, D; Pinho, D | 1 |
Dufield, D; Graneto, M; Llinas, MT; Masferrer, JL; Radabaugh, M; Reverte, V; Saez, F; Salazar, F; Salazar, FJ; Zweifel, B | 1 |
Almeida, AP; Damasceno, DD; Drummond, LR; Ferreira, AJ; Lima, MP; Motta, DF; Natali, AJ; Pesquero, JL; Quintão-Junior, JF | 1 |
Idikio, H; Jugdutt, BI; Jugdutt, C; Menon, V; Palaniyappan, A; Uwiera, RR | 1 |
Chaston, DJ; Edwards, FR; Hill, CE; Howitt, L; Matthaei, KI; Sandow, SL | 1 |
Cortes, MA; Ferrer, EG; Islas, MS; Lezama, L; Merino, MG; Puyol, MR; Rojo, T; Williams, PA | 1 |
Horio, N; Iwata, S; Margolskee, RF; Ninomiya, Y; Ohkuri, T; Sanematsu, K; Shigemura, N; Yasumatsu, K; Yoshida, R | 1 |
Borrajo, A; Diaz-Ruiz, C; Guerra, MJ; Labandeira-Garcia, JL; Rodriguez-Perez, AI | 1 |
Harris, RA; Sullivan, JC; Zimmerman, MA | 1 |
Amann, K; Brand, S; Mandel, P; Schupp, N; Zimnol, A | 1 |
Bathgate-Siryk, A; Dabul, S; Jafferjee, M; Koch, WJ; Lymperopoulos, A; McDonald, P; Sturchler, E; Valero, TR | 1 |
Fan, F; Jiang, G; Liu, Z; Lu, Y; Shen, C; Tao, L; Tian, C; Wu, H | 1 |
Gyombolai, P; Hunyady, L; Szalai, B; Tóth, AD; Turu, G; Várnai, P | 1 |
Jöhren, O; Mildner, M; Müller-Fielitz, H; Raasch, W; Steckelings, M; Stölting, I | 1 |
Huang, J; Liu, X; Lu, L; Niu, Y; Wang, Y; Yu, C; Yu, Y; Zhao, L; Zhou, L | 1 |
Bornstein, SR; Brown, NF; Brunssen, C; Eisenhofer, G; Frenzel, A; Hofmann, A; Morawietz, H; Peitzsch, M; Weldon, SM; Willenberg, HS; Ziegler, CG | 1 |
Inagaki, Y; Kaneko, S; Kitano, T; Ohkura, SI; Okamoto, Y; Sugimoto, N; Takamura, M; Takashima, SI; Takuwa, N; Takuwa, Y; Usui, S; Wada, T; Yoshioka, K | 1 |
Bessaguet, F; Danigo, A; Demiot, C; Desmoulière, A; Magy, L; Sturtz, F | 1 |
Cechova, S; Chan, F; Dong, F; Kelley, MJ; Le, TH; Ruiz, P | 1 |
Cai, Y; Deng, H; Feng, Q; Li, Z; Qiu, S; Tian, W; Wang, X; Wang, Y; Wu, J | 1 |
Hu, G; Ito, O; Kohzuki, M; Miura, T; Muroya, Y; Ogawa, Y; Rong, R; Wang, W | 1 |
Bratlie, SO; Casselbrant, A; Edebo, A; Fändriks, L; Wallenius, V | 1 |
Dang, Z; Jia, Q; Li, L; Ma, K; Si, J; Tan, C; Zhang, A; Zhang, X | 1 |
Casselbrant, A; Edebo, A; Fändriks, L; Hallersund, P; Spak, E | 1 |
Bishop, NM; Cipolla, MJ; Li, Z; Lindner, DP | 1 |
Cartwright, JE; Dechend, R; Desoye, G; El-Heliebi, A; Fischer, C; Forstner, D; Gauster, M; Geisberger, S; Herse, F; Huppertz, B; Kollmann, M; Kroneis, T; Nonn, O; Pecks, U; Staff, AC; Stern, C; Sugulle, M; Thilaganathan, B; Wadsack, C; Whitley, GS | 1 |
Chen, JW; Jiang, Y; Liu, D; Murao, K; Sun, WP; Wang, LH; Xue, R; Zhang, GX | 1 |
Amann, K; Ditting, T; Hilgers, K; Hindermann, M; Ott, C; Rodionova, K; Schiffer, M; Schmieder, RE; Veelken, R | 1 |
Boily, M; Girouard, H; Li, L; Vallerand, D | 1 |
Ahmed, MA; Ali, FEM; Gad-Elrab, WM; Hassanein, EHM; Kamel, EO; Mohammedsaleh, ZM | 1 |
Fischer, C; Forstner, D; Gauster, M; Ghaffari-Tabrizi-Wizsy, N; Guettler, J; Juch, H; Kummer, D; Neuper, L; Nonn, O | 1 |
Huang, Q; Tian, S; Wu, T; Zheng, Y | 1 |
26 review(s) available for candesartan and angiotensin ii
Article | Year |
---|---|
Angiotensin II receptors.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Endothelium; Humans; Imidazoles; Kidney; Losartan; Peptide Fragments; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Tetrazoles | 1999 |
Mesangial AT1 receptors: expression, signaling, and regulation.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Binding, Competitive; Biphenyl Compounds; Cells, Cultured; Gene Expression Regulation; Glomerular Mesangium; Humans; Losartan; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Signal Transduction; Tetrazoles | 1999 |
Role of tissue angiotensin II in myocardial remodelling induced by mechanical stress.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Hydralazine; Hypertension; Myocardium; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Stress, Mechanical; Tetrazoles; Ventricular Remodeling | 1999 |
Intrarenal angiotensin II generation and renal effects of AT1 receptor blockade.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Glomerular Filtration Rate; Hypertension, Renovascular; Kidney; Natriuresis; Rats; Receptors, Angiotensin; Renal Circulation; Renin-Angiotensin System; Tetrazoles | 1999 |
Angiotensin and cerebral blood flow.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Cerebrovascular Circulation; Cerebrovascular Disorders; Homeostasis; Humans; Hypertension; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Angiotensin; Tetrazoles | 1999 |
Angiotensin-II receptor antagonists: their place in therapy.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Clinical Trials as Topic; Drug Administration Schedule; Drug Interactions; Heart Failure; Humans; Hypertension; Irbesartan; Losartan; Renin-Angiotensin System; Telmisartan; Tetrazoles; Valine; Valsartan | 1999 |
Angiotensin II receptor antagonists in the treatment of hypertension.
Topics: Algorithms; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Humans; Hypertension; Irbesartan; Losartan; Receptors, Angiotensin; Telmisartan; Tetrazoles; Valine; Valsartan | 1999 |
Angiotensin II antagonists for hypertension: are there differences in efficacy?
Topics: Angiotensin II; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Humans; Hypertension; Irbesartan; Losartan; Randomized Controlled Trials as Topic; Tetrazoles; Valine; Valsartan | 2000 |
Angiotensin receptor antagonists.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Humans; Hypertension; Irbesartan; Losartan; Telmisartan; Tetrazoles | 2000 |
Putting the efficacy of candesartan cilexetil into perspective: a review of new comparative data.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cattle; Cerebellum; Circadian Rhythm; Female; Heart; Humans; Hypertension; In Vitro Techniques; Irbesartan; Kinetics; Losartan; Male; Middle Aged; Prodrugs; Rabbits; Randomized Controlled Trials as Topic; Receptors, Angiotensin; Renin; Tetrazoles; Time Factors | 2000 |
Expanded role for ARBs in cardiovascular and renal disease? Recent observations have far-reaching implications.
Topics: Acrylates; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Biological Availability; Biphenyl Compounds; Cardiovascular Diseases; Humans; Imidazoles; Irbesartan; Kidney Diseases; Losartan; Metabolic Clearance Rate; Patient Selection; Renin-Angiotensin System; Telmisartan; Tetrazoles; Thiophenes; Treatment Outcome; Valine; Valsartan | 2001 |
Angiotensin receptor blockers for chronic heart failure and acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Drug Therapy, Combination; Heart Failure; Humans; Losartan; Models, Cardiovascular; Myocardial Infarction; Randomized Controlled Trials as Topic; Tetrazoles | 2001 |
Dual angiotensin II blockade: a promise of enhanced renal protection?
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Drug Synergism; Humans; Hypertension; Kidney Diseases; Proteinuria; Receptor, Angiotensin, Type 1; Tetrazoles | 2002 |
Central angiotensin modulation of baroreflex control of renal sympathetic nerve activity in the rat: influence of dietary sodium.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Baroreflex; Benzimidazoles; Bicuculline; Biphenyl Compounds; Blood Pressure; Brain; Cerebral Ventricles; Kidney; Losartan; Medulla Oblongata; Paraventricular Hypothalamic Nucleus; Rats; Renin; Renin-Angiotensin System; Sodium, Dietary; Sympathetic Nervous System; Tetrazoles | 2003 |
[Treatment for diastolic failure].
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin Receptor Antagonists; Benzimidazoles; Biphenyl Compounds; Calcium Channel Blockers; Diastole; Heart Failure; Humans; Losartan; Practice Guidelines as Topic; Receptor, Angiotensin, Type 1; Tetrazoles | 2003 |
Angiotensin II AT1 receptor antagonists. Clinical implications of active metabolites.
Topics: Acrylates; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Growth Hormone; Humans; Hypertension; Imidazoles; Irbesartan; Losartan; Models, Molecular; Receptor, Angiotensin, Type 1; Tetrazoles; Thiophenes; Thromboxane A2 | 2003 |
Multiple actions of angiotensin II in hypertension: benefits of AT1 receptor blockade.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Fibrinolysis; Humans; Hypertension; Inflammation; Inflammation Mediators; Oxidative Stress; Reactive Oxygen Species; Tetrazoles | 2003 |
Left ventricular hypertrophy regression with antihypertensive treatment: focus on Candesartan.
Topics: Angiotensin II; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Electrocardiography; Humans; Hypertrophy, Left Ventricular; Renin-Angiotensin System; Tetrazoles; Treatment Outcome | 2003 |
[Organ protection by angiotensin II receptor blockers].
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Cognition Disorders; Heart Failure; Humans; Hypertension; Kidney Diseases; Losartan; Membrane Proteins; Mineralocorticoid Receptor Antagonists; Proteins; Proteinuria; Randomized Controlled Trials as Topic; Stroke; Tetrazoles | 2004 |
[Angiotensin II receptor blockers--evidence along the cardiovascular continuum].
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Albuminuria; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dogs; Drug Therapy, Combination; Female; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Myocardial Infarction; Placebos; Rabbits; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Risk Factors; Stroke; Tetrazoles; Time Factors | 2005 |
[The Diabetic Retinopathy Candesartan Trials (DIRECT) programme].
Topics: Albuminuria; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Diabetic Retinopathy; Humans; Hypertension; Randomized Controlled Trials as Topic; Receptors, Vascular Endothelial Growth Factor; Renin-Angiotensin System; Retina; Risk Factors; Tetrazoles; Vascular Endothelial Growth Factor A | 2005 |
[Endothelin-1, angiotensin II and cancer].
Topics: Angiogenesis Inhibitors; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Antineoplastic Agents; Benzimidazoles; Biphenyl Compounds; Clinical Trials as Topic; Endothelin-1; Humans; Neoplasm Invasiveness; Neoplasms; Neovascularization, Pathologic; Receptors, Angiotensin; Receptors, Endothelin; Tetrazoles | 2006 |
[Stimulatory effects of angiotensin II on angiogenesis].
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Diabetic Retinopathy; Humans; Neoplasms; Neovascularization, Pathologic; Neovascularization, Physiologic; Tetrazoles; Vascular Endothelial Growth Factor A | 2006 |
Brain and peripheral angiotensin II play a major role in stress.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Brain; Cold Temperature; Corticotropin-Releasing Hormone; Gastritis; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Restraint, Physical; Stress, Physiological; Tetrazoles | 2007 |
A novel mechanism of mechanical stress-induced angiotensin II type 1-receptor activation without the involvement of angiotensin II.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Cardiomegaly; Drug Inverse Agonism; Extracellular Signal-Regulated MAP Kinases; Humans; Receptor, Angiotensin, Type 1; Stress, Mechanical; Tetrazoles | 2008 |
[Upstream approach for atrial fibrillation].
Topics: Amiodarone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Fibrillation; Benzimidazoles; Biphenyl Compounds; Drug Therapy, Combination; Humans; Irbesartan; Tetrazoles | 2010 |
26 trial(s) available for candesartan and angiotensin ii
Article | Year |
---|---|
Angiotensin II antagonism and plasma radioreceptor-kinetics of candesartan in man.
Topics: Administration, Oral; Adult; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Humans; Male; Prodrugs; Rats; Receptors, Angiotensin; Tetrazoles | 1998 |
Pharmacokinetics and pharmacodynamics of candesartan cilexetil in patients with normal to severely impaired renal function.
Topics: Adult; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Female; Humans; Hypertension; Kidney; Kidney Diseases; Male; Middle Aged; Prodrugs; Renin; Tetrazoles | 1999 |
Dose-dependent blockade of the angiotensin II type 1 receptor with losartan in normal volunteers.
Topics: Adult; Analysis of Variance; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Dose-Response Relationship, Drug; Female; Humans; Losartan; Male; Middle Aged; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Tetrazoles; Vasoconstrictor Agents | 2001 |
Comparative angiotensin II receptor blockade in healthy volunteers: the importance of dosing.
Topics: Adult; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Cross-Over Studies; Dose-Response Relationship, Drug; Humans; Irbesartan; Losartan; Male; Renin; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan | 2002 |
The effects of candesartan on vascular responses to angiotensin II and norepinephrine in normal volunteers.
Topics: Adult; Angiotensin II; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Blood Vessels; Brachial Artery; Cross-Over Studies; Double-Blind Method; Female; Forearm; Humans; Injections, Intra-Arterial; Injections, Intravenous; Male; Norepinephrine; Reference Values; Regional Blood Flow; Tetrazoles; Time Factors; Vasoconstrictor Agents | 2001 |
Pharmacodynamic studies on the angiotensin II type 1 antagonists irbesartan and candesartan based on angiotensin II dose response in humans.
Topics: Adult; Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Half-Life; Humans; Irbesartan; Male; Radioligand Assay; Receptor, Angiotensin, Type 1; Renin; Tetrazoles | 2002 |
Forearm vasodilator response to angiotensin II in elderly women receiving candesartan: role of AT(2)- receptors.
Topics: Aged; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Cross-Over Studies; Double-Blind Method; Female; Forearm; Humans; Imidazoles; Middle Aged; Pyridines; Receptor, Angiotensin, Type 1; Regional Blood Flow; Tetrazoles; Vascular Resistance; Vasoconstrictor Agents; Vasodilation | 2002 |
Angiotensin II type 1 receptor antagonism improves hypercholesterolemia-associated endothelial dysfunction.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Biomarkers; Biphenyl Compounds; Blood Pressure; Calcium Channel Blockers; Cholesterol, LDL; Double-Blind Method; Endothelium, Vascular; Felodipine; Female; Forearm; Humans; Hypercholesterolemia; Inflammation; Male; Middle Aged; Prospective Studies; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Regional Blood Flow; Tetrazoles | 2002 |
Influence of AT1 receptor blockade on blood pressure, renal haemodynamics and hormonal responses to intravenous angiotensin II infusion in hypertensive patients.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Female; Hemodynamics; Humans; Hypertension; Infusions, Intravenous; Losartan; Male; Middle Aged; Receptor, Angiotensin, Type 1; Renal Circulation; Renin; Tetrazoles; Valine; Valsartan | 2002 |
Effect of candesartan, a type 1 angiotensin II receptor antagonist, on bronchial hyper-responsiveness to methacholine in patients with bronchial asthma.
Topics: Administration, Inhalation; Adult; Aged; Angiotensin II; Angiotensin Receptor Antagonists; Asthma; Benzimidazoles; Biphenyl Compounds; Bronchi; Bronchoconstrictor Agents; Cross-Over Studies; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Male; Methacholine Chloride; Middle Aged; Tetrazoles | 2002 |
Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial.
Topics: Adult; Angiotensin II; Angiotensin Receptor Antagonists; Benzimidazoles; Biphenyl Compounds; Cross-Over Studies; Double-Blind Method; Humans; Middle Aged; Migraine Disorders; Severity of Illness Index; Tetrazoles; Treatment Outcome | 2003 |
Angiotensin II receptor blockade prevents acute renal sodium retention induced by low levels of orthostatic stress.
Topics: Acute Disease; Adult; Angiotensin II; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cross-Over Studies; Heart Rate; Humans; Hypotension, Orthostatic; Kidney Tubules; Lower Body Negative Pressure; Male; Natriuresis; Sodium; Tetrazoles | 2004 |
Rationale for the use of combination angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker therapy in heart failure.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Drug Synergism; Drug Therapy, Combination; Exercise Tolerance; Female; Heart Failure; Heart Function Tests; Humans; Losartan; Male; Middle Aged; Natriuretic Peptide, Brain; Receptors, Angiotensin; Renin; Tetrazoles; Valine; Valsartan | 2004 |
Comparison of effects of losartan, irbesartan, and candesartan on flow-mediated brachial artery dilation and on inflammatory and thrombolytic markers in patients with systemic hypertension.
Topics: Angiotensin II; Antihypertensive Agents; Benzimidazoles; Biomarkers; Biphenyl Compounds; Brachial Artery; Double-Blind Method; Female; Humans; Hypertension; Irbesartan; Losartan; Male; Middle Aged; Tetrazoles; Vasodilation | 2004 |
The effect of statins on angiotensin II-induced hemodynamic changes in young, mildly hypercholesterolemic men.
Topics: Adolescent; Adult; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biomarkers; Biphenyl Compounds; Blood Pressure; Cholesterol, HDL; Cholesterol, LDL; Cross-Over Studies; Dose-Response Relationship, Drug; Heart Rate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Pyridines; Severity of Illness Index; Tetrazoles; Triglycerides; Vascular Resistance; Vasoconstrictor Agents | 2004 |
Angiotensin II plays an important role in maintaining blood pressure in postmenopausal women receiving hormone replacement therapy.
Topics: Administration, Oral; Aldosterone; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Biomarkers; Biphenyl Compounds; Blood Pressure; Bradykinin; Drug Therapy, Combination; Epinephrine; Estrogens; Female; Heart Rate; Hormone Replacement Therapy; Humans; Middle Aged; Norepinephrine; Peptidyl-Dipeptidase A; Postmenopause; Renin; Tetrazoles; Treatment Outcome | 2005 |
Effects of spironolactone during an angiotensin II receptor blocker treatment on the left ventricular mass reduction in hypertensive patients with concentric left ventricular hypertrophy.
Topics: Aged; Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Echocardiography; Female; Heart Ventricles; Hemodynamics; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Natriuretic Peptide, Brain; Spironolactone; Tetrazoles; Ventricular Remodeling | 2006 |
Actions by angiotensin II on esophageal contractility in humans.
Topics: Aged; Aged, 80 and over; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Benzimidazoles; Biphenyl Compounds; Esophageal Sphincter, Lower; Esophagus; Female; Gene Expression; Humans; In Vitro Techniques; Male; Manometry; Middle Aged; Muscle Contraction; Peptidyl-Dipeptidase A; Peristalsis; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin; Tetrazoles; Vasoconstrictor Agents | 2007 |
Exaggerated hypertensive response to exercise in patients with diastolic heart failure.
Topics: Aged; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Echocardiography; Exercise; Exercise Test; Female; Heart Failure, Diastolic; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Quality of Life; Tetrazoles; Treatment Outcome | 2008 |
Effects of enalapril, candesartan or both on neurohumoral activation and LV volumes and function in patients with heart failure not treated with a beta-blocker.
Topics: Aged; Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Double-Blind Method; Drug Therapy, Combination; Enalapril; Endothelin-1; Female; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Norepinephrine; Peptide Fragments; Radionuclide Angiography; Stroke Volume; Tetrazoles; Treatment Outcome; Ventricular Function, Left | 2009 |
Comparison of the long-term effects of candesartan and olmesartan on plasma angiotensin II and left ventricular mass index in patients with hypertension.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Imidazoles; Male; Middle Aged; Natriuretic Peptide, Brain; Peptidyl-Dipeptidase A; Tetrazoles | 2010 |
Fibrinolysis and insulin sensitivity in imidapril and candesartan (FISIC study) recipients with hypertension.
Topics: Adolescent; Adult; Aged; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Endothelium, Vascular; Female; Fibrinolysis; Humans; Hypertension; Imidazolidines; Insulin Resistance; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Prospective Studies; Signal Transduction; Single-Blind Method; Tetrazoles; Tissue Plasminogen Activator; Treatment Outcome; Young Adult | 2011 |
Role of angiotensin II in plasma PAI-1 changes induced by imidapril or candesartan in hypertensive patients with metabolic syndrome.
Topics: Adolescent; Adult; Aged; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Blood Glucose; Blood Pressure; Body Mass Index; Cholesterol; Cholesterol, HDL; Female; Humans; Hypertension; Imidazolidines; Insulin; Male; Metabolic Syndrome; Middle Aged; Plasminogen Activator Inhibitor 1; Tetrazoles; Triglycerides; Young Adult | 2011 |
Effects of olmesartan on the renin-angiotensin-aldosterone system for patients with essential hypertension after cardiac surgery--investigation using a candesartan change-over study.
Topics: Aged; Aldosterone; Analysis of Variance; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Arteries; Benzimidazoles; Biphenyl Compounds; Cardiac Surgical Procedures; Compliance; Drug Substitution; Female; Hemodynamics; Humans; Hypertension; Hypertrophy, Left Ventricular; Imidazoles; Japan; Male; Middle Aged; Prospective Studies; Renin; Renin-Angiotensin System; Tetrazoles; Time Factors; Treatment Outcome | 2011 |
Proteomic Approach to the Potential Role of Angiotensin II in Barrett Dysplasia.
Topics: Adult; Aged; Angiotensin II; Barrett Esophagus; Benzimidazoles; Biopsy; Biphenyl Compounds; Enalapril; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Neoplasm Proteins; Proteomics; Tetrazoles | 2019 |
The human duodenal mucosa harbors all components for a local renin angiotensin system.
Topics: Adult; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Duodenum; Female; Gastrointestinal Motility; Humans; Intestinal Mucosa; Losartan; Male; Middle Aged; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin; Renin-Angiotensin System; Tetrazoles; Young Adult | 2019 |
364 other study(ies) available for candesartan and angiotensin ii
Article | Year |
---|---|
Distinction between surmountable and insurmountable selective AT1 receptor antagonists by use of CHO-K1 cells expressing human angiotensin II AT1 receptors.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Cattle; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Humans; Inositol Phosphates; Receptors, Angiotensin; Recombinant Proteins; Tetrazoles; Transfection | 1999 |
Structural determinants of subtype selectivity and functional activity of angiotensin II receptors.
Topics: Amino Acid Sequence; Angiotensin II Type 1 Receptor Blockers; Binding Sites; Ligands; Molecular Docking Simulation; Protein Binding; Protein Structure, Tertiary; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Sequence Alignment | 2016 |
Mimicking of Arginine by Functionalized N(ω)-Carbamoylated Arginine As a New Broadly Applicable Approach to Labeled Bioactive Peptides: High Affinity Angiotensin, Neuropeptide Y, Neuropeptide FF, and Neurotensin Receptor Ligands As Examples.
Topics: Angiotensin II; Arginine; Cells, Cultured; Dose-Response Relationship, Drug; Humans; Ligands; Molecular Structure; Neuropeptide Y; Neurotensin; Oligopeptides; Peptide Fragments; Receptors, Angiotensin; Receptors, Neuropeptide; Receptors, Neurotensin; Structure-Activity Relationship | 2016 |
Regional hemodynamic effects of the AT1 receptor antagonist CV-11974 in conscious renal hypertensive rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Consciousness; Hemodynamics; Hypertension, Renal; Laser-Doppler Flowmetry; Male; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Tetrazoles; Vasodilation | 1995 |
Effects of an angiotensin II receptor antagonist, CV-11974, on angiotensin II-induced increases in cytosolic free calcium concentration, hyperplasia, and hypertrophy of cultured vascular smooth muscle cells.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta, Thoracic; Benzimidazoles; Biphenyl Compounds; Calcium; Cells, Cultured; Cytosol; Dinoprost; DNA; Fura-2; Hyperplasia; Hypertrophy; Ionomycin; Muscle Proteins; Muscle, Smooth, Vascular; Rats; Rats, Wistar; Tetrazoles | 1994 |
Angiotensin II inhibits cytokine-stimulated inducible nitric oxide synthase expression in vascular smooth muscle cells.
Topics: Amino Acid Oxidoreductases; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta, Thoracic; Benzimidazoles; Biphenyl Compounds; Cells, Cultured; Diglycerides; Enzyme Induction; Humans; Imidazoles; Interleukin-1; Kinetics; Muscle, Smooth, Vascular; Nitric Oxide Synthase; Pyridines; Rats; Recombinant Proteins; RNA, Messenger; Tetradecanoylphorbol Acetate; Tetrazoles; Tumor Necrosis Factor-alpha | 1994 |
Protein kinase cascade activated by mechanical stress in cardiocytes: possible involvement of angiotensin II.
Topics: Angiotensin II; Animals; Benzimidazoles; Biphenyl Compounds; Gene Expression; Mitogen-Activated Protein Kinase Kinases; Myocardium; Protein Kinases; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-raf; Rats; Rats, Wistar; Stress, Mechanical; Tetrazoles | 1995 |
Angiotensin II stimulates interleukin-6 release from cultured mouse mesangial cells.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Cell Division; Cells, Cultured; DNA; Gene Expression; Glomerular Mesangium; Glomerulonephritis, Membranoproliferative; Interleukin-6; Kinetics; Mice; RNA, Messenger; Tetrazoles | 1995 |
Angiotensin II receptor antagonist CV-11974 and cerebral blood flow autoregulation.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cerebrovascular Circulation; Homeostasis; Hypertension; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrazoles | 1995 |
Angiotensin II partly mediates mechanical stress-induced cardiac hypertrophy.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Cardiomegaly; Cells, Cultured; Electrophoresis, Polyacrylamide Gel; Enzyme Activation; Mitogen-Activated Protein Kinase Kinases; Myocardium; Phenylalanine; Protein Kinases; Rats; Rats, Wistar; Receptors, Angiotensin; Saralasin; Signal Transduction; Stress, Mechanical; Tetrazoles | 1995 |
Effects of TCV-116 and CV-11974 on angiotensin II-induced responses in vascular smooth muscle cells.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta; Benzimidazoles; Binding, Competitive; Biphenyl Compounds; Muscle, Smooth, Vascular; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Tetrazoles | 1995 |
Angiotensin II transduces its signal to focal adhesions via angiotensin II type 1 receptors in vascular smooth muscle cells.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Cell Adhesion; Cell Adhesion Molecules; Cells, Cultured; Cytoskeletal Proteins; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Imidazoles; Muscle, Smooth, Vascular; Paxillin; Phosphoproteins; Phosphorylation; Protein-Tyrosine Kinases; Pyridines; Rats; Receptors, Angiotensin; Signal Transduction; Tetrazoles | 1995 |
Effect of captopril and angiotensin II receptor blockade on pressure natriuresis in transgenic TGR(mRen-2)27 rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Animals, Genetically Modified; Benzimidazoles; Biphenyl Compounds; Captopril; Glomerular Filtration Rate; Kidney; Male; Natriuresis; Rats; Rats, Sprague-Dawley; Renal Circulation; Renin; Tetrazoles | 1995 |
Angiotensin II Receptor Antagonists: Can they Go Beyond ACE Inhibitors? Proceedings of a satellite symposium to the 15th scientific meeting of the International Society of Hypertension. Melbourne, Australia, March 1994.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Humans; Hypertension; Tetrazoles | 1994 |
Angiotensin II subtype 1 receptor modulates epinephrine release from isolated rat adrenal gland.
Topics: Adrenal Glands; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Epinephrine; Male; Rats; Rats, Wistar; Receptors, Angiotensin; Tetrazoles | 1994 |
Activated angiotensin II generation and regulation in rat mesenteric arteries following nephrectomy.
Topics: Angiotensin II; Animals; Benzimidazoles; Biphenyl Compounds; Feedback; Hypertension; Kidney; Male; Mesenteric Arteries; Nephrectomy; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin; Tetrazoles | 1994 |
Effects of CV-11974 on renal haemodynamics and renal function in dogs.
Topics: Anesthesia; Angiotensin II; Animals; Benzimidazoles; Biphenyl Compounds; Dogs; Infusions, Intra-Arterial; Kidney; Kidney Tubules; Pentobarbital; Renal Circulation; Tetrazoles | 1994 |
Effect of an AT1 receptor antagonist (CV-11974) on angiotensin II-induced cardiomyocyte hypertrophy in vitro.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Blotting, Northern; Cardiomegaly; Cells, Cultured; DNA, Complementary; Endothelin-1; Endothelins; Heart; Imidazoles; Muscle, Smooth, Vascular; Myocardium; Protein Precursors; Pyridines; Rats; Rats, Wistar; Receptors, Angiotensin; Receptors, Endothelin; RNA, Messenger; Tetrazoles | 1994 |
Angiotensin II inhibition of L-type Ca2+ current in sinoatrial node cells of rabbits.
Topics: Acetylcholine; Action Potentials; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Calcium; Cyclic AMP-Dependent Protein Kinases; Heart Rate; In Vitro Techniques; Intracellular Fluid; Ion Transport; Kinetics; Membrane Potentials; Myocardial Contraction; Rabbits; Renin-Angiotensin System; Sinoatrial Node; Tetrazoles | 1995 |
Effect of an angiotensin II receptor antagonist, CV-11974, and its prodrug, TCV-116, on production of aldosterone.
Topics: Administration, Oral; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Cells, Cultured; Corticosterone; Hypertension; Imidazoles; Infusions, Intravenous; Male; Pyridines; Rabbits; Rats; Rats, Inbred SHR; Rats, Wistar; Tetrazoles; Zona Glomerulosa | 1994 |
Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethy
Topics: Adrenal Cortex; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Aorta; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cattle; Imidazoles; In Vitro Techniques; Iodine Radioisotopes; Kinetics; Losartan; Male; Muscle Contraction; Muscle, Smooth, Vascular; Prodrugs; Protein Binding; Rabbits; Rats; Rats, Sprague-Dawley; Substrate Specificity; Tetrazoles | 1993 |
Inhibition of rabbit aortic angiotensin II (AII) receptor by CV-11974, a new nonpeptide AII antagonist.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta; Benzimidazoles; Binding Sites; Binding, Competitive; Biphenyl Compounds; Iodine Radioisotopes; Isomerism; Male; Rabbits; Tetrazoles | 1993 |
Brain angiotensin II contributes to the development of hypertension in Dahl-Iwai salt-sensitive rats.
Topics: Angiotensin II; Animals; Arteries; Baroreflex; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Brain; Drug Resistance; Heart Rate; Hormones; Hypertension; Injections, Intraventricular; Male; Rats; Rats, Inbred Strains; Sodium Chloride; Tetrazoles | 1995 |
Angiotensin II induces ovulation and oocyte maturation in rabbit ovaries via the AT2 receptor subtype.
Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Autoradiography; Benzimidazoles; Biphenyl Compounds; Cellular Senescence; Female; Imidazoles; Oocytes; Ovary; Ovulation Induction; Pyridines; Rabbits; Receptors, Angiotensin; Saralasin; Tetrazoles | 1996 |
The angiotensin receptor antagonist 2-ethoxy-1-[[2'-(1H- tetrazol-5-yl) biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV11974) attenuates the tubuloglomerular feedback response during NO synthase blockade in rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arginine; Benzimidazoles; Biphenyl Compounds; Feedback; Hemodynamics; Homeostasis; Kidney Glomerulus; Kidney Tubules; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Tetrazoles | 1996 |
Inhibitory effect of an angiotensin II type 1 receptor antagonist on growth of vascular smooth muscle cells from spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Cell Division; DNA; Indans; Male; Muscle, Smooth, Vascular; Prodrugs; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrazoles; Vasoconstrictor Agents | 1996 |
CV-11974, the active metabolite of TCV-116 (Candesarten), inhibits the synergistic or additive effect of different growth factors on angiotensin II-induced proliferation of vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Becaplermin; Benzimidazoles; Biphenyl Compounds; Cell Division; Cells, Cultured; Drug Synergism; Epidermal Growth Factor; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-sis; Rats; Rats, Inbred WKY; Tetrazoles | 1996 |
A long-term receptor stimulation is requisite for angiotensin II-dependent DNA synthesis in vascular smooth muscle cells from spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta; Base Sequence; Benzimidazoles; Biphenyl Compounds; Calcium; Cells, Cultured; DNA Replication; Fibroblast Growth Factor 2; Imidazoles; In Vitro Techniques; Losartan; Molecular Sequence Data; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor; Pyridines; Rats; Rats, Inbred SHR; Receptors, Platelet-Derived Growth Factor; Tetrazoles | 1995 |
Angiotensin type 1 receptor antagonists CV-11974 and EXP 3174 cause selective renal vasodilatation in conscious spontaneously hypertensive rats.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Imidazoles; Losartan; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renal Circulation; Tetrazoles; Vasodilation | 1996 |
Carbocyclic thromboxane A2 enhances the angiotensin II-induced DNA synthesis in smooth muscle cells.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Cell Division; Cells, Cultured; DNA; Muscle, Smooth, Vascular; Platelet Aggregation Inhibitors; Proto-Oncogene Proteins c-fos; Rats; Rats, Inbred WKY; RNA, Messenger; Tetrazoles; Thromboxane A2; Vasoconstrictor Agents | 1996 |
The presence of angiotensin II receptors in elasmobranchs.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Atrial Natriuretic Factor; Benzimidazoles; Binding, Competitive; Biphenyl Compounds; Bradykinin; Branchial Region; Dose-Response Relationship, Drug; Elasmobranchii; Iodine Radioisotopes; Membrane Proteins; Natriuretic Peptide, C-Type; Oligopeptides; Proteins; Radioligand Assay; Receptors, Angiotensin; Tetrazoles; Time Factors; Tissue Distribution | 1997 |
Candesartan (CV-11974) dissociates slowly from the angiotensin AT1 receptor.
Topics: Adrenal Cortex; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Cattle; Imidazoles; In Vitro Techniques; Losartan; Male; Rabbits; Receptors, Angiotensin; Tetrazoles; Vasoconstriction | 1997 |
Angiotensin-converting enzyme inhibitor up-regulates cardiac beta-receptors in cultured neonatal rat myocytes.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Newborn; Benzimidazoles; Biphenyl Compounds; Captopril; Cells, Cultured; Myocardial Contraction; Myocardium; Radioligand Assay; Rats; Receptors, Adrenergic, beta; Tetrazoles; Up-Regulation | 1997 |
Mapping of angiotensin II receptor subtypes in peripheral tissues of spontaneously hypertensive rats by in vitro autoradiography.
Topics: Adrenal Glands; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Autoradiography; Benzimidazoles; Biphenyl Compounds; Heart; Hypertension; Kidney; Male; Muscle, Smooth, Vascular; Myocardium; Oligopeptides; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Angiotensin; Tetrazoles | 1995 |
Stimulation of angiotensin subtype 2 receptor reduces basal cGMP levels in the neointima of rat aorta after balloon injury.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta, Thoracic; Benzimidazoles; Biphenyl Compounds; Catheterization; Cyclic AMP; Cyclic GMP; Imidazoles; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Pyridines; Rats; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Tetrazoles; Tunica Intima | 1997 |
Stretch-induced MAP kinase activation in cardiomyocytes of angiotensinogen-deficient mice.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensinogen; Animals; Benzimidazoles; Biphenyl Compounds; Blotting, Western; Calcium-Calmodulin-Dependent Protein Kinases; Cells, Cultured; Endothelin Receptor Antagonists; Endothelin-1; Enzyme Activation; Gene Targeting; Mice; Mice, Transgenic; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Myocardium; Peptides, Cyclic; Renin-Angiotensin System; Tetrazoles | 1997 |
Role of the angiotensin II type 1 receptor in preconditioning against infarction.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Rabbits; Radioimmunoassay; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Tetrazoles | 1997 |
Analysis of the effects of candesartan in the mesenteric vascular bed of the cat.
Topics: Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Blood Vessels; Cats; Female; Imidazoles; Male; Perfusion; Pressure; Pyridines; Splanchnic Circulation; Tetrazoles | 1997 |
Enhancement by exogenous and locally generated angiotensin II of purinergic neurotransmission via angiotensin type 1 receptor in the guinea-pig isolated mesenteric artery.
Topics: Adenosine Triphosphate; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Electric Stimulation; Evoked Potentials; Female; Guinea Pigs; Imidazoles; In Vitro Techniques; Membrane Potentials; Mesenteric Arteries; Muscle Contraction; Muscle, Smooth, Vascular; Oligopeptides; Purinergic P2 Receptor Antagonists; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Suramin; Synaptic Transmission; Tetrazoles; Vasoconstrictor Agents | 1997 |
Possible role of P-450 metabolite of arachidonic acid in vasodilator mechanism of angiotensin II type 2 receptor in the isolated microperfused rabbit afferent arteriole.
Topics: 8,11,14-Eicosatrienoic Acid; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arachidonic Acid; Arterioles; Benzimidazoles; Biphenyl Compounds; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Endothelium, Vascular; Humans; Imidazoles; In Vitro Techniques; Kidney Glomerulus; Large-Conductance Calcium-Activated Potassium Channels; Male; Norepinephrine; Perfusion; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Calcium-Activated; Pyridines; Rabbits; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Tetraethylammonium; Tetrazoles; Vasoconstrictor Agents; Vasodilator Agents | 1997 |
Function of angiotensin II type 2 receptor in the postglomerular efferent arteriole.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arterioles; Benzimidazoles; Biphenyl Compounds; Imidazoles; In Vitro Techniques; Male; Microcirculation; Norepinephrine; Pyridines; Rabbits; Receptors, Angiotensin; Renal Circulation; Tetrazoles; Vasodilation | 1997 |
Pharmacological profiles of a novel non-peptide angiotensin II type I receptor antagonist HR720 in vitro and in vivo.
Topics: Adrenal Glands; Adult; Aged; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cricetinae; Humans; Imidazoles; In Vitro Techniques; Losartan; Male; Mesocricetus; Middle Aged; Muscle, Smooth, Vascular; Rabbits; Rats; Tetrazoles; Thermodynamics | 1997 |
Central amino acids mediate cardiovascular response to angiotensin II in the rat.
Topics: Adrenergic alpha-Agonists; Angiotensin II; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Brain Chemistry; Heart Rate; Hemodynamics; Injections, Intraventricular; Male; Microdialysis; Microinjections; Neurotransmitter Agents; Nitroglycerin; Phenylephrine; Rats; Rats, Inbred SHR; Tetrazoles; Vasodilator Agents | 1998 |
Responses to angiotensin peptides are mediated by AT1 receptors in the rat.
Topics: Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Female; Hindlimb; Imidazoles; Losartan; Male; Norepinephrine; Peptide Fragments; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Tetrazoles | 1998 |
Murine double nullizygotes of the angiotensin type 1A and 1B receptor genes duplicate severe abnormal phenotypes of angiotensinogen nullizygotes.
Topics: Adrenal Glands; Anesthetics; Angiotensin II; Angiotensinogen; Animals; Benzimidazoles; beta-Galactosidase; Biphenyl Compounds; Blood Pressure; Imidazoles; Infusions, Intravenous; Kidney; Losartan; Mice; Mice, Knockout; Myocardium; Phenotype; Pyridines; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Saralasin; Staining and Labeling; Tetrazoles; Thiopental; Zygote | 1998 |
Biphasic activation of the JAK/STAT pathway by angiotensin II in rat cardiomyocytes.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Cardiomegaly; Cells, Cultured; Interferon-gamma; Interferons; Janus Kinase 2; Myocardium; Phosphorylation; Phosphotransferases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Rats; Rats, Wistar; Signal Transduction; Stereoisomerism; Tetrazoles; Trans-Activators; Tyrosine | 1998 |
Role of ion channels and exchangers in mechanical stretch-induced cardiomyocyte hypertrophy.
Topics: Angiotensin II; Animals; Benzimidazoles; Biphenyl Compounds; Calcium-Calmodulin-Dependent Protein Kinases; Cardiomegaly; Cytoplasm; Endothelin-1; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Guanidines; Hydrogen-Ion Concentration; Ion Channels; MAP Kinase Kinase 1; Mechanoreceptors; Mitogen-Activated Protein Kinase Kinases; Muscle Proteins; Peptides, Cyclic; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-raf; Rats; Rats, Wistar; Signal Transduction; Sodium-Hydrogen Exchangers; Sulfones; Tetrazoles | 1998 |
Interaction of myocytes and nonmyocytes is necessary for mechanical stretch to induce ANP/BNP production in cardiocyte culture.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Atrial Natriuretic Factor; Benzimidazoles; Biphenyl Compounds; Cell Communication; Cells, Cultured; Coculture Techniques; Myocardium; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Physical Stimulation; Rats; Tetrazoles | 1998 |
Activation of angiotensinogen gene in cardiac myocytes by angiotensin II and mechanical stretch.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensinogen; Animals; Animals, Newborn; Benzimidazoles; beta-Galactosidase; Biphenyl Compounds; Cells, Cultured; Chloramphenicol O-Acetyltransferase; Cycloheximide; Dactinomycin; Gene Expression Regulation; Heart; Heart Ventricles; Imidazoles; Liver; Lung; Myocardium; Promoter Regions, Genetic; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Recombinant Fusion Proteins; RNA, Messenger; RNA, Ribosomal, 18S; Stress, Mechanical; Tetrazoles; Transcription, Genetic; Transfection | 1998 |
Angiotensin II and intracellular calcium of adult cardiac fibroblasts.
Topics: Angiotensin II; Animals; Benzimidazoles; Biphenyl Compounds; Calcium; Collagen; Culture Media; Dose-Response Relationship, Drug; Egtazic Acid; Fetal Blood; Fibroblasts; Fura-2; Heart Ventricles; Imidazoles; Pyridines; Rats; Spectrometry, Fluorescence; Tetrazoles | 1998 |
Functional evidence for alternative ANG II-forming pathways in hamster cardiovascular system.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta, Thoracic; Aprotinin; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Captopril; Chymases; Cricetinae; Heart Ventricles; Humans; In Vitro Techniques; Male; Mesocricetus; Muscle Contraction; Muscle, Smooth, Vascular; Myocardium; Oligopeptides; Serine Endopeptidases; Substrate Specificity; Tetrazoles; Vasoconstriction | 1998 |
Effects of renin-angiotensin system blockade and dietary salt intake on left ventricular hypertrophy in Dahl salt-sensitive rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Diet; Hypertrophy, Left Ventricular; Rats; Rats, Inbred Strains; Renin; Renin-Angiotensin System; Sodium, Dietary; Tetrazoles; Time Factors | 1998 |
Central and peripheral mechanisms involved in hypertension induced by chronic inhibition of nitric oxide synthase in rats.
Topics: Acute Disease; Adrenergic alpha-Antagonists; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Chronic Disease; Denervation; Enzyme Inhibitors; Hypertension; Injections, Intravenous; Injections, Intraventricular; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Phentolamine; Rats; Rats, Wistar; Sinoatrial Node; Tetrazoles | 1998 |
Roles of brain angiotensin II and C-type natriuretic peptide in deoxycorticosterone acetate-salt hypertension in rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arginine Vasopressin; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Brain; Desoxycorticosterone; Hypertension; Infusions, Parenteral; Injections, Intravenous; Injections, Intraventricular; Male; Natriuretic Peptide, C-Type; Rats; Rats, Wistar; Sodium Chloride; Tetrazoles | 1998 |
Interactions between the renin-angiotensin system (RAS) and the sympathetic system.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Dose-Response Relationship, Drug; Imidazoles; Losartan; Male; Norepinephrine; Presynaptic Terminals; Rats; Rats, Inbred SHR; Receptors, Angiotensin; Renin-Angiotensin System; Sympathetic Nervous System; Tetrazoles; Vasoconstrictor Agents | 1998 |
Angiotensin II stimulates both aldosterone secretion and DNA synthesis via type 1 but not type 2 receptors in bovine adrenocortical cells.
Topics: Adrenal Cortex; Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Cattle; Cells, Cultured; DNA; Imidazoles; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Tetrazoles; Zona Glomerulosa | 1998 |
Angiotensin II interferes with leukemia inhibitory factor-induced STAT3 activation in cardiac myocytes.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Cytoprotection; DNA-Binding Proteins; Dose-Response Relationship, Drug; Growth Inhibitors; Heart Ventricles; Humans; Interleukin-6; Leukemia Inhibitory Factor; Lymphokines; Mice; Myocardium; Phosphorylation; Rats; Rats, Sprague-Dawley; Signal Transduction; STAT3 Transcription Factor; Tetrazoles; Trans-Activators; Tyrosine | 1998 |
The effects of candesartan on human AT1 receptor-expressing Chinese hamster ovary cells.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Inositol Phosphates; Lithium Chloride; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Tetrazoles; Transfection | 1999 |
AT1 calcium signaling in renal vascular smooth muscle cells.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Calcium; Calcium Signaling; Cells, Cultured; Egtazic Acid; Kidney Glomerulus; Male; Muscle, Smooth, Vascular; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Tetrazoles | 1999 |
The influence of candesartan and PD123319 on responses to angiotensin II in the hindquarters vascular bed of the rat.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Calcium Channel Agonists; Dose-Response Relationship, Drug; Female; Hemodynamics; Hindlimb; Imidazoles; Injections, Intravenous; Male; Norepinephrine; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles; Vasoconstrictor Agents | 1999 |
Effects of candesartan and PD123319 on responses to angiotensin II in the anesthetized mouse.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Epinephrine; Imidazoles; Mice; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles | 1999 |
Analysis of the effects of candesartan on responses to angiotensin II in the hindquarters vascular bed of the cat.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cats; Dose-Response Relationship, Drug; Female; Hindlimb; Male; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles; Time Factors; Vasoconstrictor Agents; Vasodilator Agents | 1999 |
Renal responses of the nonclipped kidney of two-kidney/one-clip Goldblatt hypertensive rats to type 1 angiotensin II receptor blockade with candesartan.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Dose-Response Relationship, Drug; Glomerular Filtration Rate; Hypertension, Renal; Kidney; Male; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Regional Blood Flow; Sodium; Tetrazoles; Time Factors; Vasodilation | 1999 |
Effects of candesartan on angiotensin II-induced renal vasoconstriction in rats and mice.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Dose-Response Relationship, Drug; Hypertension; Kidney; Mice; Mice, Knockout; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Regional Blood Flow; Renal Artery; Tetrazoles; Time Factors; Vasoconstriction | 1999 |
Nitric oxide participates in the renal vasodilatory effect of candesartan in anesthetized rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arginine; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Regional Blood Flow; Tetrazoles; Vasodilation | 1999 |
AT1 receptor inhibition blunts angiotensin II-stimulated nitric oxide release in renal arteries.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Endothelium, Vascular; In Vitro Techniques; Losartan; Male; Microelectrodes; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renal Artery; Tetrazoles; Vasoconstriction | 1999 |
Angiotensin II stimulates macula densa basolateral sodium/hydrogen exchange via type 1 angiotensin II receptors.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Hydrogen-Ion Concentration; In Vitro Techniques; Kidney Glomerulus; Rabbits; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Signal Transduction; Sodium-Hydrogen Exchangers; Tetrazoles | 1999 |
Proximal tubular angiotensin II levels and renal functional responses to AT1 receptor blockade in nonclipped kidneys of Goldblatt hypertensive rats.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Data Interpretation, Statistical; Glomerular Filtration Rate; Hypertension, Renovascular; Kidney; Kidney Tubules, Proximal; Male; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Renal Circulation; Renin-Angiotensin System; Tetrazoles | 1999 |
Angiotensin II type 1 receptor-mediated peroxide production in human macrophages.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Benzimidazoles; Biphenyl Compounds; Cell Differentiation; Humans; Imidazoles; Kinetics; Leukemia, Monocytic, Acute; Macrophages; Oxidative Stress; Peroxides; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Tetradecanoylphorbol Acetate; Tetrazoles; Tumor Cells, Cultured | 1999 |
Cardioprotective effect of angiotensin-converting enzyme inhibition against hypoxia/reoxygenation injury in cultured rat cardiac myocytes.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Bradykinin; Cell Hypoxia; Cells, Cultured; Cilazapril; Creatine Kinase; Cyclic GMP; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Guanidines; Indomethacin; Methylene Blue; Muscle Fibers, Skeletal; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Oxygen; Rats; Rats, Wistar; Staurosporine; Tetrazoles | 1999 |
Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Bradykinin; Bradykinin Receptor Antagonists; Cilazapril; Collagen; Disease Models, Animal; Glomerulonephritis, Membranoproliferative; Hydralazine; Kidney Failure, Chronic; Male; Proteinuria; Rats; Rats, Wistar; Renal Circulation; Renin-Angiotensin System; Tetrazoles; Transforming Growth Factor beta | 1999 |
Differential kinetics of circulating angiotensin IV and II after treatment with angiotensin II type 1 receptor antagonist and their plasma levels in patients with chronic renal failure.
Topics: Aged; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Female; Humans; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Rats; Rats, Wistar; Renal Dialysis; Tetrazoles | 1999 |
Resetting of exaggerated tubuloglomerular feedback activity in acutely volume-expanded young SHR.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Feedback; Kidney Glomerulus; Kidney Tubules; Loop of Henle; Perfusion; Plasma Substitutes; Pressure; Punctures; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Sodium Chloride; Tetrazoles | 1999 |
Binding of the antagonist [3H]candesartan to angiotensin II AT1 receptor-transfected [correction of tranfected] Chinese hamster ovary cells.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; CHO Cells; Computer Simulation; Cricetinae; Female; Humans; In Vitro Techniques; Inositol Phosphates; Ligands; Losartan; Protein Binding; Receptors, Angiotensin; Tetrazoles; Time Factors; Transfection | 1999 |
Angiotensin II inhibits interleukin-1 beta-induced nitric oxide production in cultured rat mesangial cells.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antibodies; Benzimidazoles; Biphenyl Compounds; Blotting, Northern; Cells, Cultured; Gene Expression; Glomerular Mesangium; Imidazoles; Interleukin-1; Male; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Pyridines; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta | 1999 |
Role of angiotensin in cardioprotective effect of ischemic preconditioning.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Coronary Circulation; Creatine Kinase; Female; Heart Rate; Imidazoles; In Vitro Techniques; Ischemic Preconditioning, Myocardial; L-Lactate Dehydrogenase; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Pyridines; Rats; Rats, Wistar; Tetrazoles | 1999 |
Production of angiotensin II by homogeneous cultures of vascular smooth muscle cells from spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aspartic Acid Endopeptidases; Benzimidazoles; Biphenyl Compounds; Cathepsin D; Cathepsin E; Cell Division; Cells, Cultured; Culture Media, Conditioned; Hyperplasia; Hypertension; Hypertrophy; Indans; Kallikreins; Male; Muscle, Smooth, Vascular; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin; Renin-Angiotensin System; RNA, Messenger; Tetrazoles; Tissue Kallikreins | 1999 |
Mechanistic differences of various AT1-receptor blockers in isolated vessels of different origin.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Aorta; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Blood Proteins; Female; Humans; Imidazoles; In Vitro Techniques; Irbesartan; Kinetics; Losartan; Male; Muscle Contraction; Muscle, Smooth, Vascular; Portal Vein; Rabbits; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles | 1999 |
Insurmountable angiotensin AT1 receptor antagonists: the role of tight antagonist binding.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Binding, Competitive; Biphenyl Compounds; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Humans; Imidazoles; Irbesartan; Losartan; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Recombinant Proteins; Tetrazoles | 1999 |
The angiotensin II AT1-receptor antagonist candesartan improves functional recovery and reduces the no-reflow area in reperfused ischemic rat hearts.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Coronary Vessels; Heart; In Vitro Techniques; Male; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Tetrazoles | 1999 |
Action of AT1 receptor antagonists on angiotensin II-induced tone in human isolated subcutaneous resistance arteries.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Arteries; Benzimidazoles; Biphenyl Compounds; Endothelium, Vascular; Humans; Imidazoles; Losartan; Muscle Tonus; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Tetrazoles; Vasoconstrictor Agents | 1999 |
Alternative angiotensin II formation in rat arteries occurs only at very high concentrations of angiotensin I.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aorta; Arteries; Benzimidazoles; Biphenyl Compounds; Carotid Arteries; Cricetinae; Male; Mesocricetus; Pressoreceptors; Rats; Rats, Inbred WKY; Serine Proteinase Inhibitors; Tetrazoles; Time Factors; Vasoconstriction | 1999 |
Angiotensin converting enzyme inhibitors block mitogenic signalling pathways in rat cardiac fibroblasts.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Newborn; Benzimidazoles; Biphenyl Compounds; Calcium-Calmodulin-Dependent Protein Kinases; Cell Division; Cells, Cultured; DNA-Binding Proteins; Dose-Response Relationship, Drug; Enzyme Activation; Fibroblasts; Flavonoids; Heart; Immunoblotting; Isoquinolines; Phosphorylation; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Signal Transduction; STAT3 Transcription Factor; Tetrahydroisoquinolines; Tetrazoles; Time Factors; Trans-Activators | 1999 |
Effects of the insurmountable angiotensin AT1 receptor antagonist candesartan and the surmountable antagonist losartan on ischemia/reperfusion injury in rat hearts.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Creatine Kinase; Dose-Response Relationship, Drug; Heart; Hemodynamics; In Vitro Techniques; Losartan; Male; Myocardial Reperfusion Injury; Norepinephrine; Perfusion; Pressure; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles; Time Factors; Vasoconstriction; Vasoconstrictor Agents | 1999 |
Effect of beta(2)-adrenoceptor activation and angiotensin II on tumour necrosis factor and interleukin 6 gene transcription in the rat renal resident macrophage cells.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Angiotensin II; Animals; Animals, Newborn; Benzimidazoles; Biphenyl Compounds; Cells, Cultured; Dose-Response Relationship, Drug; Gene Expression Regulation; Genes, Reporter; Interleukin-6; Kidney; Lipopolysaccharides; Macrophages; Promoter Regions, Genetic; Rats; Rats, Wistar; Receptors, Adrenergic, beta-2; Tetrazoles; Transfection; Tumor Necrosis Factor-alpha | 1999 |
Role of AT(1) receptors and autonomic nervous system in mediating acute pressor responses to ANG II in anesthetized mice.
Topics: Adrenergic beta-Antagonists; Anesthesia; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Atropine; Autonomic Nervous System; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cardiac Output; Dose-Response Relationship, Drug; Enalaprilat; Heart Rate; Hexamethonium; Imidazoles; Mice; Mice, Inbred Strains; Parasympatholytics; Phentolamine; Propranolol; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Tetrazoles; Vascular Resistance; Vasoconstrictor Agents | 1999 |
Blockade of the renin angiotensin system in heart failure: the potential place of angiotensin II receptor blockers.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Heart Failure; Humans; Losartan; Receptors, Angiotensin; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan | 2000 |
Effects of angiotensin II and antagonists on AT(1) receptor expression in mesangial cells.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Dexamethasone; Dose-Response Relationship, Drug; Gene Expression Regulation; Glomerular Mesangium; Imidazoles; Losartan; Male; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger; Tetrazoles | 1999 |
Development of EIA systems for active-form MAP kinase.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antibody Specificity; Benzimidazoles; Biphenyl Compounds; Cells, Cultured; Enzyme Activation; Glomerular Mesangium; Humans; Immunoenzyme Techniques; Male; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; PC12 Cells; Rabbits; Rats; Rats, Wistar; Tetrazoles | 2000 |
Angiotensin-II subtype 2 receptor agonist (CGP-42112) inhibits catecholamine biosynthesis in cultured porcine adrenal medullary chromaffin cells.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adrenal Medulla; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Binding, Competitive; Biphenyl Compounds; Catecholamines; Cells, Cultured; Chromaffin Cells; Cyclic GMP; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Induction; Imidazoles; Oligopeptides; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger; Swine; Tetrazoles; Tyrosine 3-Monooxygenase | 2000 |
Comparative effects of angiotensin II AT-1-type receptor antagonists in vitro on human platelet activation.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Adult; Angiotensin II; Angiotensin Receptor Antagonists; Antibodies, Monoclonal; Benzimidazoles; Benzoates; Binding, Competitive; Biphenyl Compounds; Blood Platelets; Dose-Response Relationship, Drug; Humans; Imidazoles; Irbesartan; Losartan; Platelet Activation; Pyridines; Radioligand Assay; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Telmisartan; Tetrazoles; Thromboxane A2; Time Factors; Valine; Valsartan | 2000 |
Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Atrial Fibrillation; Atrial Function; Benzimidazoles; Biphenyl Compounds; Captopril; Dogs; Female; Heart Conduction System; Male; Myocardium; Pacemaker, Artificial; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Sinoatrial Node; Tetrazoles; Time Factors | 2000 |
Roles of ANG II and bradykinin in the renal regional blood flow responses to ACE inhibition in sodium-depleted dogs.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Bradykinin; Diet, Sodium-Restricted; Dogs; Laser-Doppler Flowmetry; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renal Circulation; Sodium; Tetrazoles | 2000 |
ACE inhibition and AT(1) receptor blockers: efficacy and duration in hypertension.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Blood Pressure Determination; Circadian Rhythm; Delayed-Action Preparations; Evidence-Based Medicine; Humans; Hypertension; Losartan; Patient Compliance; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles | 2000 |
Comparison of the antihypertensive effects of the new angiotensin II (AT1) receptor antagonist candesartan cilexetil (TCV-116) and the angiotensin converting enzyme inhibitor enalapril in rats.
Topics: Administration, Oral; Angiotensin I; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Bradykinin; Enalapril; Enzyme Activation; Hypertension, Renal; Male; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renal Artery; Surgical Instruments; Tetrazoles; Vasoconstrictor Agents | 1996 |
Angiotensin II activates collagen I gene through a mechanism involving the MAP/ER kinase pathway.
Topics: Analysis of Variance; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta; Benzimidazoles; Biphenyl Compounds; Collagen; Decorin; Enzyme Activation; Enzyme Inhibitors; Extracellular Matrix Proteins; Flavonoids; Gene Expression Regulation, Enzymologic; Genes, fos; Genetic Markers; Humans; Imidazoles; Kidney; Luciferases; Male; Mice; Mice, Transgenic; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Proteoglycans; Proto-Oncogene Mas; Pyridines; Tetrazoles; Transcriptional Activation; Transforming Growth Factor beta | 2000 |
Increased gene expression of components of the renin-angiotensin system in glomeruli of genetically hypertensive rats.
Topics: Albuminuria; Angiotensin II; Angiotensinogen; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Blotting, Northern; Fibronectins; Gene Expression; Glomerulosclerosis, Focal Segmental; Hydralazine; Hypertension, Renal; Kidney Glomerulus; Male; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin; Renin-Angiotensin System; Ribonucleases; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2000 |
Angiotensin peptides acting at rostral ventrolateral medulla contribute to hypertension of TGR(mREN2)27 rats.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Animals, Genetically Modified; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Heart Rate; Hypertension; Male; Medulla Oblongata; Microinjections; Peptide Fragments; Rats; Rats, Sprague-Dawley; Renin; Tetrazoles | 2000 |
Angiotensin II AT(1) blockade normalizes cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Binding, Competitive; Biphenyl Compounds; Blood Flow Velocity; Blood Pressure; Brain Edema; Brain Ischemia; Cerebrovascular Circulation; Homeostasis; Hypertension; Infarction, Middle Cerebral Artery; Infusion Pumps, Implantable; Injections, Subcutaneous; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Tetrazoles | 2000 |
Role of the angiotensin AT(1) receptor in rat aortic and cardiac PAI-1 gene expression.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Newborn; Antihypertensive Agents; Aorta; Benzimidazoles; Biphenyl Compounds; Cells, Cultured; Gene Expression; Heart Ventricles; Infusions, Intravenous; Male; Muscle, Smooth, Vascular; Myocardium; Plasminogen Activator Inhibitor 1; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger; Tetrazoles | 2000 |
Angiotensin II regulates the cell cycle of vascular smooth muscle cells from SHR.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; CDC2-CDC28 Kinases; Cell Cycle; Cell Cycle Proteins; Cells, Cultured; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; DNA; Flow Cytometry; Male; Microtubule-Associated Proteins; Muscle, Smooth, Vascular; Protein Serine-Threonine Kinases; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Tetrazoles; Tumor Suppressor Proteins | 2000 |
Angiotensin II blockade in existing hypovolemia: effects of candesartan in the porcine splanchnic and renal circulation.
Topics: Acid-Base Equilibrium; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Female; Hemodynamics; Hypovolemia; Intestinal Mucosa; Liver Circulation; Male; Microcirculation; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renal Circulation; Splanchnic Circulation; Swine; Tetrazoles | 2000 |
Angiotensin II type 1 receptor antagonists. Why do some of them produce insurmountable inhibition?
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Binding Sites; Biphenyl Compounds; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Humans; Irbesartan; Losartan; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Recombinant Proteins; Tetrazoles | 2000 |
Diastolic wall stress and ANG II in cardiac hypertrophy and gene expression induced by volume overload.
Topics: Adrenomedullin; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Blood Volume; Calcium Channel Blockers; Diastole; Dihydropyridines; Gene Expression; Heart Rate; Hypertrophy, Left Ventricular; Male; Nitrobenzenes; Peptides; Piperazines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Stress, Mechanical; Tetrazoles; Vasoconstrictor Agents | 2000 |
Glial angiotensinogen regulates brain angiotensin II receptors in transgenic rats TGR(ASrAOGEN).
Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Angiotensin II; Angiotensinogen; Animals; Animals, Genetically Modified; Antihypertensive Agents; Astrocytes; Autoradiography; Benzimidazoles; Biphenyl Compounds; Blood-Brain Barrier; Brain Chemistry; Diabetes Insipidus; Drinking; Imidazoles; Injections, Intraventricular; Iodine Radioisotopes; Pyridines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Antisense; Salts; Subfornical Organ; Tetrazoles; Vasoconstrictor Agents | 2001 |
Myocardial ischemia activates the JAK-STAT pathway through angiotensin II signaling in in vivo myocardium of rats.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blotting, Western; Coronary Vessels; DNA; DNA-Binding Proteins; Drosophila Proteins; Electrophoresis, Polyacrylamide Gel; Enzyme Activation; Enzyme Inhibitors; Guanine Nucleotide Exchange Factors; Imidazoles; Imidazolidines; Immunoblotting; Janus Kinase 1; Janus Kinase 2; Male; Myocardial Infarction; Myocardial Ischemia; Peptidyl-Dipeptidase A; Phosphorylation; Precipitin Tests; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Signal Transduction; STAT1 Transcription Factor; STAT3 Transcription Factor; Tetrazoles; Time Factors; Trans-Activators | 2001 |
A two-state receptor model for the interaction between angiotensin II type 1 receptors and non-peptide antagonists.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; CHO Cells; Computer Simulation; Cricetinae; Dose-Response Relationship, Drug; Inositol Phosphates; Irbesartan; Kinetics; Losartan; Models, Biological; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Tetrazoles | 2001 |
Angiotensin II binding sites in the heart of Scyliorhinus canicula: an autoradiographic study.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Autoradiography; Benzimidazoles; Binding Sites; Biphenyl Compounds; Dogfish; Endocardium; Heart Atria; Iodine Radioisotopes; Myocardium; Oligopeptides; Receptors, Angiotensin; Tetrazoles | 2001 |
The mechanism of action of angiotensin II is dependent on direct activation of vascular smooth muscle carbonic anhydrase I.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Carbonic Anhydrases; Dose-Response Relationship, Drug; Enzyme Inhibitors; Erythrocytes; Female; Humans; In Vitro Techniques; Irbesartan; Male; Middle Aged; Muscle, Smooth, Vascular; Tetrazoles | 2000 |
Alterations of the renin-angiotensin system at the RVLM of transgenic rats with low brain angiotensinogen.
Topics: Angiotensin II; Angiotensinogen; Animals; Animals, Genetically Modified; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Brain; Functional Laterality; Heart Rate; Male; Medulla Oblongata; Microinjections; Peptide Fragments; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Tetrazoles | 2001 |
Effects of angiotensin IV and angiotensin-(1-7) on basal and angiotensin II-stimulated cytosolic Ca2+ in mesangial cells.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Calcium; Cell Culture Techniques; Cytosol; Dose-Response Relationship, Drug; Glomerular Mesangium; Inositol Phosphates; Male; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Tetrazoles; Vasoconstrictor Agents | 2001 |
Can angiotensin II receptor blockers be used in patients who have developed a cough or angioedema as a result of taking an ACE inhibitor?
Topics: Acrylates; Angioedema; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Black or African American; Clinical Trials as Topic; Cough; Female; Humans; Imidazoles; Irbesartan; Losartan; Male; Randomized Controlled Trials as Topic; Sex Factors; Telmisartan; Tetrazoles; Thiophenes; Valine; Valsartan | 2001 |
Tight binding of the angiotensin AT(1) receptor antagonist.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biological Transport; Biphenyl Compounds; Cell Membrane; CHO Cells; Cricetinae; Endocytosis; Gene Deletion; Inositol Phosphates; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Tetrazoles; Thymidine; Tritium | 2001 |
Effects of blockade of the renin-angiotensin system on tissue factor and plasminogen activator inhibitor-1 synthesis in human cultured monocytes.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Captopril; Cells, Cultured; Culture Media; Humans; Monocytes; Peptidyl-Dipeptidase A; Plasminogen Activator Inhibitor 1; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin-Angiotensin System; RNA, Messenger; Tetrazoles; Thromboplastin; Tumor Necrosis Factor-alpha | 2001 |
Endogenous angiotensin II in the NTS contributes to sympathetic activation in rats with aortocaval shunt.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Aorta; Arteriovenous Shunt, Surgical; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Echocardiography; Heart Rate; Hemodynamics; Imidazoles; Kidney; Male; Microinjections; Pyridines; Rats; Rats, Inbred WKY; Solitary Nucleus; Sympathetic Nervous System; Tetrazoles; Venae Cavae | 2001 |
Angiotensin II and its metabolites stimulate PAI-1 protein release from human adipocytes in primary culture.
Topics: Adipose Tissue; Adolescent; Adult; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Cells, Cultured; Female; Humans; Middle Aged; Plasminogen Activator Inhibitor 1; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Tetrazoles; Valine; Valsartan | 2001 |
Combined effects of AT(1) and ET(A) receptor antagonists, candesartan, and A-127722 in DOCA-salt hypertensive rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Atrasentan; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Body Weight; Desoxycorticosterone; Disease Models, Animal; Drug Therapy, Combination; Endothelin Receptor Antagonists; Endothelin-1; Hypertension; Kidney; Male; Natriuresis; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles | 2000 |
Protective effect of agiotensin II type I receptor antagonist, CV-11974, on ischemia and reperfusion injury of the liver.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aspartate Aminotransferases; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Dogs; Female; Hemodynamics; Hepatic Veins; Ischemia; Liver; Liver Circulation; Liver Function Tests; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Regional Blood Flow; Renin; Reperfusion Injury; Tetrazoles; Time Factors | 2001 |
Mildly oxidized low-density lipoprotein acts synergistically with angiotensin II in inducing vascular smooth muscle cell proliferation.
Topics: Acetylcysteine; Aldehydes; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antioxidants; Benzimidazoles; Biphenyl Compounds; Cardiovascular Diseases; Cell Division; Cells, Cultured; DNA; Drug Synergism; Flavonoids; Humans; Hydrogen Peroxide; Lipoproteins, LDL; Lysophosphatidylcholines; Muscle, Smooth, Vascular; Probucol; Rabbits; Receptor, Angiotensin, Type 1; Tetrazoles; Tyrphostins | 2001 |
Activation of angiotensin II subtype 2 receptor induces catecholamine release in an extracellular Ca(2+)-dependent manner through a decrease of cyclic guanosine 3',5'-monophosphate production in cultured porcine adrenal medullary chromaffin Cells.
Topics: Adrenal Medulla; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Calcium; Catecholamines; Cells, Cultured; Chromaffin Cells; Cyclic GMP; Extracellular Space; Imidazoles; Inositol 1,4,5-Trisphosphate; Intracellular Membranes; Oligopeptides; Pyridines; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Swine; Tetrazoles; Virulence Factors, Bordetella | 2001 |
Role of nNOS in regulation of renal function in angiotensin II-induced hypertension.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Citrulline; Enzyme Inhibitors; Glomerular Filtration Rate; Hypertension, Renal; Kidney; Male; Natriuresis; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renal Plasma Flow; Tetrazoles; Thiourea | 2001 |
Mechanism of action of angiotensin II in human isolated subcutaneous resistance arteries.
Topics: Amlodipine; Angiotensin II; Arteries; Benzimidazoles; Biphenyl Compounds; Calcium; Calcium Channel Blockers; Dihydropyridines; Dose-Response Relationship, Drug; Flavonoids; Genistein; Humans; In Vitro Techniques; Nickel; Norepinephrine; Potassium; Ryanodine; Skin; Tetrazoles; Vascular Resistance; Vasoconstriction; Vasoconstrictor Agents | 2001 |
Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats.
Topics: Angiotensin II; Animals; Benzimidazoles; Biphenyl Compounds; Endothelial Growth Factors; Immunohistochemistry; Liver Cirrhosis, Experimental; Lymphokines; Male; Perindopril; Rats; Rats, Inbred F344; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin-Angiotensin System; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2001 |
Angiotensin II induces circadian gene expression of clock genes in cultured vascular smooth muscle cells.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta, Thoracic; ARNTL Transcription Factors; Basic Helix-Loop-Helix Transcription Factors; Benzimidazoles; Biological Clocks; Biomarkers; Biphenyl Compounds; Blotting, Northern; Cell Cycle Proteins; Cells, Cultured; Circadian Rhythm; DNA-Binding Proteins; Gene Expression; Imidazoles; Male; Mice; Mice, Inbred BALB C; Muscle, Smooth, Vascular; Nuclear Proteins; Period Circadian Proteins; Pyridines; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Tetrazoles; Transcription Factors | 2001 |
Effects of all-trans retinoic acid on renin-angiotensin system in rats with experimental nephritis.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensinogen; Animals; Antibodies; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Kidney; Kidney Glomerulus; Male; Nephritis; Peptidyl-Dipeptidase A; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptors, Mineralocorticoid; Renin; Renin-Angiotensin System; RNA, Messenger; Tetrazoles; Thy-1 Antigens; Tretinoin | 2001 |
Angiotensin subtype-2 receptor (AT2 ) negatively regulates subtype-1 receptor (AT1 ) in signal transduction pathways in cultured porcine adrenal medullary chromaffin cells.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Cells, Cultured; Chromaffin Cells; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; DNA-Binding Proteins; Drug Combinations; Enzyme Activation; Imidazoles; Isoenzymes; Milk Proteins; Mitogen-Activated Protein Kinases; Protein Kinase C; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Signal Transduction; STAT1 Transcription Factor; STAT3 Transcription Factor; STAT5 Transcription Factor; Swine; Tetrazoles; Trans-Activators | 2001 |
Inhibition of facilitation of sympathetic neurotransmission and angiotensin II-induced pressor effects in the pithed rat: comparison between valsartan, candesartan, eprosartan and embusartan.
Topics: Acrylates; Adrenergic alpha-Agonists; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Decerebrate State; Dihydropyridines; Dose-Response Relationship, Drug; Imidazoles; Male; Norepinephrine; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Sympathetic Nervous System; Synaptic Transmission; Tetrazoles; Thiophenes; Valine; Valsartan | 2001 |
Angiotensin II directly stimulates macula densa Na-2Cl-K cotransport via apical AT(1) receptors.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biological Transport; Biphenyl Compounds; Cytosol; Diuretics; Furosemide; Imidazoles; Kidney Glomerulus; Microscopy, Fluorescence; Pyridines; Rabbits; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Sodium; Sodium Chloride; Sodium-Potassium-Chloride Symporters; Tetrazoles; Vasoconstrictor Agents | 2002 |
Dilatation of cerebral parenchymal vessels mediated by angiotensin type 1 receptor in cats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cats; Cerebral Arteries; Cerebral Cortex; Cerebrovascular Circulation; Dose-Response Relationship, Drug; Female; Imidazoles; Male; Microcirculation; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Tetrazoles; Vasodilation | 2002 |
Ang II accumulation in rat renal endosomes during Ang II-induced hypertension: role of AT(1) receptor.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antibodies; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Dextrans; Endosomes; Flow Cytometry; Fluoresceins; Hypertension; Kidney; Male; Microvilli; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Renin; Systole; Tetrazoles | 2002 |
Angiotensin II type 2 receptor counter-regulates type 1 receptor in catecholamine synthesis in cultured porcine adrenal medullary chromaffin cells.
Topics: Adrenal Medulla; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Catecholamines; Cells, Cultured; Cyclic GMP; Imidazoles; Phosphodiesterase Inhibitors; Protein Kinase C; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger; Swine; Tetrazoles; Tyrosine 3-Monooxygenase | 2002 |
Angiotensin I-converting enzyme inhibition increases cardiac catecholamine content and reduces monoamine oxidase activity via an angiotensin type 1 receptor-mediated mechanism.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Brain Chemistry; Catecholamines; Heart; Hemodynamics; In Vitro Techniques; Kinetics; Liver; Male; Mitochondria; Mitochondria, Liver; Monoamine Oxidase; Myocardium; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Tetrazoles | 2002 |
Direct left ventricular wall stretch activates GATA4 binding in perfused rat heart: involvement of autocrine/paracrine pathways.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Autocrine Communication; Benzimidazoles; Biphenyl Compounds; Bosentan; Catheterization; DNA-Binding Proteins; Endothelin Receptor Antagonists; Endothelin-1; GATA4 Transcription Factor; In Vitro Techniques; Male; Myocardium; Paracrine Communication; Perfusion; Rats; Rats, Sprague-Dawley; RNA, Messenger; Signal Transduction; Sulfonamides; Tetrazoles; Transcription Factor AP-1; Transcription Factors; Ventricular Function | 2002 |
Salt intake and non-ACE pathways for intrarenal angiotensin II generation in man.
Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Captopril; Diet, Sodium-Restricted; Female; Hemodynamics; Humans; Kidney; Male; Middle Aged; Renal Circulation; Tetrazoles | 2001 |
Valsartan and candesartan can inhibit deteriorating effects of angiotensin II on coronary endothelial function.
Topics: Angiotensin II; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Cells, Cultured; Collagenases; Coronary Vessels; Endothelins; Endothelium, Vascular; Enzyme Precursors; Humans; Male; Matrix Metalloproteinase 1; Plasminogen Activator Inhibitor 1; Tetrazoles; Valine; Valsartan; Vasoconstrictor Agents | 2001 |
Volume expansion during acute angiotensin II receptor (AT(1)) blockade and NOS inhibition in conscious dogs.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Blood Proteins; Blood Volume; Consciousness; Dogs; Enzyme Inhibitors; Female; Glomerular Filtration Rate; Heart Rate; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Osmolar Concentration; Potassium; Receptor, Angiotensin, Type 1; Sodium; Tetrazoles | 2002 |
Aortic blood flow subtraction: an alternative method for measuring total renal blood flow in conscious dogs.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Aorta, Abdominal; Arterial Occlusive Diseases; Benzimidazoles; Biphenyl Compounds; Blood Flow Velocity; Blood Pressure; Carotid Arteries; Dogs; Endothelin-1; Female; Homeostasis; Regional Blood Flow; Renal Artery; Renal Circulation; Reproducibility of Results; Rheology; Subtraction Technique; Tetrazoles; Ultrasonography; Vascular Resistance; Vasoconstrictor Agents | 2002 |
Angiotensin II directly stimulates ENaC activity in the cortical collecting duct via AT(1) receptors.
Topics: Amiloride; Analysis of Variance; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Benzofurans; Biphenyl Compounds; Hydrogen-Ion Concentration; Intracellular Membranes; Ionophores; Kidney Tubules, Collecting; Losartan; Mice; Microscopy, Fluorescence; Monensin; Rabbits; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Signal Transduction; Sodium Chloride; Tetrazoles | 2002 |
Involvement of Rho-kinase pathway for angiotensin II-induced plasminogen activator inhibitor-1 gene expression and cardiovascular remodeling in hypertensive rats.
Topics: Amides; Angiotensin II; Animals; Benzimidazoles; Biphenyl Compounds; Body Weight; Hemodynamics; Hypertension; Intracellular Signaling Peptides and Proteins; Male; Mitogen-Activated Protein Kinases; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Organ Size; Plasminogen Activator Inhibitor 1; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-fos; Pyridines; Rats; Rats, Inbred WKY; rho-Associated Kinases; rhoA GTP-Binding Protein; Ribosomal Protein S6 Kinases; RNA, Messenger; Tetrazoles; Ventricular Remodeling | 2002 |
Angiotensin II increases L-type Ca2+ current in gramicidin D-perforated adult rabbit ventricular myocytes: comparison with conventional patch-clamp method.
Topics: Action Potentials; Alkaloids; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Anti-Bacterial Agents; Benzimidazoles; Benzophenanthridines; Biphenyl Compounds; Calcium Channels, L-Type; Cell Separation; Electrophysiology; Enzyme Inhibitors; Gramicidin; Guanidines; Heart; Heart Ventricles; In Vitro Techniques; Male; Myocardium; Patch-Clamp Techniques; Phenanthridines; Protein Kinase C; Rabbits; Receptor, Angiotensin, Type 1; Sodium-Hydrogen Exchangers; Sulfones; Tetrazoles | 2002 |
Comparison of nitric oxide production in response to carbachol between macrovascular and microvascular cardiac endothelial cells.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Captopril; Carbachol; Cells, Cultured; Coronary Circulation; Endothelium, Vascular; Male; Microcirculation; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Osmolar Concentration; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Muscarinic M3; Receptors, Angiotensin; Receptors, Muscarinic; Tetrazoles; Type C Phospholipases | 2002 |
Angiotensin II angiogenic effect in vivo involves vascular endothelial growth factor- and inflammation-related pathways.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antibodies, Monoclonal; Benzimidazoles; Biphenyl Compounds; Collagen; Cyclooxygenase 2; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Endothelial Growth Factors; Female; Imidazoles; Isoenzymes; Laminin; Lymphokines; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Prostaglandin-Endoperoxide Synthases; Proteoglycans; Pyridines; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Sulfonamides; Tetrazoles; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2002 |
Peripherally applied candesartan inhibits central responses to angiotensin II in conscious rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arginine Vasopressin; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Dose-Response Relationship, Drug; Drinking; Male; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Tetrazoles; Wakefulness | 2002 |
Prejunctional and postjunctional inhibitory actions of eprosartan and candesartan in the isolated rabbit mesenteric artery.
Topics: Acrylates; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Dose-Response Relationship, Drug; Female; Imidazoles; In Vitro Techniques; Male; Mesenteric Arteries; Rabbits; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Receptors, Presynaptic; Tetrazoles; Thiophenes | 2002 |
Neurohormonal influences on maintenance and reversal of two-kidney one-clip renal hypertension.
Topics: Angiotensin II; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Catecholamines; Heart Rate; Hypertension, Renovascular; Kidney; Male; Neurotransmitter Agents; Phentolamine; Propranolol; Rats; Rats, Wistar; Reference Values; Renal Circulation; Renin; Renin-Angiotensin System; Sympathetic Nervous System; Tetrazoles | 2002 |
Influence of angiotensin II type 1-receptor antagonist CV11974 on infarct size and adjacent regional function after ischemia-reperfusion in dogs.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Dogs; Hemodynamics; Myocardial Infarction; Receptors, Angiotensin; Reperfusion Injury; Tetrazoles; Ventricular Function, Left | 2002 |
Role of angiotensin II and angiotensin II receptors in vascular smooth muscle cell migration in vitro.
Topics: Actins; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Cell Movement; Cells, Cultured; Cytoskeleton; Dose-Response Relationship, Drug; Female; Focal Adhesions; Imidazoles; Immunohistochemistry; Male; Muscle, Smooth, Vascular; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Tetrazoles | 2002 |
AT1 receptor blockade reduces cardiac calcineurin activity in hypertensive rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Calcineurin; Cardiomegaly; Echocardiography; Fibrosis; Gene Expression Regulation; Hypertension; Male; Myocardium; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; RNA, Messenger; Stress, Mechanical; Tacrolimus; Tetrazoles; Time Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2002 |
In vitro and in vivo characterization of the activity of telmisartan: an insurmountable angiotensin II receptor antagonist.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Pressure; Cell Membrane; In Vitro Techniques; Irbesartan; Kinetics; Muscle, Smooth, Vascular; Radioligand Assay; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Telmisartan; Tetrazoles | 2002 |
Antagonist interaction with endogenous AT(1) receptors in human cell lines.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Binding, Competitive; Biphenyl Compounds; Cell Line; CHO Cells; Cricetinae; Humans; Inositol Phosphates; Iodine Radioisotopes; Irbesartan; Muscle, Smooth, Vascular; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Tetrazoles; Transfection | 2002 |
Role of ANG II in coronary capillary angiogenesis at the insulin-resistant stage of a NIDDM rat model.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Capillaries; Coronary Circulation; Diabetes Mellitus, Type 2; Disease Models, Animal; Endothelial Growth Factors; Extracellular Matrix Proteins; Gene Expression; Glycation End Products, Advanced; Hypoxia-Inducible Factor 1, alpha Subunit; Insulin Resistance; Lymphokines; Male; Neovascularization, Physiologic; Rats; Rats, Inbred OLETF; Rats, Long-Evans; Receptor Protein-Tyrosine Kinases; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Receptors, Growth Factor; Receptors, Vascular Endothelial Growth Factor; RNA, Messenger; Tetrazoles; Transcription Factors; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2002 |
Rostral ventrolateral medulla neurons of neonatal Wistar-Kyoto and spontaneously hypertensive rats.
Topics: Action Potentials; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Animals, Newborn; Benzimidazoles; Biphenyl Compounds; Brain Stem; Cells, Cultured; Hypertension; Kinetics; Membrane Potentials; Neurons; Patch-Clamp Techniques; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Spinal Cord; Tetrazoles | 2002 |
Dose-dependent regulation of NAD(P)H oxidase expression by angiotensin II in human endothelial cells: protective effect of angiotensin II type 1 receptor blockade in patients with coronary artery disease.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Benzimidazoles; Biphenyl Compounds; Cells, Cultured; Coronary Artery Bypass; Coronary Artery Disease; Dose-Response Relationship, Drug; Endothelium, Vascular; Humans; Imidazoles; Mammary Arteries; Membrane Glycoproteins; NADH, NADPH Oxidoreductases; NADPH Oxidase 2; NADPH Oxidases; Oxidative Stress; Preoperative Care; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin-Angiotensin System; Retrospective Studies; Superoxides; Tetrazoles; Umbilical Veins | 2002 |
Renal segmental microvascular responses to ANG II in AT1A receptor null mice.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arterioles; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Dose-Response Relationship, Drug; Female; In Vitro Techniques; Kidney; Male; Mice; Mice, Knockout; Microcirculation; Nephrons; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Tetrazoles; Vascular Patency; Vascular Resistance | 2003 |
Comparison of the antagonistic effects of different angiotensin II receptor blockers in human coronary arteries.
Topics: Adult; Angiotensin II; Angiotensin Receptor Antagonists; Base Sequence; Benzimidazoles; Biphenyl Compounds; Coronary Vessels; Culture Techniques; Dose-Response Relationship, Drug; Female; Humans; Imidazoles; Losartan; Male; Middle Aged; Molecular Sequence Data; Probability; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazoles; Valine; Valsartan; Vasoconstriction | 2002 |
Endothelin-1 contributes to the Frank-Starling response in hypertrophic rat hearts.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensinogen; Animals; Animals, Genetically Modified; Benzimidazoles; Biphenyl Compounds; Bosentan; Endothelin Receptor Antagonists; Endothelin-1; Heart Ventricles; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Myocardial Contraction; Organ Culture Techniques; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renin; RNA, Messenger; Stress, Mechanical; Sulfonamides; Tetrazoles | 2003 |
Control of dendritic cell differentiation by angiotensin II.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antibodies; Benzimidazoles; Biphenyl Compounds; Cell Differentiation; Cells, Cultured; Dendritic Cells; Endocytosis; Hematopoietic Stem Cells; Humans; Irbesartan; Losartan; Lymphocyte Activation; Mice; Models, Biological; Monocytes; Phenotype; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Tetrazoles | 2003 |
Binding of KRH-594, an antagonist of the angiotensin II type 1 receptor, to cloned human and rat angiotensin II receptors.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Chlorocebus aethiops; COS Cells; Dose-Response Relationship, Drug; Humans; Imidazoles; In Vitro Techniques; Liver; Losartan; Membranes; Oligopeptides; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Tetrazoles; Thiadiazoles; Time Factors; Transfection | 2002 |
Effects of ANG II type 1 and 2 receptors on oxidative stress, renal NADPH oxidase, and SOD expression.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Body Weight; Gene Expression Regulation, Enzymologic; Imidazoles; Isoprostanes; Kidney; Male; Malondialdehyde; NADPH Oxidases; Oxidative Stress; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Superoxide Dismutase; Tetrazoles; Vasoconstrictor Agents | 2003 |
Down-regulation of bradykinin B2-receptor mRNA in the heart in pressure-overload cardiac hypertrophy in the rat.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Aorta; Benzimidazoles; Biphenyl Compounds; Cardiomegaly; Cell Membrane; Down-Regulation; Gene Expression; Heart; Humans; Kallikreins; Kininogens; Male; Myocardium; Rats; Rats, Wistar; Receptor, Bradykinin B2; Receptors, Bradykinin; RNA, Messenger; Tetrazoles; Vasoconstriction | 2003 |
Angiotensin II-induced modulation of endothelium-dependent relaxation in rabbit mesenteric resistance arteries.
Topics: Acetylcholine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Cell Membrane Permeability; Cyclic GMP; Enalaprilat; Endothelium, Vascular; In Vitro Techniques; Kinetics; Male; Mesenteric Arteries; Muscle, Smooth, Vascular; Nitroarginine; Rabbits; Receptor, Angiotensin, Type 1; Tetrazoles; Thiazepines; Vasodilation | 2003 |
Functional antagonism of different angiotensin II type I receptor blockers in human arteries.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Benzimidazoles; Biphenyl Compounds; Dose-Response Relationship, Drug; Humans; Imidazoles; In Vitro Techniques; Losartan; Mammary Arteries; Muscle Contraction; Muscle, Smooth, Vascular; Receptor, Angiotensin, Type 1; Tetrazoles; Valine; Valsartan; Vasoconstrictor Agents | 2002 |
AT1 receptors in the RVLM mediate pressor responses to emotional stress in rabbits.
Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Baroreflex; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Consciousness; Female; Glutamates; Heart Rate; Hypertension; Kidney; Losartan; Male; Medulla Oblongata; Rabbits; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Stress, Psychological; Sympathetic Nervous System; Tetrazoles | 2003 |
Long-term regulation of ENaC expression in kidney by angiotensin II.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Benzothiadiazines; Bicarbonates; Biphenyl Compounds; Diuretics; Epithelial Sodium Channels; Gene Expression Regulation; Immunoblotting; Infusion Pumps; Injections, Subcutaneous; Kidney; Kidney Cortex; Kidney Medulla; Kidney Tubules, Distal; Male; Mineralocorticoid Receptor Antagonists; Potassium; Protein Subunits; Quaternary Ammonium Compounds; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sodium Channels; Sodium Chloride Symporter Inhibitors; Sodium Chloride Symporters; Sodium Chloride, Dietary; Spironolactone; Symporters; Tetrazoles; Time Factors | 2003 |
Anti-inflammatory effects of angiotensin II AT1 receptor antagonism prevent stress-induced gastric injury.
Topics: Adrenal Medulla; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arteries; Benzimidazoles; Biphenyl Compounds; Blood Flow Velocity; Cold Temperature; Corticosterone; Dinoprostone; Endothelium, Vascular; Epinephrine; Gastric Mucosa; Intercellular Adhesion Molecule-1; Leukocyte Count; Male; Neutrophils; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Restraint, Physical; RNA, Messenger; Stomach Ulcer; Stress, Physiological; Tetrazoles; Tumor Necrosis Factor-alpha; Tyrosine 3-Monooxygenase | 2003 |
[Angiotensin II antagonist treatment as a contributory cause of acute renal failure].
Topics: Acute Kidney Injury; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Humans; Male; Middle Aged; Renin-Angiotensin System; Tetrazoles | 2003 |
Intraluminal pressure increases vascular neuronal nitric oxide synthase expression.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Carotid Artery, Common; Circadian Rhythm; Endothelium, Vascular; Indoles; Isoenzymes; Isometric Contraction; Male; Models, Animal; Models, Cardiovascular; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Rats; Rats, Wistar; Tetrazoles; Time Factors; Vasoconstrictor Agents | 2003 |
Angiotensin II inhibits endothelial cell motility through an AT1-dependent oxidant-sensitive decrement of nitric oxide availability.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Cell Division; Cell Movement; Dose-Response Relationship, Drug; Endothelial Cells; Endothelium, Vascular; Glutathione; Humans; NADPH Oxidases; Nitric Oxide; Oxidants; Oxidation-Reduction; Oxidative Stress; Reactive Oxygen Species; Tetrazoles; Time Factors | 2003 |
Effect of AT1 receptor blockade on hepatic redox status in SHR: possible relevance for endothelial function?
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Aorta; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Endothelium, Vascular; Gene Expression Regulation, Enzymologic; Glutathione; Glutathione Disulfide; Glutathione Peroxidase; Glutathione Reductase; Hypertension; Liver; Malondialdehyde; Membrane Transport Proteins; NADPH Dehydrogenase; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Oxidation-Reduction; Oxidative Stress; Phosphoproteins; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Tetrazoles | 2003 |
Influence of plasma insulin levels on antinatriuretic and vasoconstrictor actions of angiotensin-II.
Topics: Angiotensin II; Animals; Anti-Bacterial Agents; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Diabetes Mellitus, Experimental; Diuresis; Drug Interactions; Enzyme Inhibitors; Ganglionic Blockers; Heart Rate; Hypoglycemic Agents; Insulin; Kidney; Natriuresis; Nitric Oxide Synthase; Nitroarginine; Rats; Rats, Sprague-Dawley; Streptozocin; Tetrazoles; Vasoconstrictor Agents | 2003 |
Angiotensin II blockade augments renal cortical microvascular pO2 indicating a novel, potentially renoprotective action.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Enalaprilat; Hypertension; Hypoxia; Kidney Cortex; Male; Microcirculation; Oxygen; Oxygen Consumption; Partial Pressure; Pilot Projects; Porphyrins; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Tetrazoles | 2003 |
Endogenous angiotensin affects responses to stimulation of baroreceptor afferent nerves.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Aorta; Baroreflex; Benzimidazoles; Biphenyl Compounds; Diet, Sodium-Restricted; Electric Stimulation; Male; Neurons, Afferent; Pressoreceptors; Rats; Rats, Sprague-Dawley; Sodium Chloride, Dietary; Sympathetic Nervous System; Tetrazoles; Vagus Nerve | 2003 |
Myogenic constriction is increased in mesenteric resistance arteries from rats with chronic heart failure: instantaneous counteraction by acute AT1 receptor blockade.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Bridged Bicyclo Compounds, Heterocyclic; Captopril; Chronic Disease; Coronary Vessels; Disease Models, Animal; Endothelium-Dependent Relaxing Factors; Endothelium, Vascular; Fatty Acids, Unsaturated; Heart; Heart Failure; Hydrazines; Imidazoles; Indomethacin; Lisinopril; Losartan; Male; Mesenteric Arteries; Nitric Oxide; omega-N-Methylarginine; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Superoxide Dismutase; Sympathetic Nervous System; Tetrazoles; Tetrodotoxin; Vascular Resistance | 2003 |
In salt-sensitive hypertension, increased superoxide production is linked to functional upregulation of angiotensin II.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Endothelium, Vascular; Hypertension; Hypertrophy; Hypertrophy, Left Ventricular; Isoprostanes; Proteinuria; Rats; Rats, Inbred Dahl; Sodium Chloride; Superoxides; Tetrazoles; Up-Regulation; Vasodilation | 2003 |
Angiotensin II receptor blockade prevents microangiopathy and preserves diastolic function in the diabetic rat heart.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Blood Glucose; Body Weight; Capillaries; Cytokines; Diabetic Angiopathies; Heme Oxygenase (Decyclizing); Immunohistochemistry; Male; Matrix Metalloproteinases; Organ Size; Rats; Rats, Inbred OLETF; Reverse Transcriptase Polymerase Chain Reaction; Tetrazoles; Tissue Inhibitor of Metalloproteinase-2; Ventricular Dysfunction, Left | 2003 |
Angiotensin II type 1 receptor-mediated augmentation of renal interstitial fluid angiotensin II in angiotensin II-induced hypertension.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Body Weight; Extracellular Fluid; Hypertension, Renal; Kidney; Male; Microdialysis; Organ Size; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Tetrazoles; Vasoconstrictor Agents | 2003 |
[Dosage equivalents of AT1-receptor antagonists available in Germany].
Topics: Acrylates; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Clinical Trials as Topic; Germany; Humans; Hypertension; Imidazoles; Irbesartan; Losartan; Olmesartan Medoxomil; Placebos; Telmisartan; Tetrazoles; Therapeutic Equivalency; Thiophenes; Time Factors; Valine; Valsartan | 2003 |
ROS during the acute phase of Ang II hypertension participates in cardiovascular MAPK activation but not vasoconstriction.
Topics: Acute Disease; Adrenergic alpha-Agonists; Angiotensin II; Animals; Antioxidants; Aorta; Benzimidazoles; Biphenyl Compounds; Cyclic N-Oxides; Enzyme Activation; Heart Ventricles; Hemodynamics; Hypertension; Male; Mitogen-Activated Protein Kinases; Oxidative Stress; Phenylephrine; Prazosin; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Spin Labels; Tetrazoles; Thiobarbituric Acid Reactive Substances; Vasoconstrictor Agents | 2004 |
Angiotensin II blockade prevents hyperglycemia-induced activation of JAK and STAT proteins in diabetic rat kidney glomeruli.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Diabetic Nephropathies; DNA-Binding Proteins; Enzyme Inhibitors; Hyperglycemia; Intracellular Signaling Peptides and Proteins; Janus Kinase 2; Kidney Glomerulus; Male; Milk Proteins; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Signal Transduction; STAT1 Transcription Factor; STAT3 Transcription Factor; STAT5 Transcription Factor; Tetrazoles; Trans-Activators; Transcription, Genetic; Tyrphostins | 2004 |
Pressure-independent effects of angiotensin II on hypertensive myocardial fibrosis.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cell Movement; Constriction; Coronary Vessels; Fibrosis; Hypertension; Hypertrophy, Left Ventricular; Inflammation; Macrophages; Male; Myocardium; Peptidyl-Dipeptidase A; Pressure; Rats; Rats, Wistar; Tetrazoles | 2004 |
Sub-depressor dose of angiotensin type-1 receptor blocker inhibits transforming growth factor-beta-mediated perivascular fibrosis in hypertensive rat hearts.
Topics: Administration, Oral; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Benzimidazoles; Biphenyl Compounds; Collagen; Constriction; Disease Models, Animal; Dose-Response Relationship, Drug; Endomyocardial Fibrosis; Fibroblasts; Hypertension; Male; Myocytes, Cardiac; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Tetrazoles; Time Factors; Transforming Growth Factor beta; Ventricular Remodeling | 2003 |
Cerebral ischemia enhances vascular angiotensin AT1 receptor-mediated contraction in rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Brain Ischemia; Culture Techniques; Infarction, Middle Cerebral Artery; Losartan; Male; Middle Cerebral Artery; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; RNA, Messenger; Tetrazoles; Vasoconstriction; Vasoconstrictor Agents | 2004 |
Effect of saponin and filipin on antagonist binding to AT 1 receptors in intact cells.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Binding, Competitive; Biphenyl Compounds; CHO Cells; Cricetinae; Drug Interactions; Female; Filipin; Humans; Kinetics; Radioligand Assay; Receptor, Angiotensin, Type 1; Saponins; Tetrazoles; Transfection | 2004 |
The effects of candesartan and ramipril on adrenal catecholamine release in anaesthetized dogs.
Topics: Adrenal Glands; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Catecholamines; Chromatography, High Pressure Liquid; Denervation; Dogs; Electric Stimulation; Homeostasis; Male; Ramipril; Stimulation, Chemical; Tetrazoles | 2004 |
Plasma aldosterone concentration in the patient with diabetes mellitus.
Topics: Adolescent; Adult; Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Case-Control Studies; Diabetes Mellitus, Type 1; Female; Humans; Male; Middle Aged; Osmolar Concentration; Renin; Tetrazoles | 2004 |
Aldosterone antagonist facilitates the cardioprotective effects of angiotensin receptor blockers in hypertensive rats.
Topics: Aldosterone; Angiotensin II; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Body Weight; Cardiomegaly; Cardiotonic Agents; Collagen Type I; Collagen Type III; Drug Synergism; Fibrosis; Hypertension; Male; Mineralocorticoid Receptor Antagonists; Myocardium; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; RNA, Messenger; Spironolactone; Tetrazoles | 2004 |
Chronic production of angiotensin IV in the brain leads to hypertension that is reversible with an angiotensin II AT1 receptor antagonist.
Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Allosteric Regulation; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Brain; Calcium Signaling; CHO Cells; Cricetinae; Cricetulus; Gene Expression; Genes, Synthetic; Glial Fibrillary Acidic Protein; Globins; Humans; Hypertension; Imidazoles; Mice; Mice, Transgenic; Organ Specificity; Protein Sorting Signals; Pyridines; Rabbits; Receptor, Angiotensin, Type 1; Recombinant Fusion Proteins; Renin; Renin-Angiotensin System; Tetrazoles; Transgenes | 2004 |
Plasma and kidney angiotensin II levels and renal functional responses to AT(1) receptor blockade in hypertensive Ren-2 transgenic rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Animals, Genetically Modified; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Glomerular Filtration Rate; Hypertension; Kidney Function Tests; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renal Plasma Flow; RNA, Messenger; Sodium; Tetrazoles | 2004 |
Angiotensin II stimulates the release of interleukin-6 and interleukin-8 from cultured human adipocytes by activation of NF-kappaB.
Topics: Adipocytes; Adult; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Cells, Cultured; Electrophoretic Mobility Shift Assay; Female; Humans; Imidazoles; Inflammation; Interleukin-6; Interleukin-8; NF-kappa B; Nitriles; Phosphorylation; Protein Processing, Post-Translational; Protein Transport; Pyridines; Receptor, Angiotensin, Type 1; RNA, Messenger; Sulfones; Tetrazoles; Transcription Factor RelA; Transcriptional Activation | 2004 |
Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Cardiomegaly; COS Cells; Cytosol; GTP-Binding Proteins; Humans; Janus Kinase 2; Mice; Mice, Knockout; Mitogen-Activated Protein Kinases; Muscle Contraction; Myocytes, Cardiac; Phosphatidylinositols; Protein Transport; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Stress, Mechanical; Tetrazoles; Up-Regulation | 2004 |
Pharmacological properties of angiotensin II receptors in cultured rabbit gingival fibroblasts.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Binding, Competitive; Biphenyl Compounds; Blotting, Western; Cell Division; Cells, Cultured; Dose-Response Relationship, Drug; Fibroblasts; Gingiva; Kinetics; Losartan; Rabbits; Radioligand Assay; Receptors, Angiotensin; Saralasin; Tetrazoles; Tritium | 2004 |
Angiotensin II AT1 receptor blockade decreases brain artery inflammation in a stress-prone rat strain.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arteritis; Benzimidazoles; Biphenyl Compounds; Brain; Cell Adhesion; Intercellular Adhesion Molecule-1; Macrophages; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Angiotensin; Stress, Physiological; Tetrazoles | 2004 |
Effects of angiotensin II type 1 receptor antagonist on pressor responses to pulsatile compression of the rostral ventrolateral medulla in rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Excitatory Amino Acid Antagonists; Glutamic Acid; Hypertension; Imidazoles; Injections, Intravenous; Kynurenic Acid; Male; Medulla Oblongata; Pulsatile Flow; Pyridines; Rats; Rats, Wistar; Sympathetic Nervous System; Tetrazoles; Vasoconstrictor Agents | 2004 |
Regulation of renal proximal fluid uptake by luminal and peritubular angiotensin II.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Benzimidazoles; Biological Transport; Biphenyl Compounds; Capillaries; Kidney Tubules, Proximal; Male; Rats; Rats, Wistar; Tetrazoles; Vasoconstrictor Agents | 2004 |
Metabolism of angiotensin II is required for its in vivo effect on dopamine release in the striatum of the rat.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Hemoglobins; Imidazoles; Male; Methionine; Microdialysis; Naltrexone; Narcotic Antagonists; Peptide Fragments; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 2; Sulfonic Acids; Tetrazoles; Time Factors | 2004 |
Endogenous angiotensin II in the regulation of hypoxic pulmonary vasoconstriction in anaesthetized dogs.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Dogs; Enalaprilat; Endothelium, Vascular; Hypertension, Pulmonary; Hypoxia; Lung; Models, Animal; Renin-Angiotensin System; Tetrazoles; Vascular Resistance; Vasoconstriction; Vasoconstrictor Agents | 2004 |
Extracellular signal regulated kinase and SMAD signaling both mediate the angiotensin II driven progression towards overt heart failure in homozygous TGR(mRen2)27.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Genetically Modified; Atrial Natriuretic Factor; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Collagen Type I; Disease Models, Animal; DNA-Binding Proteins; Enzyme Activation; Enzyme Inhibitors; Fibrosis; Heart Failure; Homozygote; Hypertrophy, Left Ventricular; Imidazoles; Immunohistochemistry; Male; Mitogen-Activated Protein Kinases; Myocardium; Protein-Tyrosine Kinases; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Renin; Smad Proteins; Tetrazoles; Time Factors; Trans-Activators; Tyrphostins | 2004 |
Oral administration of an AT1 receptor antagonist prevents the central effects of angiotensin II in spontaneously hypertensive rats.
Topics: Administration, Oral; Adrenal Glands; Adrenocorticotropic Hormone; Analysis of Variance; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Catechols; Corticosterone; Drug Administration Schedule; Drug Interactions; Injections, Intraventricular; Locus Coeruleus; Male; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; RNA, Messenger; Tetrazoles; Tyrosine 3-Monooxygenase | 2004 |
Transforming growth factor beta receptor endoglin is expressed in cardiac fibroblasts and modulates profibrogenic actions of angiotensin II.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Antibodies, Monoclonal; Benzimidazoles; Biphenyl Compounds; Cells, Cultured; Collagen Type I; Endoglin; Fibroblasts; Flavonoids; Gene Expression Regulation; Imidazoles; Intracellular Signaling Peptides and Proteins; Losartan; MAP Kinase Signaling System; Matrix Metalloproteinase 1; Myocardium; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Transforming Growth Factor beta; RNA, Messenger; Signal Transduction; Tetrazoles; Valine; Valsartan | 2004 |
Hepatocyte growth factor induces an endothelin-mediated decline in glomerular filtration rate.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Bosentan; Cattle; Cells, Cultured; Drug Administration Schedule; Endothelin-1; Glomerular Filtration Rate; Hepatocyte Growth Factor; Kidney; Kidney Glomerulus; Male; Rats; Rats, Sprague-Dawley; Sulfonamides; Tetrazoles | 2005 |
Renal angiotensin II type-2 receptors are upregulated and mediate the candesartan-induced natriuresis/diuresis in obese Zucker rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Diuresis; Imidazoles; Kidney; Male; Natriuresis; Obesity; Oligopeptides; Pyridines; Rats; Rats, Zucker; Receptor, Angiotensin, Type 2; Tetrazoles; Up-Regulation | 2005 |
Combination therapy with an angiotensin-converting enzyme inhibitor and an angiotensin II receptor blocker synergistically suppresses chronic pancreatitis in rats.
Topics: Actins; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Body Weight; Chronic Disease; Cytokines; Dose-Response Relationship, Drug; Drug Synergism; Fibrosis; Genes, ras; Hydroxyproline; Immunohistochemistry; Lisinopril; Male; Organ Size; Pancreatitis; Peptidyl-Dipeptidase A; Peroxidase; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; RNA, Messenger; Tetrazoles | 2005 |
The renal vascular response to ANG II injection is reduced in the nonclipped kidney of two-kidney, one-clip hypertension.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Blotting, Western; Cyclooxygenase Inhibitors; Down-Regulation; Hemodynamics; Hypertension, Renovascular; Indomethacin; Male; Organ Size; Proteins; Rats; Receptors, Angiotensin; Renal Circulation; Renin; Reverse Transcriptase Polymerase Chain Reaction; RNA; RNA, Messenger; Tetrazoles; Vascular Resistance; Vasoconstrictor Agents | 2005 |
Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination.
Topics: Adenocarcinoma; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antigens, CD34; Benzimidazoles; Biphenyl Compounds; Cell Line, Tumor; Dose-Response Relationship, Drug; Female; Humans; Immunohistochemistry; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Neovascularization, Pathologic; Ovarian Neoplasms; Peritoneum; Receptor, Angiotensin, Type 1; Tetrazoles; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2005 |
Critical role of angiotensin II in excess salt-induced brain oxidative stress of stroke-prone spontaneously hypertensive rats.
Topics: Amlodipine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Blood-Brain Barrier; Calcium Channel Blockers; Cell Proliferation; Cerebral Arteries; Cerebral Cortex; Disease Models, Animal; Hippocampus; Hypertensive Encephalopathy; Male; Neurons; Oxidative Stress; Rats; Rats, Inbred SHR; Sodium Chloride; Stroke; Superoxides; Tetrazoles | 2005 |
Candesartan prevents angiotensin II-induced facilitation of hypoxic neuronal damage through PKCdelta inhibition.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Blotting, Western; Cell Death; Cell Hypoxia; Dose-Response Relationship, Drug; Drug Interactions; Gene Expression Regulation; Imidazoles; In Situ Nick-End Labeling; Mice; PC12 Cells; Phosphorylation; Protein Kinase C; Protein Kinase C-delta; Pyridines; Rats; Serine; Tetrazoles; Time Factors; Transfection | 2005 |
Ligand binding and functional properties of human angiotensin AT1 receptors in transiently and stably expressed CHO-K1 cells.
Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Binding, Competitive; Biphenyl Compounds; CHO Cells; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; Gene Expression; Green Fluorescent Proteins; Humans; Inositol Phosphates; Kinetics; Ligands; Microscopy, Confocal; Radioligand Assay; Receptor, Angiotensin, Type 1; Recombinant Fusion Proteins; Tetrazoles; Transfection; Tritium | 2005 |
ATR blockade reduces IFN-gamma production in lymphocytes in vivo and in vitro.
Topics: Adult; Aged; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Female; Humans; Interferon-gamma; Losartan; Lymphocyte Activation; Lymphocytes; Male; Middle Aged; Polymerase Chain Reaction; RNA, Messenger; Tetrazoles | 2005 |
Angiotensin II and nitric oxide in neural control of intrarenal blood flow.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Dose-Response Relationship, Drug; Electric Stimulation; Enzyme Inhibitors; Kidney Cortex; Laser-Doppler Flowmetry; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rabbits; Receptor, Angiotensin, Type 1; Renal Circulation; Sympathetic Nervous System; Tetrazoles | 2005 |
Calcium and chloride channel activation by angiotensin II-AT1 receptors in preglomerular vascular smooth muscle cells.
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Angiotensin II; Animals; Benzimidazoles; Biphenyl Compounds; Calcium; Calcium Channel Blockers; Calcium Channels; Calibration; Capillaries; Cell Separation; Chloride Channels; Diltiazem; Gallic Acid; In Vitro Techniques; Inositol 1,4,5-Trisphosphate; Male; Muscle, Smooth, Vascular; ortho-Aminobenzoates; Potassium Chloride; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Tetrazoles; Vasoconstrictor Agents | 2005 |
Angiotensin II promotes leptin production in cultured human fat cells by an ERK1/2-dependent pathway.
Topics: Adipocytes; Adult; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Blotting, Western; Butadienes; Cells, Cultured; Chromans; Drug Interactions; Extracellular Signal-Regulated MAP Kinases; Female; Fibrinolytic Agents; Humans; Leptin; MAP Kinase Signaling System; Nitriles; Protein Kinase Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazoles; Thiazolidinediones; Troglitazone | 2005 |
Electrophysiological properties of rostral ventrolateral medulla neurons in angiotensin II 1a receptor knockout mice.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Electrophysiology; Imidazoles; Medulla Oblongata; Mice; Mice, Inbred C57BL; Mice, Knockout; Neurons; Pyridines; Receptor, Angiotensin, Type 1; Tetrazoles | 2005 |
The role of intrarenal angiotensin II in the development of hypertension in Ren-2 transgenic rats.
Topics: Angiotensin II; Animals; Animals, Genetically Modified; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Blotting, Western; Hypertension; Kidney; Proteins; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Renal Circulation; Sodium; Tetrazoles | 2005 |
Enhanced tubuloglomerular feedback in Cyp1a1-Ren2 transgenic rats with inducible ANG II-dependent malignant hypertension.
Topics: Angiotensin II; Animals; Animals, Genetically Modified; Benzimidazoles; Biphenyl Compounds; Cytochrome P-450 CYP1A1; Feedback; Glomerular Filtration Rate; Hypertension, Malignant; Indoles; Kidney Glomerulus; Kidney Tubules; Male; Rats; Rats, Inbred F344; Receptor, Angiotensin, Type 1; Renal Circulation; Renin; Tetrazoles | 2005 |
In vivo characterization of the angiotensin-(1-7)-induced dopamine and gamma-aminobutyric acid release in the striatum of the rat.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Chromatography; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; gamma-Aminobutyric Acid; Imidazoles; Male; Microdialysis; NG-Nitroarginine Methyl Ester; Peptide Fragments; Pyridines; Rats; Rats, Wistar; Sulfonic Acids; Tetrazoles; Time Factors | 2005 |
Angiotensin II in dorsomedial hypothalamus modulates cardiovascular arousal caused by stress but not feeding in rabbits.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Cardiovascular Physiological Phenomena; Dorsomedial Hypothalamic Nucleus; Eating; Excitatory Amino Acid Agonists; GABA Agonists; Kainic Acid; Muscimol; Rabbits; Stress, Psychological; Tetrazoles | 2006 |
Peripheral sympatholytic actions of four AT1 antagonists: are they relevant for long-term antihypertensive efficacy?
Topics: Acrylates; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Dose-Response Relationship, Drug; Electric Stimulation; Imidazoles; Irbesartan; Losartan; Male; Norepinephrine; Rats; Rats, Inbred SHR; Sympathetic Fibers, Postganglionic; Sympatholytics; Tetrazoles; Thiophenes; Time Factors; Treatment Outcome | 2005 |
Acute effects of candesartan on rat renal haemodynamics and proximal tubular reabsorption.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Diuresis; Glomerular Filtration Rate; Kidney; Kidney Tubules, Proximal; Lithium; Male; Natriuresis; Potassium; Rats; Rats, Wistar; Renal Plasma Flow; Tetrazoles | 2005 |
A centrally acting, anxiolytic angiotensin II AT1 receptor antagonist prevents the isolation stress-induced decrease in cortical CRF1 receptor and benzodiazepine binding.
Topics: Amphibian Proteins; Analysis of Variance; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Autoradiography; Behavior, Animal; Benzimidazoles; Benzodiazepines; Biphenyl Compounds; Cerebral Cortex; Disease Models, Animal; Flunitrazepam; GABA Modulators; In Situ Hybridization; Male; Maze Learning; Peptide Hormones; Peptides; Protein Binding; Pyrimidines; Pyrroles; Rats; Receptor, Angiotensin, Type 2; Receptors, Corticotropin-Releasing Hormone; RNA, Messenger; Social Isolation; Stress, Physiological; Tetrazoles; Tyrosine 3-Monooxygenase | 2006 |
Increased aortic NADPH oxidase activity in rats with genetically high angiotensin-converting enzyme levels.
Topics: Acetylcholine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Benzimidazoles; Biphenyl Compounds; In Vitro Techniques; Male; NADPH Oxidases; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Rats; Rats, Inbred BN; Rats, Inbred Lew; Superoxides; Tetrazoles; Vasodilation; Vasodilator Agents | 2005 |
Activation of AP-1 through reactive oxygen species by angiotensin II in rat cardiomyocytes.
Topics: Acetylcysteine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Benzimidazoles; Biphenyl Compounds; Cells, Cultured; Dose-Response Relationship, Drug; Heart Ventricles; HL-60 Cells; Humans; Myocytes, Cardiac; NADPH Oxidases; Onium Compounds; Oxidation-Reduction; Rats; Rats, Wistar; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Tetrazoles; Time Factors; Transcription Factor AP-1 | 2005 |
Angiotensin II blockade improves mitochondrial function in spontaneously hypertensive rats.
Topics: Actins; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Creatinine; Electron Transport Complex IV; Hydrogen Peroxide; Hypertension; Immunohistochemistry; Kidney Cortex; Male; Membrane Potentials; Mitochondria; Nitric Oxide Synthase; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrazoles | 2005 |
Biphasic effects of angiotensin II and receptor antagonism on aggregability and protein kinase C phosphorylation in human platelets.
Topics: Adult; Aged; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Blood Platelets; Female; Humans; Imidazoles; In Vitro Techniques; Isoenzymes; Male; Middle Aged; Phosphorylation; Platelet Aggregation; Protein Kinase C; Pyridines; Receptor, Angiotensin, Type 1; Tetrazoles; Valine; Valsartan; Vasoconstrictor Agents | 2005 |
High glucose increases extracellular matrix production in pancreatic stellate cells by activating the renin-angiotensin system.
Topics: Angiotensin I; Angiotensin II; Animals; Benzimidazoles; Biphenyl Compounds; Collagen; Connective Tissue Growth Factor; Dose-Response Relationship, Drug; Extracellular Matrix; Extracellular Matrix Proteins; Fibronectins; Fibrosis; Glucose; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Male; Pancreas; Pancreatitis; Ramipril; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Tetrazoles; Transforming Growth Factor beta | 2006 |
Angiotensin II-induced vasodilatation in cerebral arteries is mediated by endothelium-derived hyperpolarising factor.
Topics: Adenosine Triphosphate; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apamin; Benzimidazoles; Biological Factors; Biphenyl Compounds; Cerebral Arteries; Charybdotoxin; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Imidazoles; In Vitro Techniques; Indomethacin; Male; Neurotoxins; Nitric Oxide Synthase; Nitroarginine; Pyridines; Rats; Rats, Sprague-Dawley; Serotonin; Tetrazoles; Vasoconstriction; Vasoconstrictor Agents | 2006 |
Angiotensin II inhibition reduces stress sensitivity of hypothalamo-pituitary-adrenal axis in spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Corticosterone; Gene Expression Regulation; Hypothalamus; Male; Mibefradil; Pituitary-Adrenal System; Ramipril; Rats; Rats, Inbred SHR; Tetrazoles | 2006 |
AT1 receptor blockade regulates the local angiotensin II system in cerebral microvessels from spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Brain; Gene Expression Regulation; Hypertension; Male; Microcirculation; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Signal Transduction; Tetrazoles | 2006 |
Role of chymase-dependent angiotensin II formation in monocrotaline-induced pulmonary hypertensive rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cell Proliferation; Chymases; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Monocrotaline; Peptidyl-Dipeptidase A; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; RNA, Messenger; Serine Endopeptidases; Tetrazoles; Tunica Media | 2006 |
Angiotensin II mediates downregulation of aquaporin water channels and key renal sodium transporters in response to urinary tract obstruction.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aquaporin 1; Aquaporin 2; Aquaporin 3; Aquaporins; Benzimidazoles; Biphenyl Compounds; Cyclooxygenase 2; Down-Regulation; Glomerular Filtration Rate; Male; Phosphates; Polyuria; Rats; Rats, Wistar; Sodium; Sodium-Phosphate Cotransporter Proteins, Type II; Sodium-Potassium-Chloride Symporters; Solute Carrier Family 12, Member 1; Tetrazoles; Ureteral Obstruction; Vasoconstrictor Agents | 2006 |
Involvement of the somatostatin-2 receptor in the anti-convulsant effect of angiotensin IV against pilocarpine-induced limbic seizures in rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Anticonvulsants; Benzimidazoles; Biphenyl Compounds; Dopamine; Glutamic Acid; Hippocampus; Injections, Intraventricular; Limbic System; Male; Microdialysis; Oligopeptides; Pilocarpine; Rats; Rats, Wistar; Receptors, Somatostatin; Seizures; Serotonin; Somatostatin; Tetrazoles | 2006 |
Long-term regulation of proximal tubule acid-base transporter abundance by angiotensin II.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Gene Expression Regulation; Gene Expression Regulation, Enzymologic; Kidney Tubules, Proximal; Male; Rats; Rats, Inbred SHR; RNA, Messenger; Sodium-Bicarbonate Symporters; Sodium-Hydrogen Exchangers; Sodium-Phosphate Cotransporter Proteins, Type II; Sodium-Potassium-Exchanging ATPase; Tetrazoles | 2006 |
Anti-inflammatory effect of spironolactone on human peripheral blood mononuclear cells.
Topics: Adult; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents; Benzimidazoles; Biphenyl Compounds; Captopril; Cells, Cultured; Chemokine CCL2; Dose-Response Relationship, Drug; Female; Humans; Leukocytes, Mononuclear; Male; Mineralocorticoid Receptor Antagonists; Spironolactone; Tetrazoles; Tumor Necrosis Factor-alpha | 2006 |
Atorvastatin inhibits angiotensin II-induced T-type Ca2+ channel expression in endothelial cells.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Atorvastatin; Benzimidazoles; Biphenyl Compounds; Calcium Channels, T-Type; Cells, Cultured; Endothelial Cells; Flavonoids; Gene Expression; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Microscopy, Fluorescence; Pyrroles; ras Proteins; Receptor, Angiotensin, Type 1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Tetrazoles; Vasoconstrictor Agents | 2006 |
Tumor necrosis factor-alpha and vascular angiotensin II in estrogen-deficient rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Endothelium, Vascular; Estrogens; Etanercept; Female; Immunoglobulin G; Mesenteric Arteries; Peptidyl-Dipeptidase A; Phenylephrine; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, Tumor Necrosis Factor; Tetrazoles; Tumor Necrosis Factor-alpha; Vasoconstriction; Vasoconstrictor Agents | 2006 |
Angiotensin II, interstitial inflammation, and the pathogenesis of salt-sensitive hypertension.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Blood Volume; Hypertension, Renal; Lymphocytes; Macrophages; Male; Microcirculation; Nephritis; Rats; Rats, Sprague-Dawley; Renal Circulation; Sodium Chloride, Dietary; Tetrazoles; Vasculitis; Vasoconstrictor Agents | 2006 |
Systemic effects of angiotensin III in conscious dogs during acute double blockade of the renin-angiotensin-aldosterone-system.
Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin III; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Dogs; Dose-Response Relationship, Drug; Enalaprilat; Female; Glomerular Filtration Rate; Metabolic Clearance Rate; Receptor, Angiotensin, Type 1; Renin; Renin-Angiotensin System; Tetrazoles | 2006 |
Endothelin-1 and angiotensin II contribute to BNP but not c-fos gene expression response to elevated load in isolated mice hearts.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Coronary Circulation; Endothelin Receptor Antagonists; Endothelin-1; Gene Expression; Gene Expression Regulation; Genes, fos; Heart; Heart Ventricles; In Vitro Techniques; Male; Mice; Natriuretic Peptide, Brain; Receptor, Angiotensin, Type 1; Tetrazoles; Up-Regulation | 2007 |
Attenuation of angiotensin II signaling recouples eNOS and inhibits nonendothelial NOX activity in diabetic mice.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Captopril; Diabetes Mellitus, Experimental; Hydrogen Peroxide; Hyperglycemia; Mice; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase Type III; Signal Transduction; Superoxides; Tetrazoles; Vasodilation | 2007 |
Angiotensin II-induced genomic damage in renal cells can be prevented by angiotensin II type 1 receptor blockage or radical scavenging.
Topics: Acetylcysteine; alpha-Tocopherol; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Cell Line; Cell Nucleus; Comet Assay; DNA Damage; Dose-Response Relationship, Drug; Flow Cytometry; Free Radical Scavengers; Humans; Imidazoles; Kidney; Pyridines; Rats; Reactive Oxygen Species; Swine; Tetrazoles | 2007 |
Pressure overload-induced transient oxidative stress mediates perivascular inflammation and cardiac fibrosis through angiotensin II.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Fibrosis; Heart Ventricles; Hypertension; Inflammation; Male; Oxidative Stress; Rats; Rats, Wistar; Reactive Oxygen Species; Tetrazoles; Time Factors; Ventricular Remodeling | 2006 |
[Renin-angiotensin system in mesenteric adipose tissues in rats with metabolic syndrome].
Topics: Adipocytes; Adipose Tissue; Angiotensin II; Angiotensinogen; Animals; Benzimidazoles; Biphenyl Compounds; Calcium; Captopril; Cells, Cultured; Male; Metabolic Syndrome; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazoles | 2006 |
Long-term, high-dosage candesartan suppresses inflammation and injury in chronic kidney disease: nonhemodynamic renal protection.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Chemokine CCL2; Chemokine CCL5; Dose-Response Relationship, Drug; Inflammation; Kidney; Kidney Failure, Chronic; Kidney Glomerulus; Male; NF-kappa B; Proteinuria; Rats; Rats, Inbred SHR; Tetrazoles; Vasoconstrictor Agents | 2007 |
Albumin overload induces adaptive responses in human proximal tubular cells through oxidative stress but not via angiotensin II type 1 receptor.
Topics: Adaptation, Physiological; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Antioxidants; Benzimidazoles; Biphenyl Compounds; Blotting, Western; Cell Line; Cell Nucleus; Cell Shape; Cell Survival; DNA, Complementary; Endocytosis; Kidney Tubules, Proximal; Lipid Metabolism; Lipid Peroxidation; Oxidative Stress; Receptor, Angiotensin, Type 1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Serum Albumin; Sulfhydryl Compounds; Tetrazoles; Transcription Factors | 2007 |
AT1 receptor blockade prevents interstitial and glomerular apoptosis but not fibrosis in pigs with neonatal induced partial unilateral ureteral obstruction.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Newborn; Apoptosis; Benzimidazoles; Biphenyl Compounds; Capillaries; Caspase 3; Cell Count; Collagen; Female; Fibrosis; Hydroxyproline; Immunohistochemistry; Kidney Glomerulus; Kidney Tubules; Nephritis, Interstitial; Swine; Tetrazoles; Tissue Fixation; Ureteral Obstruction | 2007 |
High-glucose-induced regulation of intracellular ANG II synthesis and nuclear redistribution in cardiac myocytes.
Topics: Actin Cytoskeleton; Active Transport, Cell Nucleus; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Animals, Newborn; Benzimidazoles; Biphenyl Compounds; Cell Nucleus; Cells, Cultured; Chymases; Cytoplasm; Dose-Response Relationship, Drug; Extracellular Space; Glucose; Heart Ventricles; Isoproterenol; Myocytes, Cardiac; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renin; Renin-Angiotensin System; Sympathomimetics; Tetrazoles; Time Factors | 2007 |
Intracellular renin-angiotensin system: the tip of the intracrine physiology iceberg.
Topics: Actin Cytoskeleton; Active Transport, Cell Nucleus; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Benzimidazoles; Biphenyl Compounds; Cell Nucleus; Chymases; Cytoplasm; Extracellular Space; Glucose; Isoproterenol; Myocytes, Cardiac; Peptidyl-Dipeptidase A; Rats; Receptor, Angiotensin, Type 1; Renin; Renin-Angiotensin System; Signal Transduction; Sympathomimetics; Tetrazoles | 2007 |
Angiotensin II and endothelin-1 augment the vascular complications of diabetes via JAK2 activation.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta, Thoracic; Atrasentan; Benzimidazoles; Biphenyl Compounds; Blood Glucose; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Endothelin A Receptor Antagonists; Endothelin-1; Enzyme Activation; Intracellular Signaling Peptides and Proteins; Janus Kinase 2; Male; Phosphorylation; Protein Kinase Inhibitors; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Protein Tyrosine Phosphatases; Pyrrolidines; Rats; Receptor, Angiotensin, Type 1; Receptor, Endothelin A; Signal Transduction; STAT1 Transcription Factor; STAT3 Transcription Factor; Tetrazoles; Time Factors; Tyrphostins; Vasodilation | 2007 |
Cross-inhibition of angiotensin AT1 receptors supports the concept of receptor oligomerization.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Chlorocebus aethiops; COS Cells; DNA, Complementary; Inositol Phosphates; Muscle, Smooth, Vascular; Mutagenesis, Site-Directed; Mutation; Rats; Receptor, Angiotensin, Type 1; Tetrazoles; Transfection | 2007 |
Angiotensin AT1 receptor blockers suppress ischemia/reperfusion-induced gastric injury in rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Capillary Permeability; Gastric Mucosa; Hydrogen Peroxide; Losartan; Male; Microcirculation; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Tetrazoles; Valine; Valsartan | 2007 |
Angiotensin II type 2 receptor vasoactivity in internal mammary arteries of patients with coronary artery disease.
Topics: Acetylcholine; Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Coronary Artery Disease; Female; Gene Expression; Humans; Imidazoles; In Vitro Techniques; Male; Mammary Arteries; Middle Aged; Oligopeptides; Phentolamine; Phenylephrine; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Sodium Nitrite; Tetrazoles; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2007 |
Upregulation of cortical COX-2 in salt-sensitive hypertension: role of angiotensin II and reactive oxygen species.
Topics: Amlodipine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Antioxidants; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cyclic N-Oxides; Cyclooxygenase 1; Cyclooxygenase 2; Dinoprostone; Gene Expression; Hypertension; Kidney Cortex; Kidney Medulla; Male; Membrane Proteins; Rats; Rats, Inbred Dahl; Reactive Oxygen Species; Sodium Chloride, Dietary; Spin Labels; Tetrazoles; Up-Regulation | 2008 |
Conversion of renal angiotensin II to angiotensin III is critical for AT2 receptor-mediated natriuresis in rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Angiotensin III; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; CD13 Antigens; Drug Synergism; Female; Glutamyl Aminopeptidase; Imidazoles; Kidney; Methionine; Natriuresis; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2; Sodium, Dietary; Sulfonic Acids; Tetrazoles | 2008 |
Angiotensin II type 2 receptors and nitric oxide sustain oxygenation in the clipped kidney of early Goldblatt hypertensive rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Enalaprilat; Enzyme Inhibitors; Glomerular Filtration Rate; Hypertension, Renovascular; Imidazoles; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxygen; Partial Pressure; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renal Circulation; Surgical Instruments; Tetrazoles; Vascular Resistance | 2008 |
Activation of the intracellular renin-angiotensin system in cardiac fibroblasts by high glucose: role in extracellular matrix production.
Topics: Adrenergic beta-Agonists; Amides; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Newborn; Benzazepines; Benzimidazoles; Biphenyl Compounds; Blotting, Western; Cells, Cultured; Collagen Type I; Dose-Response Relationship, Drug; Extracellular Matrix; Fibroblasts; Fumarates; Glucose; Heart Ventricles; Isoproterenol; Microscopy, Confocal; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Renin; Renin-Angiotensin System; Tetrazoles; Time Factors; Transforming Growth Factor beta; Up-Regulation | 2008 |
Chronic candesartan alters expression and activity of NKCC2, NCC, and ENaC in the obese Zucker rat.
Topics: Amiloride; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Blotting, Western; Diuretics; Epithelial Sodium Channels; Furosemide; Hypertrophy; Kidney Tubules, Proximal; Male; Obesity; Rats; Rats, Zucker; Receptor, Angiotensin, Type 1; Receptors, Drug; Renin; Sodium-Hydrogen Exchanger 3; Sodium-Hydrogen Exchangers; Sodium-Phosphate Cotransporter Proteins, Type IIb; Sodium-Potassium-Chloride Symporters; Solute Carrier Family 12, Member 1; Solute Carrier Family 12, Member 3; Symporters; Tetrazoles | 2008 |
Angiotensin II increases the expression of the transcription factor ETS-1 in mesangial cells.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Blotting, Western; Cells, Cultured; Cyclooxygenase 2; Fibronectins; Glomerular Mesangium; Male; Mitogen-Activated Protein Kinases; Protein Kinase C; Proto-Oncogene Protein c-ets-1; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Stimulation, Chemical; Tetrazoles | 2008 |
Modulation of reflex function by endogenous angiotensins in older transgenic rats with low glial angiotensinogen.
Topics: Aging; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Angiotensins; Animals; Animals, Genetically Modified; Baroreflex; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Heart Rate; Male; Neuroglia; Peptide Fragments; Rats; Renin-Angiotensin System; Solitary Nucleus; Tetrazoles | 2008 |
Regulation of endothelial proliferation by the renin-angiotensin system in human umbilical vein endothelial cells.
Topics: Angiopoietin-1; Angiopoietin-2; Angiotensin II; Benzimidazoles; Biphenyl Compounds; Cell Proliferation; Cells, Cultured; Endothelial Cells; Female; Humans; Immunohistochemistry; Neovascularization, Physiologic; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; Tetrazoles; Umbilical Veins; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1 | 2008 |
Potential role of Renin-Angiotensin-system for tumor angiogenesis in receptor negative breast cancer.
Topics: Angiopoietin-1; Angiopoietin-2; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Basic Helix-Loop-Helix Transcription Factors; Benzimidazoles; Biphenyl Compounds; Breast Neoplasms; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Humans; Neovascularization, Pathologic; Receptor, Angiotensin, Type 1; Receptors, Estrogen; Renin-Angiotensin System; Tetrazoles; Tissue Inhibitor of Metalloproteinase-1; Vascular Endothelial Growth Factor A | 2008 |
Selective type 1 angiotensin II receptor blockade attenuates oxidative stress and regulates angiotensin II receptors in the canine failing heart.
Topics: Aldehydes; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Dogs; Echocardiography; Heart Failure; Hemodynamics; Male; Oxidative Stress; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles; Ventricular Dysfunction, Left; Ventricular Remodeling | 2008 |
Pulsatile mechanical pressure promotes Angiotensin-converting enzyme expression in aortic smooth muscle cells.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Aorta; Atmospheric Pressure; Benzimidazoles; Biphenyl Compounds; Captopril; Cell Line; Cell Proliferation; Colorimetry; Dose-Response Relationship, Drug; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Gene Expression Regulation, Enzymologic; Humans; Immunoblotting; Membrane Proteins; Mitogen-Activated Protein Kinase 1; Muscle, Smooth, Vascular; Peptidyl-Dipeptidase A; Phosphorylation; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stress, Mechanical; Tetrazoles; Time Factors | 2008 |
The effect of recombinant aminopeptidase A on hypertension in spontaneously hypertensive rats: its effect in comparison with candesartan.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Baculoviridae; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Genetic Vectors; Glutamyl Aminopeptidase; Humans; Hypertension; Male; Mutation; Nitroprusside; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Recombinant Proteins; Tetrazoles | 2008 |
Intracellular angiotensin II production in diabetic rats is correlated with cardiomyocyte apoptosis, oxidative stress, and cardiac fibrosis.
Topics: Amides; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Benzazepines; Benzimidazoles; Biphenyl Compounds; Diabetes Mellitus, Experimental; Endomyocardial Fibrosis; Fumarates; Insulin; Myocytes, Cardiac; Oxidative Stress; Rats; Renin; Tetrazoles | 2008 |
Involvement of angiotensin II-dependent vascular endothelial growth factor gene expression via NADPH oxidase in the retina in a type 2 diabetic rat model.
Topics: Administration, Oral; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta, Thoracic; Benzimidazoles; Biphenyl Compounds; Blood Glucose; Diabetes Mellitus, Type 2; Disease Models, Animal; Gene Expression Regulation; NADPH Oxidases; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Retina; RNA, Messenger; Tetrazoles; Vascular Endothelial Growth Factor A | 2008 |
Loss of biphasic effect on Na/K-ATPase activity by angiotensin II involves defective angiotensin type 1 receptor-nitric oxide signaling.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Antioxidants; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Buthionine Sulfoximine; Cyclic GMP; Cyclic N-Oxides; Enzyme Inhibitors; Focal Adhesion Kinase 2; Hypertension, Renal; Kidney Tubules, Proximal; Male; Mitogen-Activated Protein Kinases; Nitric Oxide; Oxidative Stress; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Signal Transduction; Sodium-Hydrogen Exchanger 3; Sodium-Hydrogen Exchangers; Sodium-Potassium-Exchanging ATPase; Spin Labels; Tetrazoles; Vasoconstrictor Agents | 2008 |
Angiotensin II regulates V2 receptor and pAQP2 during ureteral obstruction.
Topics: Adenylyl Cyclases; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aquaporin 2; Benzimidazoles; Biphenyl Compounds; Colforsin; Cyclic AMP; Disease Models, Animal; GTP-Binding Protein alpha Subunits, Gs; Kidney Medulla; Male; Rats; Rats, Wistar; Receptors, Vasopressin; RNA, Messenger; Sodium Fluoride; Tetrazoles; Ureteral Obstruction | 2009 |
Angiotensin II upregulates acyl-CoA:cholesterol acyltransferase-1 via the angiotensin II Type 1 receptor in human monocyte-macrophages.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Atherosclerosis; Benzimidazoles; Biphenyl Compounds; Cell Differentiation; Cells, Cultured; Dose-Response Relationship, Drug; Endocytosis; Foam Cells; Humans; Imidazoles; Macrophages; Male; Oligopeptides; Radioimmunoassay; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Signal Transduction; Sterol O-Acyltransferase; Tetrazoles; Up-Regulation; Vasoconstrictor Agents; Vasodilator Agents | 2008 |
Candesartan ameliorates cardiac dysfunction observed in angiotensin-converting enzyme 2-deficient mice.
Topics: Age Factors; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Benzimidazoles; Biphenyl Compounds; Cardiomegaly; Disease Models, Animal; Echocardiography; Female; Hypertension; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Myocardium; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Tetrazoles | 2008 |
Peripherally administered angiotensin II AT1 receptor antagonists are anti-stress compounds in vivo.
Topics: Adrenocorticotropic Hormone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Brain; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Corticotropin-Releasing Hormone; Receptors, GABA-A; Social Isolation; Stomach Ulcer; Stress, Psychological; Tetrazoles | 2008 |
Plasma kallikrein mediates angiotensin II type 1 receptor-stimulated retinal vascular permeability.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Blood-Retinal Barrier; Capillary Permeability; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Disease Models, Animal; Hypertension; Kallikreins; Kinins; Male; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Retinal Artery; Streptozocin; Tetrazoles | 2009 |
Role of angiotensin II and oxidative stress in vascular insulin resistance linked to hypertension.
Topics: Acetylcholine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Body Weight; C-Reactive Protein; Cyclic N-Oxides; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelium, Vascular; Hypertension; Insulin; Insulin Resistance; JNK Mitogen-Activated Protein Kinases; Male; Nitric Oxide Synthase Type III; Oxidative Stress; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Rats, Inbred Dahl; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Signal Transduction; Sodium Chloride, Dietary; Spin Labels; Superoxide Dismutase; Tetrazoles; Vasodilation; Vasodilator Agents | 2009 |
Candesartan attenuates Angiotensin II-induced mesangial cell apoptosis via TLR4/MyD88 pathway.
Topics: Angiotensin II; Animals; Antioxidants; Apoptosis; Benzimidazoles; Biphenyl Compounds; Cell Line; Mesangial Cells; Myeloid Differentiation Factor 88; Oxidative Stress; Rats; Reactive Oxygen Species; Tetrazoles; Toll-Like Receptor 4 | 2009 |
Angiotensin II type 1 receptor mediates partially hyposmotic-induced increase of I (Ks) current in guinea pig atrium.
Topics: Action Potentials; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Cell Shape; Electrophysiological Phenomena; Enzyme Inhibitors; Guinea Pigs; Heart Atria; Hypotonic Solutions; Immunoglobulin G; Membrane Potentials; Myocytes, Cardiac; Osmolar Concentration; Potassium; Protein-Tyrosine Kinases; Receptor, Angiotensin, Type 1; Signal Transduction; Tetrazoles | 2009 |
The effect of angiotensin II on the number of macula densa cells through the AT1 receptor.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Cell Count; Cell Proliferation; Cell Transdifferentiation; Epithelial Cells; Juxtaglomerular Apparatus; Male; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Tetrazoles | 2009 |
Local angiotensin II-generation in human gastric cancer: correlation with tumor progression through the activation of ERK1/2, NF-kappaB and survivin.
Topics: Adenocarcinoma; Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Adult; Aged; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Benzimidazoles; Biphenyl Compounds; Blotting, Western; Carcinoma, Medullary; Case-Control Studies; Cell Proliferation; Disease Progression; Electrophoretic Mobility Shift Assay; Female; Gastric Mucosa; Humans; Immunoenzyme Techniques; Inhibitor of Apoptosis Proteins; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Microtubule-Associated Proteins; Middle Aged; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; NF-kappa B; Peritoneal Neoplasms; Receptor, Angiotensin, Type 1; Stomach; Stomach Neoplasms; Survival Rate; Survivin; Tetrazoles; Tumor Cells, Cultured | 2009 |
Effects of phorbol ester-sensitive PKC (c/nPKC) activation on the production of adiponectin in 3T3-L1 adipocytes.
Topics: 3T3-L1 Cells; Adipocytes; Adiponectin; Angiotensin II; Animals; Benzimidazoles; Biphenyl Compounds; Carbazoles; Chromones; Enzyme Activation; Gene Expression; Glucose; Insulin; Mice; Morpholines; NF-kappa B; PPAR gamma; Protein Kinase C; Tetradecanoylphorbol Acetate; Tetrazoles; Tumor Necrosis Factor-alpha | 2009 |
Conditional expression of type 2 angiotensin II receptor in rat vascular smooth muscle cells reveals the interplay of the angiotensin system in matrix metalloproteinase 2 expression and vascular remodeling.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Endothelium, Vascular; Imidazoles; Matrix Metalloproteinase 2; Matrix Metalloproteinase Inhibitors; Muscle, Smooth, Vascular; Pyridines; Rats; Receptor, Angiotensin, Type 2; Signal Transduction; Tetrazoles | 2009 |
Electrophysiological responses of sympathetic preganglionic neurons to ANG II and aldosterone.
Topics: Aldosterone; Anesthetics, Local; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Autonomic Fibers, Preganglionic; Benzimidazoles; Biphenyl Compounds; Eplerenone; Excitatory Postsynaptic Potentials; Female; In Vitro Techniques; Male; Mineralocorticoid Receptor Antagonists; Patch-Clamp Techniques; Presynaptic Terminals; Rats; Rats, Wistar; Spironolactone; Synaptic Transmission; Tetrazoles; Tetrodotoxin; Time Factors | 2009 |
Involvement of vascular angiotensin II-forming enzymes in the progression of aortic abdominal aneurysms in angiotensin II- infused ApoE-deficient mice.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Aortic Aneurysm, Abdominal; Apolipoproteins E; Benzimidazoles; Biphenyl Compounds; Chymases; Disease Progression; Lisinopril; Mice; Mice, Knockout; Peptidyl-Dipeptidase A; Tetrazoles | 2009 |
Effects of angiotensin on the expression of fibrosis-associated cytokines, growth factors, and matrix proteins in human lung fibroblasts.
Topics: Adult; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Cell Proliferation; Cells, Cultured; Collagen; Cytokines; Elastin; Extracellular Matrix Proteins; Fibroblasts; Gene Expression Regulation; Humans; Intercellular Signaling Peptides and Proteins; Lung; Microscopy, Confocal; RNA, Messenger; Tetrazoles | 2009 |
Exaggerated blood pressure variability superimposed on hypertension aggravates cardiac remodeling in rats via angiotensin II system-mediated chronic inflammation.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Chemokine CCL2; Chronic Disease; Disease Models, Animal; Heart Diseases; Heart Ventricles; Hypertension; Hypertrophy; Inflammation; Macrophages; Male; Myocytes, Cardiac; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrazoles; Transforming Growth Factor beta; Ventricular Remodeling | 2009 |
Changes of renal AQP2, ENaC, and NHE3 in experimentally induced heart failure: response to angiotensin II AT1 receptor blockade.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aquaporin 2; Benzimidazoles; Biphenyl Compounds; Body Water; Epithelial Sodium Channels; Heart Failure; Kidney; Kidney Cortex; Kidney Medulla; Phosphorylation; Potassium; Rats; Rats, Wistar; Sodium; Sodium-Hydrogen Exchanger 3; Sodium-Hydrogen Exchangers; Sodium-Potassium-Chloride Symporters; Solute Carrier Family 12, Member 1; Tetrazoles; Tissue Distribution | 2009 |
Angiotensin II receptors are expressed and functional in human esophageal mucosa.
Topics: Adult; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Angiotensin Receptor Antagonists; Benzimidazoles; Biopsy; Biphenyl Compounds; Blood Vessels; Electric Impedance; Electrophysiological Phenomena; Epithelial Cells; Esophagus; Female; Gene Expression; Humans; Hydrochloric Acid; Imidazoles; Losartan; Male; Middle Aged; Mucous Membrane; Peptidyl-Dipeptidase A; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Tetrazoles | 2009 |
Long-term blockade of L/N-type Ca(2+) channels by cilnidipine ameliorates repolarization abnormality of the canine hypertrophied heart.
Topics: Action Potentials; Amlodipine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Atrioventricular Block; Benzimidazoles; Biphenyl Compounds; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, N-Type; Cardiomegaly; Chronic Disease; Dihydropyridines; Dogs; Electrocardiography; Epinephrine; Female; Male; Neurotransmitter Agents; Norepinephrine; Tetrazoles; Time Factors | 2009 |
Renal vasoconstrictor and pressor responses to angiotensin IV in mice are AT1a-receptor mediated.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Base Sequence; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Body Weight; DNA Primers; Endothelin-1; Hemodynamics; Kidney; Mice; Mice, Inbred C57BL; Mice, Knockout; Organ Size; Receptor, Angiotensin, Type 1; Tetrazoles; Vasoconstriction | 2010 |
Systemic candesartan reduces brain angiotensin II via downregulation of brain renin-angiotensin system.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Blood-Brain Barrier; Body Weight; Brain Chemistry; Down-Regulation; Male; Permeability; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Tetrazoles | 2010 |
Role of angiotensin II in the remodeling induced by a chronic increase in flow in rat mesenteric resistance arteries.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Benzimidazoles; Biphenyl Compounds; Blood Flow Velocity; Blotting, Western; Butadienes; Cyclic N-Oxides; Extracellular Signal-Regulated MAP Kinases; Hydralazine; Male; Mesenteric Arteries; Mice; Mice, Knockout; Microscopy, Confocal; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Nitriles; Perindopril; Rats; Rats, Wistar; Reactive Oxygen Species; Spin Labels; Tetrazoles; Vascular Resistance; Vasodilator Agents | 2010 |
Expressions of inducible nitric oxide synthase and cyclooxygenase-2 in gastric ischemia-reperfusion: role of angiotensin II.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Captopril; Cyclooxygenase 2; Dinoprostone; Gastritis; Imidazoles; Male; Neutrophils; Nitric Oxide; Nitric Oxide Synthase Type II; Peroxidase; Pyridines; Rats; Rats, Wistar; Reperfusion Injury; Tetrazoles | 2010 |
Angiotensin II-activated protein kinase D mediates acute aldosterone secretion.
Topics: Adenoviridae; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Animals; Benzimidazoles; Biphenyl Compounds; Cattle; Enzyme Activation; Imidazoles; Mutant Proteins; Potassium; Protein Kinase C; Pyridines; Receptor, Angiotensin, Type 1; Tetradecanoylphorbol Acetate; Tetrazoles; Time Factors; Zona Glomerulosa | 2010 |
The mechanism of distinct diurnal variations of renin-angiotensin system in aorta and heart of spontaneously hypertensive rats.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Aorta; Benzimidazoles; Biphenyl Compounds; Circadian Rhythm; Down-Regulation; Genetic Markers; Male; Myocardium; NADPH Oxidases; Plasminogen Activator Inhibitor 1; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin-Angiotensin System; Serine Proteinase Inhibitors; Tetrazoles; Transforming Growth Factor beta1 | 2009 |
Angiotensin II promotes development of the renal microcirculation through AT1 receptors.
Topics: Adrenalectomy; Angiopoietin-1; Angiopoietin-2; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Newborn; Benzimidazoles; Biphenyl Compounds; Capillaries; Female; Kidney; Mice; Mice, Knockout; Neovascularization, Physiologic; Polyuria; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, TIE-2; Renal Circulation; RNA, Messenger; Tetrazoles; Vascular Endothelial Growth Factor A | 2010 |
Developmental effect of antenatal exposure to betamethasone on renal angiotensin II activity in the young adult sheep.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Benzimidazoles; Betamethasone; Biphenyl Compounds; Blood Pressure; Female; Glomerular Filtration Rate; Glucocorticoids; Imidazoles; Infusions, Intra-Arterial; Kidney; Lithium; Male; Organ Size; Pregnancy; Prenatal Exposure Delayed Effects; Pyridines; Random Allocation; Renal Blood Flow, Effective; Sheep; Sodium; Tetrazoles; Vascular Resistance | 2010 |
Aliskiren inhibits intracellular angiotensin II levels without affecting (pro)renin receptor signals in human podocytes.
Topics: Amides; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Cells, Cultured; Extracellular Signal-Regulated MAP Kinases; Fumarates; Humans; Imidazolidines; Phosphorylation; Podocytes; Prorenin Receptor; Receptors, Cell Surface; Renin; RNA, Messenger; RNA, Small Interfering; Signal Transduction; Tetrazoles | 2010 |
Mechanisms for perivascular adipose tissue-mediated potentiation of vascular contraction to perivascular neuronal stimulation: the role of adipocyte-derived angiotensin II.
Topics: Adipocytes; Adipose Tissue; Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Electric Stimulation; Male; Mesenteric Arteries; Muscle, Smooth, Vascular; Neurons; Oligodendroglia; Rats; Rats, Wistar; Receptor, Angiotensin, Type 2; Tetrazoles; Vasoconstriction | 2010 |
Regression of glomerulosclerosis in response to transient treatment with angiotensin II blockers is attenuated by blockade of matrix metalloproteinase-2.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensins; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Hypertension; Kidney; Kidney Diseases; Kidney Glomerulus; Matrix Metalloproteinase 2; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Mice, Knockout; Random Allocation; Rats; Rats, Inbred SHR; Receptors, Angiotensin; Tetrazoles; Time Factors | 2010 |
Stimulation of renin secretion by angiotensin II blockade is Gsalpha-dependent.
Topics: Adenylyl Cyclases; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Captopril; Catecholamines; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Enalapril; Female; GTP-Binding Protein alpha Subunits, Gs; Juxtaglomerular Apparatus; Male; Mice; Mice, Knockout; Models, Animal; Nitric Oxide; Prostaglandins; Renin; Signal Transduction; Tetrahydroisoquinolines; Tetrazoles | 2010 |
Angiotensin-(1-9) regulates cardiac hypertrophy in vivo and in vitro.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Bradykinin; Cardiomegaly; Cell Enlargement; Cells, Cultured; Enalapril; Humans; Hypertrophy, Left Ventricular; In Vitro Techniques; Insulin-Like Growth Factor I; Male; Myocardial Infarction; Myocytes, Cardiac; Norepinephrine; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Tetrazoles; Ventricular Function, Left | 2010 |
A single-nucleotide polymorphism of alanine to threonine at position 163 of the human angiotensin II type 1 receptor impairs Losartan affinity.
Topics: Alanine; Angiotensin II; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Pressure; Chlorocebus aethiops; COS Cells; Humans; Imidazoles; Inositol Phosphates; Irbesartan; Losartan; Polymorphism, Single Nucleotide; Receptor, Angiotensin, Type 1; Telmisartan; Tetrazoles; Threonine; Valine; Valsartan | 2010 |
Effects of angiotensin receptor blockade on atrial electrical remodelling and the 'second factor' in a goat burst-paced model of atrial fibrillation.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Atrial Fibrillation; Benzimidazoles; Biphenyl Compounds; Disease Models, Animal; Electrophysiological Phenomena; Female; Goats; Heart Atria; Receptors, Angiotensin; Tetrazoles; Time Factors; Ventricular Function | 2010 |
Involvement of angiotensin II in the remodeling induced by a chronic decrease in blood flow in rat mesenteric resistance arteries.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Blood Flow Velocity; Chronic Disease; Extracellular Signal-Regulated MAP Kinases; Hypertension; Mesenteric Arteries; Mice; Mice, Knockout; Nitric Oxide Synthase Type III; Perindopril; Rats; Rats, Wistar; Reactive Oxygen Species; Tetrazoles; Vascular Resistance; Vasoconstriction; Vasoconstrictor Agents | 2010 |
Estrogen and angiotensin interaction in the substantia nigra. Relevance to postmenopausal Parkinson's disease.
Topics: Angiotensin II; Animals; Benzimidazoles; Biphenyl Compounds; Cell Death; Dopamine; Estradiol; Estrogens; Female; Humans; Neuroglia; Neurons; Ovariectomy; Oxidopamine; Parkinson Disease; Peptidyl-Dipeptidase A; Postmenopause; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Substantia Nigra; Tetrazoles | 2010 |
[Suppression of renin-angiotensin system and cancer therapy (discussion)].
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Cimetidine; Cyclooxygenase 2 Inhibitors; Deoxycytidine; Drug Combinations; Drug Therapy, Combination; Gemcitabine; Humans; Hypertension; Interferon-alpha; Life Style; Neoplasms; Oxonic Acid; Renin-Angiotensin System; Tegafur; Tetrazoles | 2010 |
Angiotensin II type 1 receptor-mediated augmentation of urinary excretion of endogenous angiotensin II in Val5-angiotensin II-infused rats.
Topics: Analysis of Variance; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Chromatography, Liquid; Hypertension, Renal; Kidney; Male; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Tetrazoles | 2010 |
Angiotensin II sustains brain inflammation in mice via TGF-beta.
Topics: Angiotensin II; Animals; Benzimidazoles; Biphenyl Compounds; Cells, Cultured; Chronic Disease; Encephalomyelitis, Autoimmune, Experimental; Female; Mice; Mice, Inbred C57BL; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Signal Transduction; Tetrazoles; Thrombospondin 1; Transforming Growth Factor beta | 2010 |
Angiotensin II and NADPH oxidase increase ADMA in vascular smooth muscle cells.
Topics: Analysis of Variance; Angiotensin II; Animals; Arginine; Benzimidazoles; Biphenyl Compounds; Blotting, Western; Cells, Cultured; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NADPH Oxidases; Rats; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; Tetrazoles | 2010 |
Enhanced urinary angiotensinogen excretion in Cyp1a1-Ren2 transgenic rats with inducible ANG II-dependent malignant hypertension.
Topics: Angiotensin II; Angiotensinogen; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Body Weight; Cytochrome P-450 CYP1A1; Humans; Hypertension, Malignant; Male; Middle Aged; Rats; Rats, Transgenic; Renin; Tetrazoles | 2010 |
On the origin of urinary angiotensin II.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Kidney; Rats; Receptor, Angiotensin, Type 1; Swine; Tetrazoles | 2010 |
Reduction of renal dopamine receptor expression in obese Zucker rats: role of sex and angiotensin II.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Blotting, Western; Body Composition; Diet; Female; Glyceraldehyde-3-Phosphate Dehydrogenases; Insulin Resistance; Kidney; Male; Obesity; Rats; Rats, Zucker; Receptors, Dopamine; Sex Characteristics; Sodium Chloride, Dietary; Tetrazoles | 2010 |
Aging-related changes in the nigral angiotensin system enhances proinflammatory and pro-oxidative markers and 6-OHDA-induced dopaminergic degeneration.
Topics: Aging; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Dopaminergic Neurons; Inflammation Mediators; Interleukin-1beta; Male; Molecular Targeted Therapy; NADPH Oxidases; Nerve Degeneration; Oxidative Stress; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Substantia Nigra; Tetrazoles; Tumor Necrosis Factor-alpha | 2012 |
Angiotensin blockade in diabetic patients decreases insulin resistance-associated low-grade inflammation.
Topics: Adult; Aged; Angiotensin II; Angiotensin Receptor Antagonists; Benzimidazoles; Biphenyl Compounds; Diabetes Mellitus, Type 2; Female; Humans; Inflammation Mediators; Insulin Resistance; Interleukin-6; Male; Middle Aged; Regression Analysis; Tetrazoles; Time Factors; Treatment Outcome; Vasoconstrictor Agents | 2011 |
Angiotensin II induces human astrocyte senescence through reactive oxygen species production.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Antioxidants; Astrocytes; Benzimidazoles; Biphenyl Compounds; Cells, Cultured; Cellular Senescence; Cyclic N-Oxides; Dose-Response Relationship, Drug; Humans; NADPH Oxidases; Reactive Oxygen Species; Spin Labels; Superoxides; Tetrazoles | 2011 |
[Prevention of hypertension by drugs and immunization against angiotensin II].
Topics: Adult; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Female; Humans; Hypertension; Male; Middle Aged; Ramipril; Tetrazoles; Vaccines | 2011 |
AT1 receptor antagonist candesartan attenuates genomic damage in peripheral blood lymphocytes of patients on maintenance hemodialysis treatment.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Antimutagenic Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cell Nucleus; Cell Separation; Female; Glycation End Products, Advanced; Humans; Hypertension; Kidney Failure, Chronic; Kidney Function Tests; Lymphocytes; Male; Micronucleus Tests; Middle Aged; Renal Dialysis; Tetrazoles | 2011 |
Regulation of angiotensinogen by angiotensin II in mouse primary astrocyte cultures.
Topics: Adenoviridae; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Astrocytes; Benzimidazoles; Biphenyl Compounds; Brain; Brain Chemistry; Cells, Cultured; Dexamethasone; Feedback, Physiological; Imidazoles; Immunohistochemistry; Inositol Phosphates; Liver; Mice; Mice, Inbred C57BL; Pyridines; Receptors, Angiotensin; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Tetrazoles | 2011 |
Abilities of candesartan and other AT(1) receptor blockers to impair angiotensin II-induced AT(1) receptor activation after wash-out.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Chlorocebus aethiops; COS Cells; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Inositol Phosphates; Mutant Proteins; Receptor, Angiotensin, Type 1; Tetrazoles | 2012 |
Increased renin excretion is associated with augmented urinary angiotensin II levels in chronic angiotensin II-infused hypertensive rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Kidney; Male; Rats; Rats, Sprague-Dawley; Renin; Tetrazoles | 2011 |
Defective nitric oxide production impairs angiotensin II-induced Na-K-ATPase regulation in spontaneously hypertensive rats.
Topics: Angiotensin II; Animals; Arginine; Benzimidazoles; Biphenyl Compounds; Kidney Tubules, Proximal; Male; NADPH Oxidases; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Sodium-Potassium-Exchanging ATPase; Tetrazoles | 2012 |
Angiotensin II acts through the angiotensin 1a receptor to upregulate pendrin.
Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Anion Transport Proteins; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Diet, Sodium-Restricted; Female; Hypertension; Male; Mice; Nitric Oxide; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Sulfate Transporters; Tetrazoles; Up-Regulation; Vasoconstrictor Agents | 2011 |
Therapeutic effects of postischemic treatment with hypotensive doses of an angiotensin II receptor blocker on transient focal cerebral ischemia.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Brain; Brain Edema; Brain Ischemia; Hypotension; Ischemia; Rats; Rats, Sprague-Dawley; Tetrazoles; Time Factors | 2011 |
Candesartan restored cardiac Hsp72 expression and tolerance against reperfusion injury in hereditary insulin-resistant rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Newborn; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cells, Cultured; Dietary Fats; Disease Models, Animal; Genetic Predisposition to Disease; Glucose Tolerance Test; Glucose Transporter Type 4; Heredity; HSP72 Heat-Shock Proteins; Hyperthermia, Induced; Insulin Resistance; Male; Myocardial Reperfusion Injury; Myocardium; Phosphatidylinositol 3-Kinase; Phosphorylation; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Rats; Rats, Inbred OLETF; Rats, Long-Evans; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Recovery of Function; Tetrazoles; Time Factors; Ventricular Function, Left; Ventricular Pressure | 2011 |
Direct renin inhibition in a rat model of chronic allograft injury.
Topics: Amides; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Fumarates; Kidney; Kidney Transplantation; Male; Models, Animal; Peptide Fragments; Rats; Rats, Inbred F344; Rats, Inbred Lew; Receptors, Angiotensin; Renin; Renin-Angiotensin System; Tetrazoles; Transplantation, Homologous | 2011 |
Angiotensin AT1 receptor blockers suppress oxidized low-density lipoprotein-derived formation of foam cells.
Topics: Acetyl-CoA C-Acetyltransferase; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Cells, Cultured; Cholesterol Esters; Enzyme Inhibitors; ErbB Receptors; Foam Cells; Heparin-binding EGF-like Growth Factor; Humans; Intercellular Signaling Peptides and Proteins; Lipoproteins, LDL; Losartan; Macrophages; Quinazolines; Tetrazoles; Triglycerides; Tyrphostins | 2012 |
Angiotensin II regulates growth of the developing papillas ex vivo.
Topics: Angiotensin II; Angiotensinogen; Animals; Animals, Newborn; Apoptosis; Benzimidazoles; Biphenyl Compounds; Cell Proliferation; Female; Homeodomain Proteins; Kidney Medulla; Male; Mice; Mice, Knockout; Models, Animal; Morphogenesis; Receptor, Angiotensin, Type 1; Tetrazoles | 2012 |
Effects of tempol and candesartan on neural control of the kidney.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cyclic N-Oxides; Diet; Diet, High-Fat; Dinoprost; Dose-Response Relationship, Drug; Electric Stimulation; Heart Rate; Hematocrit; Kidney; Kidney Function Tests; Male; Obesity; Rabbits; Renal Circulation; Spin Labels; Superoxides; Tetrazoles; Urodynamics | 2012 |
Cardiovascular effects of angiotensin II and glutamate in the PVN of Dahl salt-sensitive rats.
Topics: Angiotensin II; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Glutamic Acid; Heart Rate; Kynurenic Acid; Male; Paraventricular Hypothalamic Nucleus; Rats; Rats, Inbred Dahl; Receptors, Angiotensin; Tetrazoles | 2012 |
Effect of angiotensin II on proliferation and differentiation of mouse induced pluripotent stem cells into mesodermal progenitor cells.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Cell Differentiation; Cell Proliferation; Cells, Cultured; Culture Media; Cyclic N-Oxides; DNA; Induced Pluripotent Stem Cells; Janus Kinases; Leukemia Inhibitory Factor; Mesoderm; Mice; p38 Mitogen-Activated Protein Kinases; Receptor, Angiotensin, Type 1; Spin Labels; STAT3 Transcription Factor; Stem Cells; Tetrazoles | 2012 |
Loss of renal medullary endothelin B receptor function during salt deprivation is regulated by angiotensin II.
Topics: Angiotensin II; Animals; Benzimidazoles; Biphenyl Compounds; Diet, Sodium-Restricted; Diuresis; Endothelin-1; Endothelin-2; Kidney Medulla; Male; Natriuresis; Rats; Rats, Sprague-Dawley; Receptor, Endothelin B; Sodium Chloride, Dietary; Sodium, Dietary; Tetrazoles; Viper Venoms | 2012 |
Intrarenal angiotensin III is the predominant agonist for proximal tubule angiotensin type 2 receptors.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Angiotensin III; Animals; Benzimidazoles; Biphenyl Compounds; Female; Imidazoles; Kidney Tubules, Proximal; Models, Animal; Natriuresis; Peptide Fragments; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2; Tetrazoles | 2012 |
Rapid, dynamic changes in glomerular permeability to macromolecules during systemic angiotensin II (ANG II) infusion in rats.
Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Ficoll; Glomerular Filtration Rate; Infusions, Intravenous; Kidney Glomerulus; Male; Mineralocorticoid Receptor Antagonists; Nimodipine; Permeability; Rats; Rats, Wistar; Spironolactone; Tetrazoles; Vasodilator Agents | 2012 |
[Studying the influence of Candesartan cilexetil on the lung fibrosis in rats exposed to silica].
Topics: Angiotensin II; Animals; Benzimidazoles; Biphenyl Compounds; Bronchoalveolar Lavage Fluid; Female; Lung; Male; Pulmonary Fibrosis; Rats; Rats, Wistar; Silicon Dioxide; Tetrazoles; Transforming Growth Factor beta1 | 2012 |
Role of angiotensin II in arterial pressure and renal hemodynamics in rats with altered renal development: age- and sex-dependent differences.
Topics: Aging; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Arterial Pressure; Benzimidazoles; Biphenyl Compounds; Female; Kidney; Male; Mesenteric Arteries; Oxidative Stress; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Sex Characteristics; Tetrazoles | 2013 |
Effect of angiotensin II on spatial memory, cerebral blood flow, cholinergic neurotransmission, and brain derived neurotrophic factor in rats.
Topics: Acetylcholine; Acetylcholinesterase; Adenosine Triphosphate; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Brain-Derived Neurotrophic Factor; Cerebrovascular Circulation; Cholinesterase Inhibitors; Donepezil; Hippocampus; Imidazoles; Indans; Male; Melatonin; Memory; Oxidative Stress; Piperidines; Pyridines; Rats; Rats, Sprague-Dawley; Synaptic Transmission; Tetrazoles | 2013 |
Direct evidence for intrarenal chymase-dependent angiotensin II formation on the diabetic renal microvasculature.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Chymases; Diabetes Mellitus, Type 2; Kidney; Male; Mice; Microvessels; Peptidyl-Dipeptidase A; Tetrazoles | 2013 |
Angiotensin II contributes to glomerular hyperfiltration in diabetic rats independently of adenosine type I receptors.
Topics: Adenosine A1 Receptor Antagonists; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dose-Response Relationship, Drug; Glomerular Filtration Rate; Kidney; Male; Rats; Receptor, Adenosine A1; Renal Circulation; Tetrazoles; Vascular Resistance; Xanthines | 2013 |
Leukotrienes, but not angiotensin II, are involved in the renal effects elicited by the prolonged cyclooxygenase-2 inhibition when sodium intake is low.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzopyrans; Biphenyl Compounds; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Diet, Sodium-Restricted; Dogs; Glomerular Filtration Rate; Kidney; Leukotrienes; Lipoxygenase Inhibitors; Pyrans; Pyrazoles; Renal Circulation; Tetrazoles | 2013 |
Cardiovascular and electrocardiographic parameters after tonin administration in Wistar rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Arterial Pressure; Benzimidazoles; Biphenyl Compounds; Calcium; Cells, Cultured; Electrocardiography; Heart; Heart Rate; Heart Ventricles; Male; Myocardial Contraction; Myocytes, Cardiac; Organ Culture Techniques; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Tetrazoles; Tissue Kallikreins | 2013 |
Attenuation of increased secretory leukocyte protease inhibitor, matricellular proteins and angiotensin II and left ventricular remodeling by candesartan and omapatrilat during healing after reperfused myocardial infarction.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Benzimidazoles; Biphenyl Compounds; Collagen; Male; Myocardial Infarction; Myocardial Reperfusion; Osteonectin; Pyridines; Rats, Sprague-Dawley; Secretory Leukocyte Peptidase Inhibitor; Tetrazoles; Thiazepines; Ventricular Remodeling | 2013 |
Spreading vasodilatation in the murine microcirculation: attenuation by oxidative stress-induced change in electromechanical coupling.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Arterioles; Benzimidazoles; Biphenyl Compounds; Calcium Channels, L-Type; Calcium Channels, T-Type; Connexins; Endothelium, Vascular; Gap Junction alpha-5 Protein; Hypertension; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microcirculation; Models, Cardiovascular; Oxidative Stress; Renin; Tetrazoles; Vasodilation | 2013 |
Improvement of the antihypertensive capacity of candesartan and trityl candesartan by their SOD mimetic copper(II) complexes.
Topics: Angiotensin II; Antihypertensive Agents; Antioxidants; Benzimidazoles; Biphenyl Compounds; Copper; Humans; Mesangial Cells; Molecular Structure; Spectroscopy, Fourier Transform Infrared; Superoxide Dismutase; Tetrazoles | 2013 |
Central mineralocorticoid receptors and the role of angiotensin II and glutamate in the paraventricular nucleus of rats with angiotensin II-induced hypertension.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Disease Models, Animal; Eplerenone; Glutamic Acid; Heart Rate; Hypertension; Infusions, Intravenous; Infusions, Intraventricular; Kynurenic Acid; Male; Mineralocorticoid Receptor Antagonists; Paraventricular Hypothalamic Nucleus; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptors, Glutamate; Receptors, Mineralocorticoid; Signal Transduction; Spironolactone; Tetrazoles | 2013 |
Angiotensin II modulates salty and sweet taste sensitivities.
Topics: Aldosterone; Amiloride; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Chorda Tympani Nerve; Epithelial Sodium Channel Blockers; Epithelial Sodium Channels; Female; Food Preferences; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Plasma; Receptor, Angiotensin, Type 2; Receptor, Cannabinoid, CB1; Receptors, G-Protein-Coupled; Taste; Taste Buds; Taste Perception; Tetrazoles; TRPM Cation Channels | 2013 |
Microglial TNF-α mediates enhancement of dopaminergic degeneration by brain angiotensin.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Cells, Cultured; Cyclic CMP; Dopaminergic Neurons; Dose-Response Relationship, Drug; Enzyme Inhibitors; Kallikreins; Male; Mesencephalon; Mice; Mice, Inbred C57BL; Microglia; Nerve Degeneration; Neurons; Neurotoxins; Pancreatic Extracts; Tetrazoles; Tumor Necrosis Factor-alpha | 2014 |
Female spontaneously hypertensive rats are more dependent on ANG (1-7) to mediate effects of low-dose AT1 receptor blockade than males.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cell Adhesion Molecules; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Hypertension; Male; Membrane Proteins; Peptide Fragments; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Sex Factors; Tetrazoles | 2014 |
Oxidative DNA damage in kidneys and heart of hypertensive mice is prevented by blocking angiotensin II and aldosterone receptors.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cyclic N-Oxides; Deoxyguanosine; DNA Damage; DNA Repair; Enzyme Activation; Eplerenone; Guanosine; Heart; Hypertension; Kidney; Male; Mice; Mice, Inbred C57BL; Mineralocorticoid Receptor Antagonists; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Reactive Oxygen Species; Renin-Angiotensin System; Spin Labels; Spironolactone; Tetrazoles | 2014 |
Suppression of adrenal βarrestin1-dependent aldosterone production by ARBs: head-to-head comparison.
Topics: Adrenal Glands; Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arrestins; Benzimidazoles; beta-Arrestins; Biphenyl Compounds; CHO Cells; Cricetinae; Cricetulus; GTP-Binding Proteins; Humans; Phosphoproteins; Rats; Receptor, Angiotensin, Type 1; Tetrazoles; Up-Regulation; Valine; Valsartan; Zona Glomerulosa | 2015 |
Candesartan attenuates angiogenesis in hepatocellular carcinoma via downregulating AT1R/VEGF pathway.
Topics: Angiogenesis Inhibitors; Angiotensin II; Animals; Benzimidazoles; Biphenyl Compounds; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Humans; Liver Neoplasms; Mice, Nude; Neovascularization, Pathologic; Receptor, Angiotensin, Type 1; Tetrazoles; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2016 |
Angiotensin type 1A receptor regulates β-arrestin binding of the β
Topics: Angiotensin II; Animals; Benzimidazoles; beta-Arrestins; Biphenyl Compounds; Cell Line; Cell Membrane; Chlorocebus aethiops; CHO Cells; COS Cells; Cricetulus; Dimerization; GTP-Binding Proteins; HEK293 Cells; Humans; Oligopeptides; Protein Binding; Receptor, Angiotensin, Type 1; Receptors, Adrenergic, beta-2; Signal Transduction; Tetrazoles | 2017 |
Glucagon increase after chronic AT
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Biphenyl Compounds; Cell Line; Dose-Response Relationship, Drug; Glucagon; Hypoglycemic Agents; Islets of Langerhans; Leptin; Male; Mice, Inbred C57BL; Rats, Sprague-Dawley; Rats, Zucker; Receptor, Angiotensin, Type 1; Telmisartan; Tetrazoles; Time Factors; Up-Regulation | 2017 |
β-Arrestin-biased AT1R stimulation promotes extracellular matrix synthesis in renal fibrosis.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; beta-Arrestin 1; beta-Arrestin 2; Biphenyl Compounds; Cell Line; Collagen Type I; Disease Models, Animal; Extracellular Matrix; Fibroblasts; Fibronectins; Fibrosis; Kidney; Kidney Diseases; Male; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Rats; Receptor, Angiotensin, Type 1; RNA Interference; Signal Transduction; Tetrazoles; Time Factors; Transfection; Ureteral Obstruction | 2017 |
Impact of Aldosterone Synthase Inhibitor FAD286 on Steroid Hormone Profile in Human Adrenocortical Cells.
Topics: Adrenal Cortex; Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Cell Line; Cytochrome P-450 CYP11B2; Enzyme Inhibitors; Fadrozole; Gene Expression Regulation, Enzymologic; Glucocorticoids; Hormones; Humans; Receptor, Angiotensin, Type 1; RNA, Messenger; Steroids; Tetrazoles | 2017 |
Augmented sphingosine 1 phosphate receptor-1 signaling in cardiac fibroblasts induces cardiac hypertrophy and fibrosis through angiotensin II and interleukin-6.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Cardiomegaly; Cells, Cultured; Fibroblasts; Heart Ventricles; Humans; Interleukin-6; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myocardium; Myocytes, Cardiac; Peptidyl-Dipeptidase A; Phosphorylation; Plasmids; Receptors, Lysosphingolipid; Signal Transduction; Tetrazoles | 2017 |
Candesartan prevents resiniferatoxin-induced sensory small-fiber neuropathy in mice by promoting angiotensin II-mediated AT2 receptor stimulation.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Calcitonin Gene-Related Peptide; Diterpenes; Ganglia, Spinal; Imidazoles; Male; Mice; Mice, Knockout; Neuroprotective Agents; Pyridines; Ramipril; Receptor, Angiotensin, Type 2; Sensory Receptor Cells; Small Fiber Neuropathy; Substance P; Tetrazoles | 2017 |
Topics: Actins; Albuminuria; Angiotensin II; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cell Movement; Cells, Cultured; Disease Models, Animal; Genotype; Hypertension; Male; Mice; Mutation, Missense; Myosin Heavy Chains; Nephrectomy; Nonmuscle Myosin Type IIA; Podocytes; Primary Cell Culture; Renal Insufficiency, Chronic; Sodium Chloride, Dietary; Stress Fibers; Tetrazoles | 2018 |
Ultrasound-Stimulated Microbubbles Enhance Radiosensitization of Nasopharyngeal Carcinoma.
Topics: Angiotensin II; Animals; Antigens, CD34; Benzimidazoles; Biphenyl Compounds; Carcinoma; Cell Line, Tumor; Cell Proliferation; Cell Survival; Contrast Media; Female; Gamma Rays; Human Umbilical Vein Endothelial Cells; Humans; Mice; Mice, Nude; Microbubbles; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Perindopril; Receptor, Angiotensin, Type 1; Sonication; Tetrazoles | 2018 |
Angiotensin II upregulates CYP4A isoform expression in the rat kidney through angiotensin II type 1 receptor.
Topics: Angiotensin II; Animals; Arachidonic Acid; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cytochrome P-450 CYP4A; Disease Models, Animal; Gene Expression Regulation; Humans; Hydroxyeicosatetraenoic Acids; Hypertension; Kidney; Protein Isoforms; Rats; Receptor, Angiotensin, Type 1; RNA, Messenger; Tetrazoles | 2018 |
[Candesartan inhibits the angiotensin II-induced proliferation and migration of rat thoracic aortic smooth muscle A7r5 cells and its mechanism].
Topics: Angiotensin II; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Cell Line; Cell Movement; Cell Proliferation; Muscle, Smooth, Vascular; Rats; Tetrazoles | 2019 |
ACE (Angiotensin-Converting Enzyme) Inhibition Reverses Vasoconstriction and Impaired Dilation of Pial Collaterals in Chronic Hypertension.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Captopril; Chronic Disease; Collateral Circulation; Hydralazine; Hypertension; Male; Pia Mater; Random Allocation; Rats; Rats, Inbred SHR; Rats, Wistar; Receptor, Angiotensin, Type 1; rho-Associated Kinases; Tetrazoles; Vasoconstriction; Vasodilator Agents; Vasomotor System | 2020 |
Maternal Angiotensin Increases Placental Leptin in Early Gestation via an Alternative Renin-Angiotensin System Pathway: Suggesting a Link to Preeclampsia.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensins; Benzimidazoles; Biphenyl Compounds; Female; Humans; Leptin; Leucyl Aminopeptidase; Placenta; Pre-Eclampsia; Pregnancy; Renin-Angiotensin System; Tetrazoles; Uterine Artery; Vascular Resistance | 2021 |
Autophagy contributes to angiotensin II induced dysfunction of HUVECs.
Topics: Acetophenones; Adenine; Angiotensin II; Animals; Autophagosomes; Autophagy; Autophagy-Related Proteins; Benzimidazoles; Biphenyl Compounds; Decanoic Acids; Human Umbilical Vein Endothelial Cells; Humans; Hydroxy Acids; Models, Biological; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphorylation; Signal Transduction; Sirolimus; Tetrazoles; Time Factors | 2021 |
AT II Receptor Blockade and Renal Denervation: Different Interventions with Comparable Renal Effects?
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Arterial Pressure; Benzimidazoles; Biphenyl Compounds; Denervation; Glomerular Filtration Rate; Heart Rate; Kidney; Male; Rats, Sprague-Dawley; Sodium; Tetrazoles; Water | 2021 |
Angiotensin II Disrupts Neurovascular Coupling by Potentiating Calcium Increases in Astrocytic Endfeet.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Astrocytes; Benzimidazoles; Biphenyl Compounds; Calcium; Calcium Signaling; Cerebrovascular Circulation; Male; Mice, Inbred C57BL; Neurovascular Coupling; Receptor, Angiotensin, Type 1; Tetrazoles; Vasoconstriction | 2021 |
Candesartan Protects Against Cadmium-Induced Hepatorenal Syndrome by Affecting Nrf2, NF-κB, Bax/Bcl-2/Cyt-C, and Ang II/Ang 1-7 Signals.
Topics: Angiotensin II; bcl-2-Associated X Protein; Cadmium; Hepatorenal Syndrome; Humans; NF-E2-Related Factor 2; NF-kappa B | 2023 |
Candesartan Does Not Activate PPARγ and Its Target Genes in Early Gestation Trophoblasts.
Topics: Angiotensin II; Female; Humans; Placenta; Placentation; PPAR gamma; Pregnancy; Receptor, Angiotensin, Type 1; Rosiglitazone; Trophoblasts | 2022 |
Paeonol improves renal and vascular angiotensin II type 1 receptor function via inhibiting oxidative stress in spontaneously hypertensive rats.
Topics: Angiotensin II; Animals; Hypertension; Kidney; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Renin; Vasoconstrictor Agents | 2023 |